BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy11546
(1634 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 213 bits (541), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 108/236 (45%), Positives = 149/236 (63%), Gaps = 10/236 (4%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFY--RAQDDYWVARLGTL 1342
IVGG ++R G+WPW ALY + + CGA+L+S WL+SA HC Y + W A LG L
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQVCGASLVSRDWLVSAAHCVYGRNMEPSKWKAVLG-L 59
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISI--LKMKTPFSNYVRPICLPHPNTP 1400
+ L SP + R I +I+++P Y NDI++ L+MK +++Y++PICLP N
Sbjct: 60 HMASNLTSPQIETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICLPEENQV 119
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF 1460
G +C++ GWG L G D LQE +P++S +C+++ +P Y +TENM CAG+
Sbjct: 120 FPPGRICSIAGWGALIYQGST-ADVLQEADVPLLSNEKCQQQ---MPEYNITENMVCAGY 175
Query: 1461 ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
E GG D+C GDSGGPLMCQE + RW L GVTS GY CA NRPGVY +V + W+
Sbjct: 176 EAGGVDSCQGDSGGPLMCQE-NNRWLLAGVTSFGYQCALPNRPGVYARVPRFTEWI 230
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 202 bits (513), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 105/236 (44%), Positives = 143/236 (60%), Gaps = 10/236 (4%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFY--RAQDDYWVARLGTL 1342
IVGG +A+ G+WPW LY + CGA+L+S WL+SA HC Y + W A LG L
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCVYGRNLEPSKWTAILG-L 59
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISI--LKMKTPFSNYVRPICLPHPNTP 1400
+ L SP R I +I+++P Y NDI++ L+ K +++Y++PI LP N
Sbjct: 60 HMKSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPEENQV 119
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF 1460
G C++ GWG + G D LQE +P++S C+++ +P Y +TENM CAG+
Sbjct: 120 FPPGRNCSIAGWGTVVYQGTT-ADILQEADVPLLSNERCQQQ---MPEYNITENMICAGY 175
Query: 1461 ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
E GG D+C GDSGGPLMCQE + RW L GVTS GY CA NRPGVY +VS + W+
Sbjct: 176 EEGGIDSCQGDSGGPLMCQE-NNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWI 230
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 181 bits (458), Expect = 4e-45, Method: Composition-based stats.
Identities = 97/246 (39%), Positives = 134/246 (54%), Gaps = 23/246 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
I GG +A G WPWQ ++ EG CG +L+S+QW+LSA HCF + + +LG +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
+ S ++ + II HP Y+ G DI++L++ P FS Y+RPI LP N
Sbjct: 61 LDSY--SEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANASF 118
Query: 1402 TDGTLCTVVGWGQLF-EIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR---------- 1450
+G CTV GWG + + + P LQ++++P+IS C LY
Sbjct: 119 PNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNA------LYNIDAKPEEPHF 172
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVS 1510
V E+M CAG+ GG+DAC GDSGGPL C +G W L G+ S G C NRPGVYT S
Sbjct: 173 VQEDMVCAGYVEGGKDACQGDSGGPLSC-PVEGLWYLTGIVSWGDACGARNRPGVYTLAS 231
Query: 1511 NYIPWL 1516
+Y W+
Sbjct: 232 SYASWI 237
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 179 bits (455), Expect = 9e-45, Method: Composition-based stats.
Identities = 92/251 (36%), Positives = 135/251 (53%), Gaps = 16/251 (6%)
Query: 1278 RSMRHSRIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVA 1337
R + RIVGG + LG WPWQ +L +G CG +L+S W+L+A HCF + + ++
Sbjct: 111 RKLPVDRIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCF--PERNRVLS 168
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYV------DAGFINDISILKMKT--PFSNYV 1389
R SP+ + ++ H Y+ NDI+++ + + P + Y+
Sbjct: 169 RWRVFAGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYI 228
Query: 1390 RPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
+P+CLP L DG +CTV GWG G+ LQE ++PIIS C +
Sbjct: 229 QPVCLPAAGQALVDGKICTVTGWGNTQYYGQQ-AGVLQEARVPIISNDVCNGADFYGN-- 285
Query: 1450 RVTENMFCAGFERGGRDACLGDSGGPLMCQEP---DGRWSLMGVTSNGYGCARANRPGVY 1506
++ MFCAG+ GG DAC GDSGGP +C++ RW L G+ S G GCA A +PGVY
Sbjct: 286 QIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVY 345
Query: 1507 TKVSNYIPWLY 1517
TKVS++ W++
Sbjct: 346 TKVSDFREWIF 356
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of An
Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of An
Inhibitory Antibody
Length = 372
Score = 179 bits (454), Expect = 1e-44, Method: Composition-based stats.
Identities = 92/251 (36%), Positives = 135/251 (53%), Gaps = 16/251 (6%)
Query: 1278 RSMRHSRIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVA 1337
R + RIVGG + LG WPWQ +L +G CG +L+S W+L+A HCF + + ++
Sbjct: 111 RKLPVDRIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCF--PERNRVLS 168
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYV------DAGFINDISILKMKT--PFSNYV 1389
R SP+ + ++ H Y+ NDI+++ + + P + Y+
Sbjct: 169 RWRVFAGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYI 228
Query: 1390 RPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
+P+CLP L DG +CTV GWG G+ LQE ++PIIS C +
Sbjct: 229 QPVCLPAAGQALVDGKICTVTGWGNTQYYGQQ-AGVLQEARVPIISNDVCNGADFYGN-- 285
Query: 1450 RVTENMFCAGFERGGRDACLGDSGGPLMCQEP---DGRWSLMGVTSNGYGCARANRPGVY 1506
++ MFCAG+ GG DAC GDSGGP +C++ RW L G+ S G GCA A +PGVY
Sbjct: 286 QIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVY 345
Query: 1507 TKVSNYIPWLY 1517
TKVS++ W++
Sbjct: 346 TKVSDFREWIF 356
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional Structure
Of The Catalytic Domain Of Human Plasma Kallikrein:
Implications For Structure-Based Design Of Protease
Inhibitors
Length = 241
Score = 178 bits (452), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 100/248 (40%), Positives = 148/248 (59%), Gaps = 17/248 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCF-YRAQDDYWVARLG 1340
IVGG N+ G WPWQ +L + Q CG +LI QW+L+A HCF D W G
Sbjct: 1 IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 1341 TLRRG--TKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPH 1396
L TK +P+ Q++ +II+H Y + +DI+++K++ P ++ + +PI LP
Sbjct: 61 ILNLSDITK-DTPFSQIK---EIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPS 116
Query: 1397 PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
T T C V GWG E G + + LQ+V +P+++ EC+KR Y++T+ M
Sbjct: 117 KGDTSTIYTNCWVTGWGFSKEKGEI-QNILQKVNIPLVTNEECQKR---YQDYKITQRMV 172
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ GG+DAC GDSGGPL+C+ +G W L+G+TS G GCAR +PGVYTKV+ Y+ W+
Sbjct: 173 CAGYKEGGKDACKGDSGGPLVCKH-NGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI 231
Query: 1517 YNNMAASE 1524
+S+
Sbjct: 232 LEKTQSSD 239
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity Determinants
At The S1 Site Using An Artificial Ala190 Protease
(ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity Determinants
At The S1 Site Using An Artificial Ala190 Protease
(Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 177 bits (449), Expect = 5e-44, Method: Composition-based stats.
Identities = 90/244 (36%), Positives = 132/244 (54%), Gaps = 16/244 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + LG WPWQ +L +G CG +L+S W+L+A HCF + + ++R
Sbjct: 1 IVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCF--PERNRVLSRWRVFAG 58
Query: 1345 GTKLPSPYEQLRPISKIILHPQYV------DAGFINDISILKMKT--PFSNYVRPICLPH 1396
SP+ + ++ H Y+ NDI+++ + + P + Y++P+CLP
Sbjct: 59 AVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPA 118
Query: 1397 PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
L DG +CTV GWG G+ LQE ++PIIS C + ++ MF
Sbjct: 119 AGQALVDGKICTVTGWGNTQYYGQQ-AGVLQEARVPIISNDVCNGADFYGN--QIKPKMF 175
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEP---DGRWSLMGVTSNGYGCARANRPGVYTKVSNYI 1513
CAG+ GG DAC GDSGGP +C++ RW L G+ S G GCA A +PGVYTKVS++
Sbjct: 176 CAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFR 235
Query: 1514 PWLY 1517
W++
Sbjct: 236 EWIF 239
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 177 bits (448), Expect = 5e-44, Method: Composition-based stats.
Identities = 96/246 (39%), Positives = 133/246 (54%), Gaps = 23/246 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
I GG +A G WPWQ ++ EG CG +L+S+QW+LSA HCF + + +LG +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
+ S ++ + II HP Y+ G DI++L++ P FS Y+RPI LP
Sbjct: 61 LDSY--SEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASF 118
Query: 1402 TDGTLCTVVGWGQLF-EIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR---------- 1450
+G CTV GWG + + + P LQ++++P+IS C LY
Sbjct: 119 PNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNS------LYNIDAKPEEPHF 172
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVS 1510
V E+M CAG+ GG+DAC GDSGGPL C +G W L G+ S G C NRPGVYT S
Sbjct: 173 VQEDMVCAGYVEGGKDACQGDSGGPLSC-PVEGLWYLTGIVSWGDACGARNRPGVYTLAS 231
Query: 1511 NYIPWL 1516
+Y W+
Sbjct: 232 SYASWI 237
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With Dffr-
Chloromethyl Ketone Inhibitor
Length = 271
Score = 177 bits (448), Expect = 5e-44, Method: Composition-based stats.
Identities = 96/246 (39%), Positives = 133/246 (54%), Gaps = 23/246 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
I GG +A G WPWQ ++ EG CG +L+S+QW+LSA HCF + + +LG +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
+ S ++ + II HP Y+ G DI++L++ P FS Y+RPI LP
Sbjct: 61 LDSY--SEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASF 118
Query: 1402 TDGTLCTVVGWGQLF-EIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR---------- 1450
+G CTV GWG + + + P LQ++++P+IS C LY
Sbjct: 119 PNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNS------LYNIDAKPEEPHF 172
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVS 1510
V E+M CAG+ GG+DAC GDSGGPL C +G W L G+ S G C NRPGVYT S
Sbjct: 173 VQEDMVCAGYVEGGKDACQGDSGGPLSC-PVEGLWYLTGIVSWGDACGARNRPGVYTLAS 231
Query: 1511 NYIPWL 1516
+Y W+
Sbjct: 232 SYASWI 237
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 176 bits (446), Expect = 9e-44, Method: Compositional matrix adjust.
Identities = 99/248 (39%), Positives = 147/248 (59%), Gaps = 17/248 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCF-YRAQDDYWVARLG 1340
IVGG + G WPWQ +L + Q CG +LI QW+L+A HCF D W G
Sbjct: 1 IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 1341 TLRRG--TKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPH 1396
L TK +P+ Q++ +II+H Y + +DI+++K++ P ++ + +PI LP
Sbjct: 61 ILELSDITK-DTPFSQIK---EIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPS 116
Query: 1397 PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
T T C V GWG E G + + LQ+V +P+++ EC+KR Y++T+ M
Sbjct: 117 KGDTSTIYTNCWVTGWGFSKEKGEI-QNILQKVNIPLVTNEECQKR---YQDYKITQRMV 172
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ GG+DAC GDSGGPL+C+ +G W L+G+TS G GCAR +PGVYTKV+ Y+ W+
Sbjct: 173 CAGYKEGGKDACKGDSGGPLVCKH-NGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI 231
Query: 1517 YNNMAASE 1524
+S+
Sbjct: 232 LEKTQSSD 239
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 170 bits (431), Expect = 5e-42, Method: Composition-based stats.
Identities = 98/244 (40%), Positives = 135/244 (55%), Gaps = 15/244 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ-CGATLISDQWLLSAGHCF-----YRAQD-DYWVA 1337
+VGG +A G WPWQ +L+ G+ CGA+LIS WL+SA HC+ +R D W A
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLP 1395
LG L ++ +P Q R + +II HP + D F DI++L+++ P +S+ VRPICLP
Sbjct: 61 FLG-LHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLP 119
Query: 1396 HPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
+ G V GWG + G LQ+ ++ +I C LP ++T M
Sbjct: 120 DASHVFPAGKAIWVTGWGHT-QYGGTGALILQKGEIRVIQQTTCEN---LLP-QQITPRM 174
Query: 1456 FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPW 1515
C GF GG D+C GDSGGPL E DGR GV S G GCA+ N+PGVYT++ + W
Sbjct: 175 MCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDW 234
Query: 1516 LYNN 1519
+ N
Sbjct: 235 IKEN 238
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 169 bits (429), Expect = 9e-42, Method: Compositional matrix adjust.
Identities = 98/241 (40%), Positives = 138/241 (57%), Gaps = 18/241 (7%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG N + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGYNCKDGEVPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVG--D 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P LP P
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPASLP--TAPP 114
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
GT C + GWG G +PD LQ + P++S A+C P ++T NMFC GF
Sbjct: 115 ATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEAS---YP-GKITSNMFCVGFL 170
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D+C GDSGGP++C L GV S G GCA+ N+PGVYTKV NY+ W+ N +A
Sbjct: 171 EGGKDSCQGDSGGPVVCNG-----QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIA 225
Query: 1522 A 1522
A
Sbjct: 226 A 226
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 169 bits (428), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 91/244 (37%), Positives = 136/244 (55%), Gaps = 11/244 (4%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
RIVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY + +
Sbjct: 387 RIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 446
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPN 1398
+ +++ + +II+H QY A DI++LK++T +++ RPICLP
Sbjct: 447 GILNQSEIKED-TSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKG 505
Query: 1399 TPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCA 1458
T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T M CA
Sbjct: 506 DRNVIYTDCWVTGWGYR-KLRDKIQNTLQKAKIPLVTNEECQKR---YRGHKITHKMICA 561
Query: 1459 GFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYN 1518
G+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+ W+
Sbjct: 562 GYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 620
Query: 1519 NMAA 1522
A
Sbjct: 621 KTQA 624
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 166 bits (421), Expect = 7e-41, Method: Compositional matrix adjust.
Identities = 102/245 (41%), Positives = 138/245 (56%), Gaps = 30/245 (12%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLG--- 1340
IVGG R S +QA+L + G CG +LIS W++SA HC+ R Q RLG
Sbjct: 1 IVGGYECRKNSASYQASL-QSGYHFCGGSLISSTWVVSAAHCYKSRIQ-----VRLGEHN 54
Query: 1341 -TLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFS--NYVRPICLPHP 1397
+ GT EQ K+I+HP Y NDI ++K+ P S +YV + LP
Sbjct: 55 IAVNEGT------EQFIDSVKVIMHPSYNSRNLDNDIMLIKLSKPASLNSYVSTVALP-- 106
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
++ + GT C V GWG L +PDTL+ + LPI+S++ C P ++T NMFC
Sbjct: 107 SSCASSGTRCLVSGWGNLSGSSSNYPDTLRCLDLPILSSSSCNSA---YPG-QITSNMFC 162
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLY 1517
AGF GG+D+C GDSGGP++C L GV S GYGCA+ N+PGVYTKV NY W+
Sbjct: 163 AGFMEGGKDSCQGDSGGPVVCNG-----QLQGVVSWGYGCAQRNKPGVYTKVCNYRSWIS 217
Query: 1518 NNMAA 1522
+ M++
Sbjct: 218 STMSS 222
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 164 bits (416), Expect = 3e-40, Method: Compositional matrix adjust.
Identities = 98/241 (40%), Positives = 133/241 (55%), Gaps = 22/241 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG N S P+Q +L G CG +LI++QW++SAGHC+ R Q RLG
Sbjct: 1 IVGGYNCEENSVPYQVSL-NSGYHFCGGSLINEQWVVSAGHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPL 1401
++ EQ +KII HPQY NDI ++K+ + + +V I LP P
Sbjct: 53 HNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLP--TAPP 110
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
GT C + GWG G +PD LQ + P++S A+C ++T NMFC GF
Sbjct: 111 ATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPG----KITSNMFCVGFL 166
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D+C GD+GGP++C L GV S G GCA+ N+PGVYTKV NY+ W+ N +A
Sbjct: 167 EGGKDSCQGDAGGPVVCNG-----QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIA 221
Query: 1522 A 1522
A
Sbjct: 222 A 222
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 164 bits (416), Expect = 3e-40, Method: Compositional matrix adjust.
Identities = 97/239 (40%), Positives = 129/239 (53%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG N S P+Q +L G CG +LI++QW++SAGHC+ R Q RLG
Sbjct: 1 IVGGYNCEENSVPYQVSL-NSGYHFCGGSLINEQWVVSAGHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
++ EQ +KII HPQY NDI ++K+ + R + P P
Sbjct: 53 HNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPAT 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++S A+C ++T NMFC GF G
Sbjct: 113 GTKCLISGWGNTASSGADXPDELQCLDAPVLSQAKCEASYPG----KITSNMFCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L GV S G GCA+ N+PGVYTKV NY+ W+ N +AA
Sbjct: 169 GKDSCQGDSGGPVVCNG-----QLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAA 222
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 164 bits (414), Expect = 4e-40, Method: Compositional matrix adjust.
Identities = 92/246 (37%), Positives = 137/246 (55%), Gaps = 17/246 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY + ++
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVES----PKILR 56
Query: 1342 LRRGTKLPSPYEQ---LRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPH 1396
+ G S ++ + +II+H QY A DI++LK++T +++ RPICLP
Sbjct: 57 VYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPS 116
Query: 1397 PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T M
Sbjct: 117 KGDRNVIYTDCWVTGWG-YRKLRDKIQNTLQKAKIPLVTNEECQKR---YRGHKITHKMI 172
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+ W+
Sbjct: 173 CAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
Query: 1517 YNNMAA 1522
A
Sbjct: 232 LEKTQA 237
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 163 bits (413), Expect = 6e-40, Method: Compositional matrix adjust.
Identities = 93/248 (37%), Positives = 136/248 (54%), Gaps = 21/248 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESP------KI 54
Query: 1342 LRRGTKLPSPYE-----QLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICL 1394
LR + + + E + +II+H QY A DI++LK++T +++ RPICL
Sbjct: 55 LRVYSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICL 114
Query: 1395 PHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTEN 1454
P T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T
Sbjct: 115 PSKGDRNVIYTDCWVTGWG-YRKLRDKIQNTLQKAKIPLVTNEECQKR---YRGHKITHK 170
Query: 1455 MFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
M CAG+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+
Sbjct: 171 MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVD 229
Query: 1515 WLYNNMAA 1522
W+ A
Sbjct: 230 WILEKTQA 237
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The Coagulation
Factor Xia In Complex With Benzamidine (s434a- T475a-k437
Mutant)
Length = 238
Score = 163 bits (413), Expect = 6e-40, Method: Compositional matrix adjust.
Identities = 91/243 (37%), Positives = 135/243 (55%), Gaps = 11/243 (4%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY + + R+ +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPK-ILRVYS 59
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ + +II+H QY A DI++LK++T +++ RPICLP
Sbjct: 60 GILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGD 119
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T M CAG
Sbjct: 120 RNVIYTDCWVTGWG-YRKLRDKIQNTLQKAKIPLVTNEECQKR---YRGHKITHKMICAG 175
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+ W+
Sbjct: 176 YREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
Query: 1520 MAA 1522
A
Sbjct: 235 TQA 237
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 163 bits (412), Expect = 8e-40, Method: Compositional matrix adjust.
Identities = 93/248 (37%), Positives = 136/248 (54%), Gaps = 21/248 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESP------KI 54
Query: 1342 LRRGTKLPSPYE-----QLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICL 1394
LR + + + E + +II+H QY A DI++LK++T +++ RPICL
Sbjct: 55 LRVYSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICL 114
Query: 1395 PHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTEN 1454
P T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T
Sbjct: 115 PSKGDRNVIYTDCWVTGWGYRALRDKI-QNTLQKAKIPLVTNEECQKR---YRGHKITHK 170
Query: 1455 MFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
M CAG+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+
Sbjct: 171 MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVD 229
Query: 1515 WLYNNMAA 1522
W+ A
Sbjct: 230 WILEKTQA 237
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 162 bits (411), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 119/340 (35%), Positives = 164/340 (48%), Gaps = 40/340 (11%)
Query: 1204 DLNEIEAVADPSTDDSIYYELSMNAINSSAATKSALLFQKTKCSQKQVVAVNCSSLECGI 1263
DLN E + T D + E S AI + AT F +CG+
Sbjct: 89 DLNYCEEAVEEETGDGLD-EDSDRAIEGATATSEYQTFFNP-------ATFGSGEADCGL 140
Query: 1264 RPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGATLISD 1317
RP R + S RIV G +A +G PWQ L+++ E CGA+LISD
Sbjct: 141 RPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISD 200
Query: 1318 QWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDA 1370
+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 201 RWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRE 259
Query: 1371 GFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE-----IGR 1420
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E +G+
Sbjct: 260 NLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK 319
Query: 1421 VFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLM 1477
P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSGGP +
Sbjct: 320 GQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSGGPFV 375
Query: 1478 CQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
+ P + RW MG+ S G GC R + G YT V W+
Sbjct: 376 MKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 415
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 162 bits (410), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 93/239 (38%), Positives = 129/239 (53%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG S P+Q +L F CG +LIS+QW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGSHF-CGGSLISEQWVVSAAHCYKTRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
K+ EQ +KII HP+Y NDI ++K+ +P R + P P
Sbjct: 53 HNIKVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPPAA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +PD L+ + P+++ AEC+ ++T +MFC GF G
Sbjct: 113 GTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPG----KITNSMFCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C D+GGP++C L GV S G+GCA NRPGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDSCQRDAGGPVVCNG-----QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAA 222
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 162 bits (410), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 94/239 (39%), Positives = 128/239 (53%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG S P+Q +L F CG +LIS+QW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGSHF-CGGSLISEQWVVSAAHCYKTRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
K+ EQ KII HP+Y NDI ++K+ +P R + P P
Sbjct: 53 HNIKVLEGNEQFINAVKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPPAA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +PD L+ + P+++ AEC+ ++T +MFC GF G
Sbjct: 113 GTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPG----KITNSMFCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C DSGGP++C L GV S G+GCA NRPGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDSCQRDSGGPVVCNG-----QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAA 222
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 161 bits (407), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 93/239 (38%), Positives = 129/239 (53%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG S P+Q +L G CG +LIS+QW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGYHFCGGSLISEQWVVSAAHCYKTRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
K+ EQ +KII HP+Y NDI ++K+ +P R + P P
Sbjct: 53 HNIKVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPPAA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +PD L+ + P+++ AEC+ ++T +MFC GF G
Sbjct: 113 GTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPG----KITNSMFCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C D+GGP++C L GV S G+GCA NRPGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDSCQRDAGGPVVCNG-----QLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAA 222
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With Clavatadine
A
Length = 238
Score = 160 bits (405), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 91/246 (36%), Positives = 136/246 (55%), Gaps = 17/246 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY + ++
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVES----PKILR 56
Query: 1342 LRRGTKLPSPYEQ---LRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPH 1396
+ G S ++ + +II+H QY A DI++LK++T +++ RPI LP
Sbjct: 57 VYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPS 116
Query: 1397 PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T M
Sbjct: 117 KGERNVIYTDCWVTGWG-YRKLRDKIQNTLQKAKIPLVTNEECQKR---YRGHKITHKMI 172
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+ W+
Sbjct: 173 CAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
Query: 1517 YNNMAA 1522
A
Sbjct: 232 LEKTQA 237
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 160 bits (405), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 89/243 (36%), Positives = 134/243 (55%), Gaps = 11/243 (4%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY + +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ +++ + +II+H QY A DI++LK++T +++ RPI LP
Sbjct: 61 ILNQSEIAED-TSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGD 119
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T M CAG
Sbjct: 120 RNVIYTDCWVTGWG-YRKLRDKIQNTLQKAKIPLVTNEECQKR---YRGHKITHKMICAG 175
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+ W+
Sbjct: 176 YREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
Query: 1520 MAA 1522
A
Sbjct: 235 TQA 237
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 160 bits (405), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 92/239 (38%), Positives = 129/239 (53%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C + F+ +T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASSSFI----ITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+DAC GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDACQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAA 222
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 160 bits (405), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 89/243 (36%), Positives = 134/243 (55%), Gaps = 11/243 (4%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY + +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ +++ + +II+H QY A DI++LK++T +++ RPI LP
Sbjct: 61 ILNQSEIKED-TSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGD 119
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T M CAG
Sbjct: 120 RNVIYTDCWVTGWG-YRKLRDKIQNTLQKAKIPLVTNEECQKR---YRGHKITHKMICAG 175
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+ W+
Sbjct: 176 YREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
Query: 1520 MAA 1522
A
Sbjct: 235 TQA 237
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 160 bits (404), Expect = 6e-39, Method: Compositional matrix adjust.
Identities = 90/238 (37%), Positives = 129/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+ST+ C+ P ++T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSTSSCKSA---YP-GQITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide Groups
In Trypsin, Trypsinogen And Its Complexes With Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen. Chemical
Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide Groups
In Trypsin, Trypsinogen And Its Complexes With Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal Structure
Of The Ternary Complex Formed By Bovine Trypsinogen,
Valine-valine And The Arg15 Analogue Of Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen. Chemical
Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen. Chemical
Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen. Chemical
Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A Factor
In The Inactivity Of Trypsinogen, A Serine Protease
Zymogen. Structure Of Dfp Inhibited Bovine Trypsinogen At
2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen. Chemical
Labelling And Low-Temperature Crystallography
Length = 229
Score = 160 bits (404), Expect = 7e-39, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 129/239 (53%), Gaps = 16/239 (6%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
+IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 6 KIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--E 58
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ SK I+HP Y NDI ++K+K+ S R + P + +
Sbjct: 59 DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA 118
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ G
Sbjct: 119 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEG 174
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 175 GKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 228
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 160 bits (404), Expect = 7e-39, Method: Compositional matrix adjust.
Identities = 90/243 (37%), Positives = 134/243 (55%), Gaps = 11/243 (4%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY + + R+ +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPK-ILRVYS 59
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ + +II+H QY A DI++LK++T +++ RPI LP
Sbjct: 60 GILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGD 119
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T M CAG
Sbjct: 120 RNVIYTDCWVTGWG-YRKLRDKIQNTLQKAKIPLVTNEECQKR---YRGHKITHKMICAG 175
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+ W+
Sbjct: 176 YREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
Query: 1520 MAA 1522
A
Sbjct: 235 TQA 237
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With Alpha-Ketothiazole
Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid Methyl
Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-1-
(Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 160 bits (404), Expect = 8e-39, Method: Compositional matrix adjust.
Identities = 90/243 (37%), Positives = 134/243 (55%), Gaps = 11/243 (4%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY + + R+ +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPK-ILRVYS 59
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ + +II+H QY A DI++LK++T +++ RPI LP
Sbjct: 60 GILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGD 119
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T M CAG
Sbjct: 120 RNVIYTDCWVTGWG-YRKLRDKIQNTLQKAKIPLVTNEECQKR---YRGHKITHKMICAG 175
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+ W+
Sbjct: 176 YREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
Query: 1520 MAA 1522
A
Sbjct: 235 TQA 237
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 160 bits (404), Expect = 8e-39, Method: Compositional matrix adjust.
Identities = 92/248 (37%), Positives = 135/248 (54%), Gaps = 21/248 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG + G WPWQ L+ Q CG ++I +QW+L+A HCFY +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESP------KI 54
Query: 1342 LRRGTKLPSPYE-----QLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICL 1394
LR + + + E + +II+H QY A DI++LK++T +++ RPI L
Sbjct: 55 LRVYSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISL 114
Query: 1395 PHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTEN 1454
P T C V GWG ++ +TLQ+ ++P+++ EC+KR +++T
Sbjct: 115 PSKGDRNVIYTDCWVTGWG-YRKLRDKIQNTLQKAKIPLVTNEECQKR---YRGHKITHK 170
Query: 1455 MFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
M CAG+ GG+DAC GDSGGPL C+ + W L+G+TS G GCA+ RPGVYT V Y+
Sbjct: 171 MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVD 229
Query: 1515 WLYNNMAA 1522
W+ A
Sbjct: 230 WILEKTQA 237
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base Copper
(Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base Copper
(Ii) Chelate
Length = 228
Score = 160 bits (404), Expect = 8e-39, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 129/239 (53%), Gaps = 16/239 (6%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
+IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 5 KIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--E 57
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ SK I+HP Y NDI ++K+K+ S R + P + +
Sbjct: 58 DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA 117
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ G
Sbjct: 118 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEG 173
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 174 GKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 227
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of Thrombin
Length = 287
Score = 159 bits (403), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 106/284 (37%), Positives = 149/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 2 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 61
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ + E++ + KI +HP+Y
Sbjct: 62 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYEANIEKISMLEKIYIHPRY 120
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 121 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 180
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSG
Sbjct: 181 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSG 236
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 237 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 280
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti (Aprotinin)
Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti (Aprotinin)
Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 159 bits (403), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 98/247 (39%), Positives = 136/247 (55%), Gaps = 15/247 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ-CGATLISDQWLLSAGHCF-----YRAQD-DYWVA 1337
+VGG +A G WPWQ +L+ G+ CGA+LIS WL+SA HC+ +R D W A
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLP 1395
LG L ++ +P Q R + +II HP + D F DI++L+++ P +S+ VRPICLP
Sbjct: 61 FLG-LHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLP 119
Query: 1396 HPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
+ G V GWG + G LQ+ ++ +I+ C LP ++T M
Sbjct: 120 DASHVFPAGKAIWVTGWGHT-QYGGTGALILQKGEIRVINQTTCEN---LLP-QQITPRM 174
Query: 1456 FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPW 1515
C GF GG D+C GDSGGPL E DGR GV S G GCA+ N+PGVYT++ + W
Sbjct: 175 MCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDW 234
Query: 1516 LYNNMAA 1522
+ N
Sbjct: 235 IKENTGV 241
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 159 bits (401), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 129/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YPG-QITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 159 bits (401), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 106/284 (37%), Positives = 148/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 8 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 67
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 68 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRY 126
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 127 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 186
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSG
Sbjct: 187 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSG 242
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 243 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 286
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 159 bits (401), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 129/239 (53%), Gaps = 16/239 (6%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
+IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 14 KIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--E 66
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ SK I+HP Y NDI ++K+K+ S R + P + +
Sbjct: 67 DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA 126
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ G
Sbjct: 127 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEG 182
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 183 GKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 236
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 158 bits (400), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 106/284 (37%), Positives = 148/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 2 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 61
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 62 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRY 120
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 121 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 180
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSG
Sbjct: 181 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSG 236
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 237 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 280
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 158 bits (400), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 106/284 (37%), Positives = 148/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 2 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 61
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 62 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRY 120
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 121 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 180
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSG
Sbjct: 181 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSG 236
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 237 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 280
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 158 bits (400), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 101/257 (39%), Positives = 144/257 (56%), Gaps = 26/257 (10%)
Query: 1284 RIVGGGNARLGSWPWQAALYKE-----GE-FQCGATLISDQWLLSAGHCFY-RAQDDYWV 1336
RI GG A + S PWQAA++ + GE F CG LIS W+LSA HCF R +
Sbjct: 13 RIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLT 72
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFS------NYVR 1390
LG R +P EQ + K I+H ++ D + NDI++L++K+ S + VR
Sbjct: 73 VILGRTYR--VVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVR 130
Query: 1391 PICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR 1450
+CLP + L D T C + G+G+ + + + L+E + + ++ C + L L R
Sbjct: 131 TVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHL---LNR 187
Query: 1451 -VTENMFCAGFERGG------RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRP 1503
VT+NM CAG R G DAC GDSGGPL+C DGR +L+G+ S G GC + + P
Sbjct: 188 TVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLN-DGRMTLVGIISWGLGCGQKDVP 246
Query: 1504 GVYTKVSNYIPWLYNNM 1520
GVYTKV+NY+ W+ +NM
Sbjct: 247 GVYTKVTNYLDWIRDNM 263
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations, X-Ray
Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations, X-ray
Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations, X-Ray
Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations, X-Ray
Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 158 bits (400), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 129/239 (53%), Gaps = 16/239 (6%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
+IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 20 KIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--E 72
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ SK I+HP Y NDI ++K+K+ S R + P + +
Sbjct: 73 DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA 132
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ G
Sbjct: 133 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEG 188
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 189 GKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 242
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties At
P1
Length = 288
Score = 158 bits (400), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 106/284 (37%), Positives = 148/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 2 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 61
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 62 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRY 120
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 121 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 180
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSG
Sbjct: 181 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSG 236
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 237 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 280
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 158 bits (400), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 106/284 (37%), Positives = 148/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 4 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 63
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 64 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRY 122
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 123 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 182
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSG
Sbjct: 183 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSG 238
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 239 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 282
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor At
1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 158 bits (399), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 106/284 (37%), Positives = 148/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 1 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 60
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 61 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRY 119
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 120 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 179
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSG
Sbjct: 180 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSG 235
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 236 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 279
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 158 bits (399), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 106/284 (37%), Positives = 148/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 8 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 67
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 68 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRY 126
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 127 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 186
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSG
Sbjct: 187 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSG 242
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 243 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 286
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 158 bits (399), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 106/284 (37%), Positives = 148/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 4 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 63
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 64 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRY 122
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 123 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 182
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSG
Sbjct: 183 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSG 238
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 239 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 282
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In Complex
With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 158 bits (399), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 128/238 (53%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 158 bits (399), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 105/284 (36%), Positives = 148/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 21 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 80
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 81 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRY 139
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 140 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 199
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GD+G
Sbjct: 200 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDAG 255
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 256 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 299
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk Type
Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide Groups
In Trypsin, Trypsinogen And Its Complexes With Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide Groups
In Trypsin, Trypsinogen And Its Complexes With Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors With
The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine Beta-
Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine Beta-
Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine Beta-
Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine Beta-
Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine Beta-
Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine Beta-
Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine Beta-
Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine Beta-
Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin 7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin 7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid (zk-
806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine Beta-
Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash Family
At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3 A
Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine Pancreatic
Trypsin At 105k To 1.21a Resolution From Laboratory
Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites Of
Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin And
A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser, Cys38->ser)
In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type Serineprotease
Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine At
High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide Groups
In Trypsin, Trypsinogen And Its Complexes With Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide Groups
In Trypsin, Trypsinogen And Its Complexes With Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen. Chemical
Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide Groups
In Trypsin, Trypsinogen And Its Complexes With Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen. Chemical
Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A Multi-
Centered Short Hydrogen Bonding Network At The Active
Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A Multi-
Centered Short Hydrogen Bonding Network At The Active
Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A Multi-
Centered Short Hydrogen Bonding Network At The Active
Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A Multi-
Centered Short Hydrogen Bonding Network At The Active
Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A Multi-
Centered Short Hydrogen Bonding Network At The Active
Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A Multi-
Centered Short Hydrogen Bonding Network At The Active
Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A Multi-
Centered Short Hydrogen Bonding Network At The Active
Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An Engineered
Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An Engineered
Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown Snake
Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin
Benzamidines Diminazene And Pentamidine By X-Ray
Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin
Benzamidines Diminazene And Pentamidine By X-Ray
Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin
Benzamidines Diminazene And Pentamidine By X-Ray
Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin
Benzamidines Diminazene And Pentamidine By X-Ray
Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin
Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin
Benzamidines Diminazene And Pentamidine By X-Ray
Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin
Benzamidines Diminazene And Pentamidine By X-Ray
Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant Tryp
Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With Pre-Synthesized
(E)-2-(4- Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With Pre-Synthesized
(E)-4-((2- Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine Protease
Inhibitor-1 From The Caribbean Sea Anemone Stichodactyla
Helianthus In Complex With Bovine Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With 2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With 4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With Cycloheptanamine
(F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported Tetragonal
Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In Trypsin
At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 157 bits (398), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 128/238 (53%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 157 bits (398), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 100/255 (39%), Positives = 139/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHCF-YRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+PG YT V W+
Sbjct: 236 KPGFYTHVFRLKKWI 250
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 157 bits (398), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 105/284 (36%), Positives = 148/284 (52%), Gaps = 32/284 (11%)
Query: 1260 ECGIRPQANNIWGSVNLTRSMRHS----RIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP R + S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 3 DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGAS 62
Query: 1314 LISDQWLLSAGHC-FYRAQDDYW-----VARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D + + R+G R T+ E++ + KI +HP+Y
Sbjct: 63 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRY 121
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI+++K+K P FS+Y+ P+CLP T L G V GWG L E
Sbjct: 122 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 181
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSG 1473
+G+ P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GD+G
Sbjct: 182 NVGKGQPSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDAG 237
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 238 GPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 281
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 157 bits (398), Expect = 4e-38, Method: Composition-based stats.
Identities = 94/248 (37%), Positives = 136/248 (54%), Gaps = 23/248 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG A WPWQ +L G + CG +LI QW+L+A HC D L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKD-----LAA 55
Query: 1342 LRRGTKLPSPY--EQLRPISKIILHPQYVDAGFINDISILKMKTPF--SNYVRPICLPHP 1397
LR + Y +QL P+S+II+HPQ+ A DI++L+++ P S++V + LP
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPA 115
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPD-TLQEVQLPIISTAECRKRTLFLPLYR------ 1450
+ G C V GWG + R+ P L++V++PI+ C + L Y
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAK-YHLGAYTGDDVRI 174
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVS 1510
V ++M CAG R RD+C GDSGGPL+C+ +G W GV S G GCA+ NRPG+YT+V+
Sbjct: 175 VRDDMLCAGNTR--RDSCQGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVT 231
Query: 1511 NYIPWLYN 1518
Y+ W+++
Sbjct: 232 YYLDWIHH 239
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 157 bits (397), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 128/238 (53%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASVSLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCAGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites
Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites
Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites
Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active Sites
Facing A Central Pore
Length = 244
Score = 157 bits (397), Expect = 4e-38, Method: Composition-based stats.
Identities = 94/248 (37%), Positives = 136/248 (54%), Gaps = 23/248 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG A WPWQ +L G + CG +LI QW+L+A HC D L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKD-----LAA 55
Query: 1342 LRRGTKLPSPY--EQLRPISKIILHPQYVDAGFINDISILKMKTPF--SNYVRPICLPHP 1397
LR + Y +QL P+S+II+HPQ+ A DI++L+++ P S++V + LP
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPA 115
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPD-TLQEVQLPIISTAECRKRTLFLPLYR------ 1450
+ G C V GWG + R+ P L++V++PI+ C + L Y
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAK-YHLGAYTGDDVRI 174
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVS 1510
V ++M CAG R RD+C GDSGGPL+C+ +G W GV S G GCA+ NRPG+YT+V+
Sbjct: 175 VRDDMLCAGNTR--RDSCQGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVT 231
Query: 1511 NYIPWLYN 1518
Y+ W+++
Sbjct: 232 YYLDWIHH 239
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 157 bits (397), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 90/240 (37%), Positives = 128/240 (53%), Gaps = 18/240 (7%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTL 1342
+IVGG S P+Q +L F CG +LI+ QW++SA HC+ R Q RLG
Sbjct: 8 KIVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQ-----VRLG-- 59
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLT 1402
+ EQ +KII HP + NDI ++K+ +P + R + P +
Sbjct: 60 EHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAA 119
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT C + GWG G +P LQ ++ P++S + C+ P ++T NM C GF
Sbjct: 120 AGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSS---YP-GQITGNMICVGFLE 175
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
GG+D+C GDSGGP++C L G+ S GYGCA+ N+PGVYTKV NY+ W+ +AA
Sbjct: 176 GGKDSCQGDSGGPVVCNG-----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAA 230
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent Non-Peptide
Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent Non-Peptide
Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent Non-Peptide
Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent Non-Peptide
Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 157 bits (396), Expect = 5e-38, Method: Composition-based stats.
Identities = 94/248 (37%), Positives = 136/248 (54%), Gaps = 23/248 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG A WPWQ +L G + CG +LI QW+L+A HC D L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKD-----LAA 55
Query: 1342 LRRGTKLPSPY--EQLRPISKIILHPQYVDAGFINDISILKMKTPF--SNYVRPICLPHP 1397
LR + Y +QL P+S+II+HPQ+ A DI++L+++ P S++V + LP
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPA 115
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPD-TLQEVQLPIISTAECRKRTLFLPLYR------ 1450
+ G C V GWG + R+ P L++V++PI+ C + L Y
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAK-YHLGAYTGDDVRI 174
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVS 1510
V ++M CAG R RD+C GDSGGPL+C+ +G W GV S G GCA+ NRPG+YT+V+
Sbjct: 175 VRDDMLCAGNTR--RDSCQGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVT 231
Query: 1511 NYIPWLYN 1518
Y+ W+++
Sbjct: 232 YYLDWIHH 239
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 157 bits (396), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 100/256 (39%), Positives = 143/256 (55%), Gaps = 26/256 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKE-----GE-FQCGATLISDQWLLSAGHCFY-RAQDDYWVA 1337
I GG A + S PWQAA++ + GE F CG LIS W+LSA HCF R +
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTV 60
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFS------NYVRP 1391
LG R +P EQ + K I+H ++ D + NDI++L++K+ S + VR
Sbjct: 61 ILGRTYR--VVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRT 118
Query: 1392 ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR- 1450
+CLP + L D T C + G+G+ + + + L+E + + ++ C + L L R
Sbjct: 119 VCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHL---LNRT 175
Query: 1451 VTENMFCAGFERGG------RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPG 1504
VT+NM CAG R G DAC GDSGGPL+C DGR +L+G+ S G GC + + PG
Sbjct: 176 VTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLN-DGRMTLVGIISWGLGCGQKDVPG 234
Query: 1505 VYTKVSNYIPWLYNNM 1520
VYTKV+NY+ W+ +NM
Sbjct: 235 VYTKVTNYLDWIRDNM 250
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 157 bits (396), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 90/238 (37%), Positives = 130/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+DAC GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine Trypsin
Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 156 bits (395), Expect = 7e-38, Method: Compositional matrix adjust.
Identities = 90/238 (37%), Positives = 130/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+DAC GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 156 bits (395), Expect = 7e-38, Method: Compositional matrix adjust.
Identities = 100/255 (39%), Positives = 139/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GCAR
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCARKG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And S195a
Trypsin
Length = 243
Score = 156 bits (395), Expect = 8e-38, Method: Composition-based stats.
Identities = 88/240 (36%), Positives = 130/240 (54%), Gaps = 16/240 (6%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
+IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 20 KIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--E 72
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ SK I+HP Y NDI ++K+K+ S R + P + +
Sbjct: 73 DNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA 132
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ G
Sbjct: 133 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEG 188
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
G+D+C GD+GGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A++
Sbjct: 189 GKDSCQGDAGGPVVCSG-----KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 243
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With Small
Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With Small
Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With Small
Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With Small
Molecule Inhibitor
Length = 223
Score = 156 bits (395), Expect = 9e-38, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 130/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+DAC GDSGGP++C L G+ S G GCA+ N+PG+YTKV NY+ W+ +A+
Sbjct: 170 KDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTIAS 222
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex With
Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex With
Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex With
Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex With
Small Molecule Inhibitor
Length = 223
Score = 156 bits (394), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 130/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+DAC GDSGGP++C L G+ S G GCA+ N+PG+YTKV NY+ W+ +A+
Sbjct: 170 KDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGIYTKVCNYVSWIKQTIAS 222
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound Acetate
Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 156 bits (394), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 91/239 (38%), Positives = 131/239 (54%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG S P+Q +L F CG +LI+ QW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P + R + P +
Sbjct: 53 HNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +P LQ ++ P++S + C+ P ++T NM C GF +G
Sbjct: 113 GTECLISGWGNTKSSGSSYPSLLQCLKAPVLSNSSCKSS---YP-GQITGNMICVGFLQG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C +G+ L G+ S GYGCA+ N+PGVYTKV NY+ W+ +AA
Sbjct: 169 GKDSCQGDSGGPVVC---NGQ--LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAA 222
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 156 bits (394), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 127/238 (53%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GD GGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDXGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine Phosphonate
Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 156 bits (394), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 97/244 (39%), Positives = 135/244 (55%), Gaps = 15/244 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ-CGATLISDQWLLSAGHCF-----YRAQD-DYWVA 1337
+VGG +A G WPWQ +L+ G+ CGA+LIS WL+SA HC+ +R D W A
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLP 1395
LG L ++ +P Q R + +II HP + D F DI++L+++ P +S+ VRPI LP
Sbjct: 61 FLG-LHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPISLP 119
Query: 1396 HPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
+ G V GWG + G LQ+ ++ +I+ C LP ++T M
Sbjct: 120 DASHVFPAGKAIWVTGWGHT-QYGGTGALILQKGEIRVINQTTCEN---LLP-QQITPRM 174
Query: 1456 FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPW 1515
C GF GG D+C GDSGGPL E DGR GV S G GCA+ N+PGVYT++ + W
Sbjct: 175 MCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDW 234
Query: 1516 LYNN 1519
+ N
Sbjct: 235 IKEN 238
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 155 bits (393), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 105/284 (36%), Positives = 147/284 (51%), Gaps = 32/284 (11%)
Query: 1260 ECGIRP--QANNIWGSVN--LTRSMRHSRIVGGGNARLGSWPWQAALYKEG--EFQCGAT 1313
+CG+RP + + L S RIV G +A +G PWQ L+++ E CGA+
Sbjct: 21 DCGLRPLFEKKQVQDQTEKELFESYIEGRIVEGQDAEVGLSPWQVMLFRKSPQELLCGAS 80
Query: 1314 LISDQWLLSAGHC-FYRAQD-----DYWVARLGTLRRGTKLPSPYEQLRPISKIILHPQY 1367
LISD+W+L+A HC Y D D + R+G R T+ E++ + KI +HP+Y
Sbjct: 81 LISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSR-TRYERKVEKISMLDKIYIHPRY 139
Query: 1368 -VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTLCTVVGWGQLFE---- 1417
DI++LK+K P S+Y+ P+CLP T L G V GWG E
Sbjct: 140 NWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTT 199
Query: 1418 -IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG-GR--DACLGDSG 1473
+ V P LQ V LP++ C+ T R+T+NMFCAG++ G G+ DAC GDSG
Sbjct: 200 SVAEVQPSVLQVVNLPLVERPVCKASTRI----RITDNMFCAGYKPGEGKRGDACEGDSG 255
Query: 1474 GPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GP + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 256 GPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 299
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 155 bits (393), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 91/239 (38%), Positives = 130/239 (54%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG S P+Q +L F CG +LI+ QW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P + R + P +
Sbjct: 53 HNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVSLPRSCAAA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +P LQ ++ P++S + C+ P ++T NM C GF G
Sbjct: 113 GTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSS---YP-GQITGNMICVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C +G+ L G+ S GYGCA+ N+PGVYTKV NY+ W+ +AA
Sbjct: 169 GKDSCQGDSGGPVVC---NGQ--LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAA 222
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 155 bits (393), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 88/237 (37%), Positives = 127/237 (53%), Gaps = 16/237 (6%)
Query: 1286 VGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRRG 1345
VGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 2 VGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--EDN 54
Query: 1346 TKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDGT 1405
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + GT
Sbjct: 55 INVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGT 114
Query: 1406 LCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGR 1465
C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ GG+
Sbjct: 115 QCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEGGK 170
Query: 1466 DACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor Pathway
Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor Pathway
Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN Inhibitor,
Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN Inhibitor,
Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin, An
Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And Guanidine-
3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With Synthetic
Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 155 bits (392), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 91/239 (38%), Positives = 130/239 (54%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG S P+Q +L F CG +LI+ QW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P + R + P +
Sbjct: 53 HNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +P LQ ++ P++S + C+ P ++T NM C GF G
Sbjct: 113 GTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSS---YP-GQITGNMICVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C +G+ L G+ S GYGCA+ N+PGVYTKV NY+ W+ +AA
Sbjct: 169 GKDSCQGDSGGPVVC---NGQ--LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAA 222
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 155 bits (392), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 96/240 (40%), Positives = 130/240 (54%), Gaps = 15/240 (6%)
Query: 1284 RIVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTL 1342
R+VGG A SWPWQ +L + G CG TLIS +W+L+A HC ++ +
Sbjct: 561 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 620
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTP 1400
+ L P+ Q +S++ L P DI++LK+ +P ++ V P CLP PN
Sbjct: 621 HQEVNL-EPHVQEIEVSRLFLEPTR------KDIALLKLSSPAVITDKVIPACLPSPNYV 673
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF 1460
+ D T C + GWG+ G L+E QLP+I C R FL RV CAG
Sbjct: 674 VADRTECFITGWGET--QGTFGAGLLKEAQLPVIENKVC-NRYEFL-NGRVQSTELCAGH 729
Query: 1461 ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNM 1520
GG D+C GDSGGPL+C E D ++ L GVTS G GCAR N+PGVY +VS ++ W+ M
Sbjct: 730 LAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 788
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala (
Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala (
Ta) In Complex With Eglin C
Length = 223
Score = 155 bits (392), Expect = 2e-37, Method: Composition-based stats.
Identities = 89/239 (37%), Positives = 131/239 (54%), Gaps = 16/239 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
+DAC GD+GGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A++
Sbjct: 170 KDACQGDAGGPVVCSG-----KLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 155 bits (392), Expect = 2e-37, Method: Composition-based stats.
Identities = 89/239 (37%), Positives = 131/239 (54%), Gaps = 16/239 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
+DAC GD+GGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A++
Sbjct: 170 KDACQGDAGGPVVCSG-----KLQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIASN 223
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186, 186a,
186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 155 bits (392), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 100/257 (38%), Positives = 138/257 (53%), Gaps = 32/257 (12%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF-----ERGGRDACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCAR 1499
R+T+NMFCAGF +RG DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGFKVNDTKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 233
Query: 1500 ANRPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 234 KGKYGFYTHVFRLKKWI 250
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 155 bits (392), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 128/238 (53%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 155 bits (392), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 99/250 (39%), Positives = 137/250 (54%), Gaps = 25/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR 1450
LP T L G V GWG L E G+ P LQ V LPI+ C+ T R
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETGQ--PSVLQVVNLPIVERPVCKDSTRI----R 173
Query: 1451 VTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVY 1506
+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R + G Y
Sbjct: 174 ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY 233
Query: 1507 TKVSNYIPWL 1516
T V W+
Sbjct: 234 THVFRLKKWI 243
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With Small
Molecule Inhibitor
Length = 223
Score = 155 bits (392), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 130/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +L++ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLLNSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+DAC GDSGGP++C L G+ S G GCA+ N+PG+YTKV NY+ W+ +A+
Sbjct: 170 KDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTIAS 222
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN Thrombin
(Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 155 bits (392), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 155 bits (391), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 91/239 (38%), Positives = 130/239 (54%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG S P+Q +L F CG +LI+ QW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCAANSVPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P + R + P +
Sbjct: 53 HNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +P LQ ++ P++S + C+ P ++T NM C GF G
Sbjct: 113 GTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSA---YP-GQITGNMICVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C +G+ L G+ S GYGCA+ N+PGVYTKV NY+ W+ +AA
Sbjct: 169 GKDSCQGDSGGPVVC---NGQ--LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAA 222
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small Molecules
Occupying The S1 Pocket
Length = 252
Score = 155 bits (391), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 99/250 (39%), Positives = 137/250 (54%), Gaps = 25/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR 1450
LP T L G V GWG L E G+ P LQ V LPI+ C+ T R
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKEKGQ--PSVLQVVNLPIVERPVCKDSTRI----R 173
Query: 1451 VTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVY 1506
+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R + G Y
Sbjct: 174 ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY 233
Query: 1507 TKVSNYIPWL 1516
T V W+
Sbjct: 234 THVFRLKKWI 243
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 155 bits (391), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a Thrombin
Complex
Length = 260
Score = 155 bits (391), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 99/256 (38%), Positives = 139/256 (54%), Gaps = 28/256 (10%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW----- 1335
RIV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D +
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 60
Query: 1336 VARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPI 1392
+ R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+
Sbjct: 61 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 119
Query: 1393 CLPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTL 1444
CLP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 179
Query: 1445 FLPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARA 1500
R+T+NMFCAG+ + G R DAC GD+GGP + + P + RW MG+ S G GC R
Sbjct: 180 I----RITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRD 235
Query: 1501 NRPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 GKYGFYTHVFRLKKWI 251
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With Small
Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With Small
Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With Small
Molecule Inhibitor
Length = 223
Score = 155 bits (391), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 129/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+DAC GDSGGP++C L G+ S G GCA+ N+PG YTKV NY+ W+ +A+
Sbjct: 170 KDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIAS 222
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 155 bits (391), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 98/249 (39%), Positives = 135/249 (54%), Gaps = 23/249 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYWVARLGT 1341
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1342 LRRGTKLPSPY----EQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPICL 1394
+R G + Y E++ + KI +HP+Y DI+++K+K P FS+Y+ P+CL
Sbjct: 61 VRIGKHSRTAYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 1395 PHPNTP---LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRV 1451
P T L G V GWG L E G+ P LQ V LPI+ C+ T R+
Sbjct: 121 PDRETAASLLQAGYKGRVTGWGNLKETGQ--PSVLQVVNLPIVERPVCKDSTRI----RI 174
Query: 1452 TENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYT 1507
T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R + G YT
Sbjct: 175 TDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYT 234
Query: 1508 KVSNYIPWL 1516
V W+
Sbjct: 235 HVFRLKKWI 243
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 155 bits (391), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 139/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ + E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 154 bits (390), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 88/237 (37%), Positives = 126/237 (53%), Gaps = 16/237 (6%)
Query: 1286 VGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRRG 1345
VGG + P+Q +L G CG +LI QW++SA HC+ RLG
Sbjct: 2 VGGYTCGANTVPYQVSL-NSGYHFCGGSLIDSQWVVSAAHCYKSGIQ----VRLG--EDN 54
Query: 1346 TKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDGT 1405
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + GT
Sbjct: 55 INVVEGNEQFISASKSIVHPSYDSNTLNNDIMLIKLKSAASLDSRVASISLPTSCASAGT 114
Query: 1406 LCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGR 1465
C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ GG+
Sbjct: 115 QCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEGGK 170
Query: 1466 DACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 154 bits (390), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 139/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ + E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 154 bits (390), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 90/239 (37%), Positives = 126/239 (52%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAA 222
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 154 bits (390), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 89/241 (36%), Positives = 128/241 (53%), Gaps = 18/241 (7%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTL 1342
+IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 10 KIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG-- 61
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLT 1402
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 62 EHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAP 121
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF
Sbjct: 122 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLE 177
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
GG+D+C GD+GGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA
Sbjct: 178 GGKDSCQGDAGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAA 232
Query: 1523 S 1523
+
Sbjct: 233 N 233
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 154 bits (390), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYWV----- 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 154 bits (389), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 95/237 (40%), Positives = 130/237 (54%), Gaps = 15/237 (6%)
Query: 1283 SRIVGGGNARLGSWPWQAAL-YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
R+VGG A SWPWQ +L + G+ CG TLIS +W+L+A HC ++ +
Sbjct: 15 GRVVGGCVAHPHSWPWQVSLRTRFGQHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 74
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ L P+ Q +S++ L P DI++LK+ +P ++ V P CLP PN
Sbjct: 75 AHQEVNL-EPHVQEIEVSRLFLEPTR------KDIALLKLSSPAVITDKVIPACLPSPNY 127
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ D T C + GWG+ G L+E QLP+I C R FL RV CAG
Sbjct: 128 MVADRTECFITGWGE--TQGTFGAGLLKEAQLPVIENKVC-NRYEFLN-GRVQSTELCAG 183
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
GG D+C GDSGGPL+C E D ++ L GVTS G GCAR N+PGVY +VS ++ W+
Sbjct: 184 HLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWI 239
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 154 bits (389), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 90/239 (37%), Positives = 126/239 (52%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAA 222
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 154 bits (389), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 96/241 (39%), Positives = 130/241 (53%), Gaps = 15/241 (6%)
Query: 1283 SRIVGGGNARLGSWPWQAAL-YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
R+VGG A SWPWQ +L + G CG TLIS +W+L+A HC ++ +
Sbjct: 16 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 75
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ L P+ Q +S++ L P DI++LK+ +P ++ V P CLP PN
Sbjct: 76 AHQEVNL-EPHVQEIEVSRLFLEPTR------KDIALLKLSSPAVITDKVIPACLPSPNY 128
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ D T C + GWG+ G L+E QLP+I C R FL RV CAG
Sbjct: 129 VVADRTECFITGWGE--TQGTFGAGLLKEAQLPVIENKVC-NRYEFLN-GRVQSTELCAG 184
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
GG D+C GDSGGPL+C E D ++ L GVTS G GCAR N+PGVY +VS ++ W+
Sbjct: 185 HLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 243
Query: 1520 M 1520
M
Sbjct: 244 M 244
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 154 bits (389), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 92/242 (38%), Positives = 129/242 (53%), Gaps = 22/242 (9%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTL 1342
+IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 22 KIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG-- 73
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTP 1400
+ EQ +KII HP + NDI ++K+ +P + +V + LP P
Sbjct: 74 EHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVALPSSCAP 133
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF 1460
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF
Sbjct: 134 A--GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGF 187
Query: 1461 ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNM 1520
GG+D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +
Sbjct: 188 LEGGKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTI 242
Query: 1521 AA 1522
AA
Sbjct: 243 AA 244
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 154 bits (389), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 96/241 (39%), Positives = 130/241 (53%), Gaps = 15/241 (6%)
Query: 1283 SRIVGGGNARLGSWPWQAAL-YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
R+VGG A SWPWQ +L + G CG TLIS +W+L+A HC ++ +
Sbjct: 19 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 78
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ L P+ Q +S++ L P DI++LK+ +P ++ V P CLP PN
Sbjct: 79 AHQEVNL-EPHVQEIEVSRLFLEPTR------KDIALLKLSSPAVITDKVIPACLPSPNY 131
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ D T C + GWG+ G L+E QLP+I C R FL RV CAG
Sbjct: 132 VVADRTECFITGWGE--TQGTFGAGLLKEAQLPVIENKVC-NRYEFLN-GRVQSTELCAG 187
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
GG D+C GDSGGPL+C E D ++ L GVTS G GCAR N+PGVY +VS ++ W+
Sbjct: 188 HLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 246
Query: 1520 M 1520
M
Sbjct: 247 M 247
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 154 bits (389), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 154 bits (389), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 90/240 (37%), Positives = 127/240 (52%), Gaps = 18/240 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 11 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 62
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 63 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPA 122
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 123 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 178
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
G+D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA+
Sbjct: 179 GKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 233
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 154 bits (389), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 90/239 (37%), Positives = 127/239 (53%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAA 222
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 154 bits (389), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGKGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 154 bits (389), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 129/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 154 bits (389), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KIGFYTHVFRLKKWI 250
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor With
Human Thrombin And A C-Terminal Hirudin Derived Exo-Sit
Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 154 bits (388), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of The
Binding To Human Thrombin Of Four Active Site-directed
Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of The
Binding To Human Thrombin Of Four Active Site-Directed
Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of The
Binding To Human Thrombin Of Four Active Site-Directed
Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of The
Binding To Human Thrombin Of Four Active Site-Directed
Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin And
Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2
And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin And
Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2
And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And Bovine
Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And Bovine
Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And Human
Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin Derivatives
And Human Alpha-Thrombin Due To Different Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin Derivatives
And Human Alpha-Thrombin Due To Different Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer Oligonucleotide
Ggttggtgtggttgg (based On Nmr Model Of Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer Oligonucleotide
Ggttggtgtggttgg (Based On X-Ray Model Of Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1- Oxopropyl]-2-Pyrrolidinyl]
Methyl]butanamide (Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel P1
Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite Inhibitor
Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv Complex
Reveals A Novel Specificity Site Recognition Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With 5-
Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The Enzyme-Substrate
Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The Enzyme-Substrate
Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type Inhibitor
And A C- Terminal Hirudin Derived Exo-Site Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity Determinants
At The S1 Site Using An Artificial Ala190 Protease
(Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound To
Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound To
Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin In
The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin In
The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small Molecules
Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672
For Processing At The Heavy Chain-B Domain Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672
For Processing At The Heavy Chain-B Domain Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A Thrombin
Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672
For Processing At The Heavy Chain-B Domain Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672
For Processing At The Heavy Chain-B Domain Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672
For Processing At The Heavy Chain-B Domain Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672
For Processing At The Heavy Chain-B Domain Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha Thrombin
And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights Of
A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha Thrombin
And Thrombin Binding Aptamer In The Presence Of Sodium
Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha Thrombin
And Thrombin Binding Aptamer In The Presence Of Potassium
Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin Through
A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin Through
A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 154 bits (388), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A (ONE
Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A (TWO
Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A (TWO
Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 154 bits (388), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 101/257 (39%), Positives = 136/257 (52%), Gaps = 32/257 (12%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMK--TPFSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI++LK+K PFS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E I + P LQ V LPI+ C+ T
Sbjct: 120 LPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRI 179
Query: 1446 LPLYRVTENMFCAGF-----ERGGRDACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCAR 1499
R+T+NMFCAGF +RG DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGFKVNDTKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDR 233
Query: 1500 ANRPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 234 KGKYGFYTHVFRLKRWI 250
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of Murine
Thrombin
Length = 259
Score = 154 bits (388), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 137/255 (53%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E I + P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 154 bits (388), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 90/239 (37%), Positives = 126/239 (52%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAA 222
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In Complex
With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti Variant
(Tyr35- >gly)
Length = 224
Score = 154 bits (388), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 128/239 (53%), Gaps = 17/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFS-NYVRPICLPHPNTPLTD 1403
+ EQ SK I+HP Y NDI ++K+K+ S R + P + +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXDSRVASISLPTSCASA 113
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG+ G
Sbjct: 114 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGYLEG 169
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 GKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 223
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa, Ser190ALA190
PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa, Ser190/ala190
Protease, Structure-based Drug Design
Length = 258
Score = 154 bits (388), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 154 bits (388), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KFGFYTHVFRLKKWI 250
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With Small
Molecule Inhibitor
Length = 223
Score = 154 bits (388), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 129/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PG YTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIAS 222
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 154 bits (388), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 126/238 (52%), Gaps = 18/238 (7%)
Query: 1286 VGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLRR 1344
VGG S P+Q +L F CG +LI+ QW++SA HC+ R Q RLG
Sbjct: 2 VGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQ-----VRLG--EH 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ +KII HP + NDI ++K+ +P + R + P + G
Sbjct: 54 NIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +P LQ ++ P++S + C+ P ++T NM C GF GG
Sbjct: 114 TECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSS---YP-GQITGNMICVGFLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S GYGCA+ N+PGVYTKV NY+ W+ +AA
Sbjct: 170 KDSCQGDSGGPVVCNG-----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAA 222
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With Small
Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With Small
Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With Small
Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With Small
Molecule Inhibitor
Length = 223
Score = 153 bits (387), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 129/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+DAC GDSGGP++C L G+ S G GCA+ N+PG YTK+ NY+ W+ +A+
Sbjct: 170 KDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKLCNYVSWIKQTIAS 222
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 153 bits (387), Expect = 6e-37, Method: Composition-based stats.
Identities = 88/239 (36%), Positives = 130/239 (54%), Gaps = 16/239 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
+DAC GD+GGP++C L G+ S G GCA+ N+PG YTKV NY+ W+ +A++
Sbjct: 170 KDACQGDAGGPVVCSG-----KLQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIASN 223
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 153 bits (387), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 101/257 (39%), Positives = 136/257 (52%), Gaps = 32/257 (12%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMK--TPFSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI++LK+K PFS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E I + P LQ V LPI+ C+ T
Sbjct: 120 LPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRI 179
Query: 1446 LPLYRVTENMFCAGF-----ERGGRDACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCAR 1499
R+T+NMFCAGF +RG DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGFKVNDTKRG--DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 233
Query: 1500 ANRPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 234 KGKYGFYTHVFRLKAWI 250
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 153 bits (387), Expect = 7e-37, Method: Composition-based stats.
Identities = 88/239 (36%), Positives = 130/239 (54%), Gaps = 16/239 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
+DAC GD+GGP++C L G+ S G GCA+ N+PG YTKV NY+ W+ +A++
Sbjct: 170 KDACQGDAGGPVVCSG-----KLQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIASN 223
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 153 bits (387), Expect = 7e-37, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 128/238 (53%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLXSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFC G+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCVGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+DAC GDSGGP++C L G+ S G GCA+ N+PG YTKV NY+ W+ +A+
Sbjct: 170 KDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIAS 222
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 153 bits (387), Expect = 7e-37, Method: Compositional matrix adjust.
Identities = 95/241 (39%), Positives = 130/241 (53%), Gaps = 15/241 (6%)
Query: 1283 SRIVGGGNARLGSWPWQAAL-YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
R+VGG A SWPWQ +L + G CG TLIS +W+L+A HC ++ +
Sbjct: 18 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 77
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ L P+ Q +S++ L P DI++LK+ +P ++ V P CLP PN
Sbjct: 78 AHQEVNL-EPHVQEIEVSRLFLEPTR------KDIALLKLSSPAVITDKVIPACLPSPNY 130
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ D T C + GWG+ G L+E QLP+I C R FL RV CAG
Sbjct: 131 VVADRTECFITGWGE--TQGTFGAGLLKEAQLPVIENKVC-NRYEFLN-GRVQSTELCAG 186
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
GG D+C GD+GGPL+C E D ++ L GVTS G GCAR N+PGVY +VS ++ W+
Sbjct: 187 HLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 245
Query: 1520 M 1520
M
Sbjct: 246 M 246
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 153 bits (387), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 90/239 (37%), Positives = 126/239 (52%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAA 222
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 153 bits (387), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 95/241 (39%), Positives = 130/241 (53%), Gaps = 15/241 (6%)
Query: 1283 SRIVGGGNARLGSWPWQAAL-YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
R+VGG A SWPWQ +L + G CG TLIS +W+L+A HC ++ +
Sbjct: 19 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 78
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ L P+ Q +S++ L P DI++LK+ +P ++ V P CLP PN
Sbjct: 79 AHQEVNL-EPHVQEIEVSRLFLEPTR------KDIALLKLSSPAVITDKVIPACLPSPNY 131
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ D T C + GWG+ G L+E QLP+I C R FL RV CAG
Sbjct: 132 VVADRTECFITGWGE--TQGTFGAGLLKEAQLPVIENKVC-NRYEFLN-GRVQSTELCAG 187
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
GG D+C GD+GGPL+C E D ++ L GVTS G GCAR N+PGVY +VS ++ W+
Sbjct: 188 HLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 246
Query: 1520 M 1520
M
Sbjct: 247 M 247
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 153 bits (386), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 95/241 (39%), Positives = 130/241 (53%), Gaps = 15/241 (6%)
Query: 1283 SRIVGGGNARLGSWPWQAAL-YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
R+VGG A SWPWQ +L + G CG TLIS +W+L+A HC ++ +
Sbjct: 17 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 76
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ L P+ Q +S++ L P DI++LK+ +P ++ V P CLP PN
Sbjct: 77 AHQEVNL-EPHVQEIEVSRLFLEPTR------KDIALLKLSSPAVITDKVIPACLPSPNY 129
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ D T C + GWG+ G L+E QLP+I C R FL RV CAG
Sbjct: 130 VVADRTECFITGWGE--TQGTFGAGLLKEAQLPVIENKVC-NRYEFLN-GRVQSTELCAG 185
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
GG D+C GD+GGPL+C E D ++ L GVTS G GCAR N+PGVY +VS ++ W+
Sbjct: 186 HLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 244
Query: 1520 M 1520
M
Sbjct: 245 M 245
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 153 bits (386), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 95/241 (39%), Positives = 130/241 (53%), Gaps = 15/241 (6%)
Query: 1283 SRIVGGGNARLGSWPWQAAL-YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
R+VGG A SWPWQ +L + G CG TLIS +W+L+A HC ++ +
Sbjct: 16 GRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILG 75
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ L P+ Q +S++ L P DI++LK+ +P ++ V P CLP PN
Sbjct: 76 AHQEVNL-EPHVQEIEVSRLFLEPTR------KDIALLKLSSPAVITDKVIPACLPSPNY 128
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ D T C + GWG+ G L+E QLP+I C R FL RV CAG
Sbjct: 129 VVADRTECFITGWGE--TQGTFGAGLLKEAQLPVIENKVC-NRYEFLN-GRVQSTELCAG 184
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
GG D+C GD+GGPL+C E D ++ L GVTS G GCAR N+PGVY +VS ++ W+
Sbjct: 185 HLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGV 243
Query: 1520 M 1520
M
Sbjct: 244 M 244
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 153 bits (386), Expect = 9e-37, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 129/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + ++ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSYI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 153 bits (386), Expect = 9e-37, Method: Compositional matrix adjust.
Identities = 99/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGPLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex With
Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 153 bits (386), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 128/238 (53%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y + NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + F+ +T NMFC G+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSFI----ITSNMFCVGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+DAC GDSGGP++C L G+ S G GCA+ N+PG YTKV NY+ W+ +A+
Sbjct: 170 KDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIAS 222
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The Antithrombin-Thrombin-Heparin
Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In Complex
Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In Complex
Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation Domain
Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation Domain
Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With S195a
Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With S195a
Thrombin
Length = 259
Score = 153 bits (386), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 98/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GD+GGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 152 bits (384), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 89/240 (37%), Positives = 127/240 (52%), Gaps = 18/240 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
G+D+C GD+GGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA+
Sbjct: 169 GKDSCQGDAGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 223
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 152 bits (384), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 125/238 (52%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCXKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G PD L+ ++ PI+S + C+ P ++T NMFCAG GG
Sbjct: 114 TQCLISGWGNTKSSGTSXPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGXLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 152 bits (384), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 98/255 (38%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y +I+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 152 bits (383), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 97/254 (38%), Positives = 138/254 (54%), Gaps = 26/254 (10%)
Query: 1287 GGGNARLGSWPWQAALYKE-----GE-FQCGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
GG + S PWQAA++ + GE F CG LIS W+L+A HCF Q+ Y +L
Sbjct: 16 GGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAHCF---QESYLPDQLK 72
Query: 1341 T-LRRGTKL-PSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPF------SNYVRPI 1392
L R ++ P EQ + K I+H ++ D + NDI++L++K+ S+ VR I
Sbjct: 73 VVLGRTYRVKPGEEEQTFKVKKYIVHKEFDDDTYNNDIALLQLKSDSPQCAQESDSVRAI 132
Query: 1393 CLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVT 1452
CLP N L D T C + G+G+ + + L+E + + ++ C + LF VT
Sbjct: 133 CLPEANLQLPDWTECELSGYGKHKSSSPFYSEQLKEGHVRLYPSSRCAPKFLFNK--TVT 190
Query: 1453 ENMFCAGFERGG------RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
NM CAG R G DAC GDSGGPL+C D +L+G+ S G GC + PGVY
Sbjct: 191 NNMLCAGDTRSGEIYPNVHDACQGDSGGPLVCMN-DNHMTLLGIISWGVGCGEKDVPGVY 249
Query: 1507 TKVSNYIPWLYNNM 1520
TKV+NY+ W+ +NM
Sbjct: 250 TKVTNYLGWIRDNM 263
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 152 bits (383), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 129/238 (54%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + ++ +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSWI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 152 bits (383), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 98/255 (38%), Positives = 137/255 (53%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC DSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 152 bits (383), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 100/257 (38%), Positives = 136/257 (52%), Gaps = 32/257 (12%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMK--TPFSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI++LK+K PFS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E I + P LQ V LPI+ C+ T
Sbjct: 120 LPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRI 179
Query: 1446 LPLYRVTENMFCAGF-----ERGGRDACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCAR 1499
R+T+NMFCAGF +RG DAC GD+GGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGFKVNDTKRG--DACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDR 233
Query: 1500 ANRPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 234 KGKYGFYTHVFRLKRWI 250
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 151 bits (382), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 89/240 (37%), Positives = 126/240 (52%), Gaps = 18/240 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
G+D+C GDSGGP++C L G+ GYGCA + PGVYTKV NY+ W+ + +AA+
Sbjct: 169 GKDSCQGDSGGPVVCNG-----ELQGIVEWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 223
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 151 bits (382), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 89/240 (37%), Positives = 126/240 (52%), Gaps = 18/240 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
G+D+C GDSGGP++C L G+ GYGCA + PGVYTKV NY+ W+ + +AA+
Sbjct: 169 GKDSCQGDSGGPVVCNG-----ELQGIVKWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 223
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of Trypsin.
Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of Trypsin.
Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of Trypsin.
Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 151 bits (381), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 126/239 (52%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + N+I ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAA 222
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 151 bits (381), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 98/255 (38%), Positives = 137/255 (53%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCRDDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 151 bits (381), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 89/240 (37%), Positives = 126/240 (52%), Gaps = 18/240 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
G+D+C GD GGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA+
Sbjct: 169 GKDSCQGDCGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 223
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 151 bits (381), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 128/238 (53%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + + +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSAI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 151 bits (381), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 126/239 (52%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + N+I ++K+ +P R + P++
Sbjct: 53 HNINVLEGDEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA
Sbjct: 169 GKDSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAA 222
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 150 bits (380), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 125/238 (52%), Gaps = 18/238 (7%)
Query: 1287 GGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLRRG 1345
GG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--EHN 62
Query: 1346 TKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDGT 1405
+ EQ +KII HP + NDI ++K+ +P R + P++ GT
Sbjct: 63 INVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGT 122
Query: 1406 LCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGR 1465
C + GWG G PD LQ + P++ A+C ++T+NM C GF GG+
Sbjct: 123 QCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEGGK 178
Query: 1466 DACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA+
Sbjct: 179 DSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 231
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 150 bits (380), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 98/250 (39%), Positives = 135/250 (54%), Gaps = 24/250 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR 1450
LP T L G V GWG L E P LQ V LPI+ C+ T R
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWGQ-PSVLQVVNLPIVERPVCKDSTRI----R 174
Query: 1451 VTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVY 1506
+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R + G Y
Sbjct: 175 ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY 234
Query: 1507 TKVSNYIPWL 1516
T V W+
Sbjct: 235 THVFRLKKWI 244
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 150 bits (380), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 125/239 (52%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+ +C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA
Sbjct: 169 GKSSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAA 222
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 150 bits (380), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 88/238 (36%), Positives = 128/238 (53%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ + + +T NMFCAG+ GG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSRI----ITSNMFCAGYLEGG 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
+D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 170 KDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 150 bits (379), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 98/255 (38%), Positives = 137/255 (53%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DAC DSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 150 bits (379), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 95/239 (39%), Positives = 128/239 (53%), Gaps = 15/239 (6%)
Query: 1285 IVGGGNARLGSWPWQAAL-YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
+VGG A SWPWQ +L + G CG TLIS +W+L+A HC ++ +
Sbjct: 18 VVGGCVAYPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAH 77
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
+ L P+ Q +S++ L P DI++LK+ +P ++ V P CLP PN +
Sbjct: 78 QEVNL-EPHVQEIEVSRLFLEPTR------KDIALLKLSSPAVITDKVIPACLPSPNYVV 130
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
D T C + GWG+ G L E QLP+I C R FL RV CAG
Sbjct: 131 ADRTECFITGWGE--TQGTFGAGLLMEAQLPVIENKVC-NRYEFLN-GRVQSTELCAGHL 186
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNM 1520
GG D+C GDSGGPL+C E D ++ L GVTS G GCAR N+PGVY +VS ++ W+ M
Sbjct: 187 AGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 244
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 150 bits (378), Expect = 7e-36, Method: Compositional matrix adjust.
Identities = 97/250 (38%), Positives = 135/250 (54%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR 1450
LP T L G V GWG L + P LQ V LPI+ C+ T R
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNL----KGQPSVLQVVNLPIVERPVCKDSTRI----R 171
Query: 1451 VTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVY 1506
+T+NMFCAG+ + G R DAC GDSGGP + + P + RW MG+ S G GC R + G Y
Sbjct: 172 ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFY 231
Query: 1507 TKVSNYIPWL 1516
T V W+
Sbjct: 232 THVFRLKKWI 241
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of Human
Fibrinogen Bound To Bovine Thrombin At 2.3 Angstroms
Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of Human
Fibrinogen Bound To Bovine Thrombin At 2.3 Angstroms
Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues 7-
19). Three Complexes, One With Epsilon-Thrombin And Two
With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues 7-
19). Three Complexes, One With Epsilon-Thrombin And Two
With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between Bovine
Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between Bovine
Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 150 bits (378), Expect = 8e-36, Method: Compositional matrix adjust.
Identities = 98/255 (38%), Positives = 136/255 (53%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQD-----DYWV 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D D +
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI++LK+K P S+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG E + V P LQ V LP++ C+ T
Sbjct: 120 LPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRI 179
Query: 1446 LPLYRVTENMFCAGFERG-GR--DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG++ G G+ DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 150 bits (378), Expect = 8e-36, Method: Compositional matrix adjust.
Identities = 98/255 (38%), Positives = 136/255 (53%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQD-----DYWV 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D D +
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI++LK+K P S+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG E + V P LQ V LP++ C+ T
Sbjct: 120 LPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRI 179
Query: 1446 LPLYRVTENMFCAGFERG-GR--DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG++ G G+ DAC GDSGGP + + P + RW MG+ S G GC R
Sbjct: 180 ----RITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure Analysis
And Refinement Of A New Crystal Form At 1.8 Angstroms
Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure Analysis
And Refinement Of A New Crystal Form At 1.8 Angstroms
Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between Bovine
ChymotrypsinogenA And Two Recombinant Variants Of Human
Pancreatic Secretory Trypsin Inhibitor (Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between Bovine
ChymotrypsinogenA And Two Recombinant Variants Of Human
Pancreatic Secretory Trypsin Inhibitor (Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A (Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure, Comparison
With Alpha-Chymotrypsin,And Implications For Zymogen
Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine Protease
Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine Protease
Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine Protease
Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine Protease
Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine Protease
Inhibitor-1 From The Caribbean Sea Anemone Stichodactyla
Helianthus In Complex With Bovine Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine Protease
Inhibitor-1 From The Caribbean Sea Anemone Stichodactyla
Helianthus In Complex With Bovine Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine Protease
Inhibitor-1 From The Caribbean Sea Anemone Stichodactyla
Helianthus In Complex With Bovine Chymotrypsin
Length = 245
Score = 150 bits (378), Expect = 8e-36, Method: Composition-based stats.
Identities = 87/247 (35%), Positives = 129/247 (52%), Gaps = 21/247 (8%)
Query: 1283 SRIVGGGNARLGSWPWQAALYKEGEFQ-CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
SRIV G A GSWPWQ +L + F CG +LI++ W+++A HC D V G
Sbjct: 14 SRIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD---VVVAGE 70
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+G+ S Q I+K+ + +Y NDI++LK+ T FS V +CLP +
Sbjct: 71 FDQGSS--SEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASD 128
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY---RVTENMF 1456
GT C GWG PD LQ+ LP++S C+K Y ++ + M
Sbjct: 129 DFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKK-------YWGTKIKDAMI 181
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG G +C+GDSGGPL+C++ +G W+L+G+ S G + PGVY +V+ + W+
Sbjct: 182 CAG--ASGVSSCMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV 238
Query: 1517 YNNMAAS 1523
+AA+
Sbjct: 239 QQTLAAN 245
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 149 bits (376), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 125/238 (52%), Gaps = 18/238 (7%)
Query: 1287 GGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLRRG 1345
GG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--EHN 62
Query: 1346 TKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDGT 1405
+ EQ +KII HP + NDI ++K+ +P R + P++ GT
Sbjct: 63 INVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGT 122
Query: 1406 LCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGR 1465
C + GWG G PD L+ + P++ A+C ++T+NM C GF GG+
Sbjct: 123 QCLISGWGNTLSSGVNEPDLLKCLDAPLLPQADCEASYPG----KITDNMVCVGFLEGGK 178
Query: 1466 DACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
D+C GDSGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA+
Sbjct: 179 DSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 231
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 149 bits (375), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 93/266 (34%), Positives = 141/266 (53%), Gaps = 24/266 (9%)
Query: 1285 IVGGGNARLGSWPWQAAL-----YKEGEFQ-CGATLISDQWLLSAGHCF-YRAQDDYWVA 1337
I+GG +A G+WPW +L + + CG +L++ QWLL+A HCF + + W
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRL 60
Query: 1338 RLGT--LRRGTKLP-SPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFS--NYVRPI 1392
G + GT P P Q R + KII+H +Y + NDI+++K+ P + +++ P
Sbjct: 61 IFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGPG 120
Query: 1393 CLPH-----PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLP 1447
CLP P P T C V GWG L E R LQE ++ +I C +
Sbjct: 121 CLPQFRAGPPRVPQT----CWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRWYNG 176
Query: 1448 LYRVTENMFCAGFERGGRDACLGDSGGPLMCQE-PDGRWSLMGVTSNGYGCARANRPGVY 1506
R+ CAG+ G D C GDSGGPLMC++ + + ++G+TS G GCARA RPGVY
Sbjct: 177 --RIRSTNVCAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVY 234
Query: 1507 TKVSNYIPWLYNNMAASEYNMMRNET 1532
T +Y+ W+ + + ++ +M++ T
Sbjct: 235 TSTWSYLNWIASKIGSTAVHMIQLPT 260
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor (Bpti)
Length = 231
Score = 149 bits (375), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 87/238 (36%), Positives = 125/238 (52%), Gaps = 18/238 (7%)
Query: 1287 GGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLRRG 1345
GG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--EHN 62
Query: 1346 TKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDGT 1405
+ EQ +KII HP + NDI ++K+ +P R + P++ GT
Sbjct: 63 INVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGT 122
Query: 1406 LCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGR 1465
C + GWG G PD LQ + P++ A+C ++T+NM C GF GG+
Sbjct: 123 QCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEGGK 178
Query: 1466 DACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
D+C G+SGGP++C L G+ S GYGCA + PGVYTKV NY+ W+ + +AA+
Sbjct: 179 DSCQGNSGGPVVCNG-----ELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN 231
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 149 bits (375), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 100/259 (38%), Positives = 138/259 (53%), Gaps = 32/259 (12%)
Query: 1285 IVGGGNARLGSWPWQAALYKE-----GE-FQCGATLISDQWLLSAGHC-FYRAQDDYW-- 1335
IV G +A +G PWQ L+ + GE F CGA+LISD+W+L+A HC Y D +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDKNFTE 60
Query: 1336 ---VARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYV 1389
+ R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+
Sbjct: 61 NDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYI 119
Query: 1390 RPICLPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRK 1441
P+CLP T L G V GWG L E +G+ P LQ V LPI+ C+
Sbjct: 120 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKD 179
Query: 1442 RTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGC 1497
T R+T+NMFCA + + G R DAC GDSGGP + + P + RW MG+ S G GC
Sbjct: 180 STRI----RITDNMFCAYYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 235
Query: 1498 ARANRPGVYTKVSNYIPWL 1516
R + G YT V W+
Sbjct: 236 DRDGKYGFYTHVFRLKKWI 254
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 147 bits (372), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 97/255 (38%), Positives = 136/255 (53%), Gaps = 28/255 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE-----IGRVFPDTLQEVQLPIISTAECRKRTLF 1445
LP T L G V GWG L E +G+ P LQ V LPI+ C+ T
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRI 179
Query: 1446 LPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARAN 1501
R+T+NMFCAG+ + G R DA GDSGGP + + P + RW MG+ S G G R
Sbjct: 180 ----RITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGADRDG 235
Query: 1502 RPGVYTKVSNYIPWL 1516
+ G YT V W+
Sbjct: 236 KYGFYTHVFRLKKWI 250
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With The
Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 147 bits (372), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 88/239 (36%), Positives = 124/239 (51%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG + S P+Q +L G CG +LI+DQW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P R + P++
Sbjct: 53 HNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPA 112
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT C + GWG G PD LQ + P++ A+C ++T+NM C GF G
Sbjct: 113 GTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG----KITDNMVCVGFLEG 168
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+ +C GDSGGP++C L G+ S GYGCA + P VYTKV NY+ W+ + +AA
Sbjct: 169 GKGSCQGDSGGPVVCNG-----ELQGIVSWGYGCALPDNPDVYTKVCNYVDWIQDTIAA 222
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 147 bits (370), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 89/238 (37%), Positives = 126/238 (52%), Gaps = 19/238 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCAG E G
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAGLE--G 167
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
D+C GDSGGP++C L G+ S G GCA+ N+PGVYTKV NY+ W+ +A+
Sbjct: 168 GDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAK-NKPGVYTKVCNYVSWIKQTIAS 219
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 147 bits (370), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 91/239 (38%), Positives = 126/239 (52%), Gaps = 21/239 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + S P Q +L G CG +L+++ W++SA HC Y+++ RLG
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHC-YKSRV---AVRLG--EH 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLT 1402
K+ EQ S++I HP Y NDI ++K+ P + YV+P+ LP P
Sbjct: 54 NIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAPA- 112
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT+CTV GWG D LQ + +PI+S ++C + +T MFCAG+
Sbjct: 113 -GTMCTVSGWGNTMS-STADGDKLQCLNIPILSYSDCNNSYPGM----ITNAMFCAGYLE 166
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D+C GDSGGP++C L GV S GYGCA PGVY KV + WL + MA
Sbjct: 167 GGKDSCQGDSGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 220
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 147 bits (370), Expect = 7e-35, Method: Compositional matrix adjust.
Identities = 90/240 (37%), Positives = 128/240 (53%), Gaps = 21/240 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + S P Q +L G CG +L+++ W++SA HC Y+++ + RLG
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHC-YKSRVE---VRLG--EH 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLT 1402
K+ EQ S++I HP Y NDI ++K+ P + YV+P+ LP P
Sbjct: 54 NIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPA- 112
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT+CTV GWG + LQ + +PI+S ++C + +T MFCAG+
Sbjct: 113 -GTMCTVSGWGNTMS-STADSNKLQCLNIPILSYSDCNNSYPGM----ITNAMFCAGYLE 166
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
GG+D+C GDSGGP++C L GV S GYGCA PGVY KV + WL + MA+
Sbjct: 167 GGKDSCQGDSGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMAS 221
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations, X-Ray
Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations, X-Ray
Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations, X-Ray
Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations, X-Ray
Structures And Association Constant Measurements
Length = 242
Score = 147 bits (370), Expect = 7e-35, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 129/241 (53%), Gaps = 21/241 (8%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
+IVGG + S P Q +L G CG +L+++ W++SA HC Y+++ + RLG
Sbjct: 20 KIVGGYECKPYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHC-YKSRVE---VRLG--E 72
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
K+ EQ S++I HP Y NDI ++K+ P + YV+P+ LP P
Sbjct: 73 HNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAP- 131
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
GT+CTV GWG + LQ + +PI+S ++C + +T MFCAG+
Sbjct: 132 -AGTMCTVSGWGNTMS-STADSNKLQCLNIPILSYSDCNNSYPGM----ITNAMFCAGYL 185
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D+C GDSGGP++C L GV S GYGCA PGVY KV + WL + MA
Sbjct: 186 EGGKDSCQGDSGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 240
Query: 1522 A 1522
+
Sbjct: 241 S 241
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 146 bits (369), Expect = 8e-35, Method: Compositional matrix adjust.
Identities = 90/239 (37%), Positives = 127/239 (53%), Gaps = 21/239 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + S P Q +L G CG +L+++ W++SA HC Y+++ + RLG
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHC-YKSRVE---VRLG--EH 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLT 1402
K+ EQ S++I HP Y NDI ++K+ P + YV+P+ LP P
Sbjct: 54 NIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAPA- 112
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT+CTV GWG + LQ + +PI+S ++C + +T MFCAG+
Sbjct: 113 -GTMCTVSGWGNTMS-STADKNKLQCLNIPILSYSDCNNSYPGM----ITNAMFCAGYLE 166
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D+C GDSGGP++C L GV S GYGCA PGVY KV + WL + MA
Sbjct: 167 GGKDSCQGDSGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 220
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 146 bits (368), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 90/239 (37%), Positives = 126/239 (52%), Gaps = 21/239 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + S P Q +L G CG +L+++ W++SA HC Y+ + + RLG
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHC-YKTRVE---VRLG--EH 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLT 1402
K+ EQ S++I HP Y NDI ++K+ P + YV+P+ LP P
Sbjct: 54 NIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAPA- 112
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT+CTV GWG + LQ + +PI+S ++C + +T MFCAG+
Sbjct: 113 -GTMCTVSGWGNTMS-STADKNKLQCLNIPILSYSDCNNSYPGM----ITNAMFCAGYLE 166
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D+C GDSGGP++C L GV S GYGCA PGVY KV + WL + MA
Sbjct: 167 GGKDSCQGDSGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNNWLTSTMA 220
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 146 bits (368), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 90/240 (37%), Positives = 127/240 (52%), Gaps = 21/240 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + S Q +L G CG +L+++ W++SA HC Y+++ + RLG
Sbjct: 1 IVGGYECKAYSQAHQVSL-NSGYHFCGGSLVNENWVVSAAHC-YKSRVE---VRLG--EH 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLT 1402
K+ EQ S++I HP Y NDI ++K+ P + YV+P+ LP P
Sbjct: 54 NIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPA- 112
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT+CTV GWG D LQ + +PI+S ++C + +T MFCAG+
Sbjct: 113 -GTMCTVSGWGNTMS-STADSDKLQCLNIPILSYSDCNDSYPGM----ITNAMFCAGYLE 166
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
GG+D+C GDSGGP++C L GV S GYGCA PGVY KV + WL + MA+
Sbjct: 167 GGKDSCQGDSGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFSDWLTSTMAS 221
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To A
Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To A
Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 145 bits (367), Expect = 1e-34, Method: Composition-based stats.
Identities = 84/242 (34%), Positives = 126/242 (52%), Gaps = 15/242 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ-CGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IV G A GSWPWQ +L + F CG +LI++ W+++A HC D V G
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD---VVVAGEFD 57
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
+G+ S Q I+K+ + +Y NDI++LK+ T FS V +CLP +
Sbjct: 58 QGSS--SEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDF 115
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
GT C GWG PD LQ+ LP++S C+K ++ + M CAG
Sbjct: 116 AAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYW----GTKIKDAMICAG-- 169
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMA 1521
G +C+GDSGGPL+C++ +G W+L+G+ S G + PGVY +V+ + W+ +A
Sbjct: 170 ASGVSSCMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA 228
Query: 1522 AS 1523
A+
Sbjct: 229 AN 230
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 145 bits (367), Expect = 2e-34, Method: Composition-based stats.
Identities = 90/248 (36%), Positives = 133/248 (53%), Gaps = 23/248 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG A WPWQ +L + CG +LI QW+L+A HC D L T
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKD-----LAT 55
Query: 1342 LRRGTKLPSPY--EQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHP 1397
LR + Y +QL P+S+II+HPQ+ DI++L+++ P S+ V + LP
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPA 115
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPD-TLQEVQLPIISTAECRKRTLFLPLYR------ 1450
+ G C V GWG + + P L++V++PI+ C + L Y
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAK-YHLGAYTGDDVRI 174
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVS 1510
+ ++M CAG + RD+C GDSGGPL+C+ +G W GV S G GCA+ NRPG+YT+V+
Sbjct: 175 IRDDMLCAGNSQ--RDSCQGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVT 231
Query: 1511 NYIPWLYN 1518
Y+ W+++
Sbjct: 232 YYLDWIHH 239
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed Inhibitor
(cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 145 bits (367), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 90/240 (37%), Positives = 128/240 (53%), Gaps = 21/240 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + S P Q +L G CG +L+++ W++SA HC Y+++ + RLG
Sbjct: 1 IVGGYECKPYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHC-YKSRVE---VRLG--EH 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLT 1402
K+ EQ S++I HP Y NDI ++K+ P + YV+P+ LP P
Sbjct: 54 NIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPA- 112
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT+CTV GWG + LQ + +PI+S ++C + +T MFCAG+
Sbjct: 113 -GTMCTVSGWGNTMS-STADSNKLQCLNIPILSYSDCNNSYPGM----ITNAMFCAGYLE 166
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
GG+D+C GDSGGP++C L GV S GYGCA PGVY KV + WL + MA+
Sbjct: 167 GGKDSCQGDSGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMAS 221
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I Tryptase
Mutant D216g In Complex With Leupeptin
Length = 245
Score = 145 bits (366), Expect = 2e-34, Method: Composition-based stats.
Identities = 90/248 (36%), Positives = 133/248 (53%), Gaps = 23/248 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG A WPWQ +L + CG +LI QW+L+A HC D L T
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKD-----LAT 55
Query: 1342 LRRGTKLPSPY--EQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHP 1397
LR + Y +QL P+S+II+HPQ+ DI++L+++ P S+ V + LP
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPA 115
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPD-TLQEVQLPIISTAECRKRTLFLPLYR------ 1450
+ G C V GWG + + P L++V++PI+ C + L Y
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAK-YHLGAYTGDDVRI 174
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVS 1510
+ ++M CAG + RD+C GDSGGPL+C+ +G W GV S G GCA+ NRPG+YT+V+
Sbjct: 175 IRDDMLCAGNSQ--RDSCKGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVT 231
Query: 1511 NYIPWLYN 1518
Y+ W+++
Sbjct: 232 YYLDWIHH 239
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A Second
Crystal Form
Length = 237
Score = 145 bits (365), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 89/241 (36%), Positives = 128/241 (53%), Gaps = 21/241 (8%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
+IVGG + S Q +L G CG +L+++ W++SA HC Y+++ + RLG
Sbjct: 15 KIVGGYECKAYSQAHQVSL-NSGYHFCGGSLVNENWVVSAAHC-YKSRVE---VRLG--E 67
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
K+ EQ S++I HP Y NDI ++K+ P + YV+P+ LP P
Sbjct: 68 HNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPA 127
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
GT+CTV GWG + LQ + +PI+S ++C + +T MFCAG+
Sbjct: 128 --GTMCTVSGWGNTMS-STADSNKLQCLNIPILSYSDCNNSYPGM----ITNAMFCAGYL 180
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D+C GDSGGP++C L GV S GYGCA PGVY KV + WL + MA
Sbjct: 181 EGGKDSCQGDSGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 235
Query: 1522 A 1522
+
Sbjct: 236 S 236
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 144 bits (362), Expect = 5e-34, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 126/239 (52%), Gaps = 21/239 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + S P Q +L G CG +L+++ W++SA HC Y+++ + RLG
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHC-YKSRVE---VRLG--EH 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMK--TPFSNYVRPICLPHPNTPLT 1402
K+ EQ S++I HP Y NDI ++K+ + YV+P+ LP P
Sbjct: 54 NIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKSATLNTYVQPVALPSSCAPA- 112
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT+CTV GWG + LQ + +PI+S ++C + +T MFCAG+
Sbjct: 113 -GTMCTVSGWGNTMS-STADKNKLQCLNIPILSYSDCNNSYPGM----ITNAMFCAGYLE 166
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D+C GDSGGP++C L GV S GYGCA PGVY KV + WL + MA
Sbjct: 167 GGKDSCQGDSGGPVVCNG-----ELQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 220
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight Into
Structural Radiation Damage
Length = 223
Score = 144 bits (362), Expect = 5e-34, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 122/238 (51%), Gaps = 16/238 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + P+Q +L G CG +LI+ QW++SA HC+ RLG
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSGIQ----VRLG--ED 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ EQ SK I+HP Y NDI ++K+K+ S R + P + + G
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAG 113
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T C + GWG G +PD L+ ++ PI+S + C+ P ++T NMFCA G
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSA---YP-GQITSNMFCAYGLEGK 169
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
D+C GDSGGP++C L G+ S G GC N+PGVYTKV NY+ W+ +A+
Sbjct: 170 GDSCQGDSGGPVVCSGK-----LQGIVSWGSGCQAKNKPGVYTKVCNYVSWIKQTIAS 222
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 143 bits (361), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 84/235 (35%), Positives = 124/235 (52%), Gaps = 12/235 (5%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDY-WVARLGTLR 1343
IVGG G WPWQA+L +G +CGATLI+ WL+SA HCF ++ W A G
Sbjct: 1 IVGGTEVEEGEWPWQASLQWDGSHRCGATLINATWLVSAAHCFTTYKNPARWTASFGVTI 60
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
+ +K+ R + +II+H +Y DIS+ ++ +P ++N V +CLP +
Sbjct: 61 KPSKMK------RGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLPDASYEF 114
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
G + V G+G L G + L++ Q+ +I C + + +T M CAG
Sbjct: 115 QPGDVMFVTGFGALKNDGYS-QNHLRQAQVTLIDATTCNEPQAYNDA--ITPRMLCAGSL 171
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
G DAC GDSGGPL+ + W L G+ S G CA+ N+PGVYT+V+ W+
Sbjct: 172 EGKTDACQGDSGGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWI 226
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With The
Elastase Inhibitor Gr143783
Length = 241
Score = 143 bits (361), Expect = 7e-34, Method: Composition-based stats.
Identities = 88/247 (35%), Positives = 131/247 (53%), Gaps = 18/247 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ----CGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
+VGG +AR SWPWQ +L + Q CG TL+ W+L+A HC ++ R+
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCISSSR----TYRVV 56
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQYVDAGFIN--DISILKMKTPFS--NYVRPICLPH 1396
R P +SK+++H + N DI++LK+ +P S + ++ CLP
Sbjct: 57 LGRHSLSTNEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQLGCLPA 116
Query: 1397 PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
T L + +C V GWG+L + PD LQ+ QL ++ A C K + V NM
Sbjct: 117 AGTILPNNYVCYVTGWGRL-QTNGASPDILQQGQLLVVDYATCSKPGWWGS--TVKTNMI 173
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG--YGCARANRPGVYTKVSNYIP 1514
CAG + G +C GDSGGPL CQ +G+W + G+ S G GC ++P V+T+VSNYI
Sbjct: 174 CAGGD-GIISSCNGDSGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTRVSNYID 232
Query: 1515 WLYNNMA 1521
W+ + +A
Sbjct: 233 WINSVIA 239
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 143 bits (361), Expect = 7e-34, Method: Composition-based stats.
Identities = 92/244 (37%), Positives = 130/244 (53%), Gaps = 18/244 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG---EFQ-CGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
IVGG +A LG +P+Q + + F CGA++ ++ + ++AGHC Y DDY
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVY--GDDYENPSGL 58
Query: 1341 TLRRG---TKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMK--TPFSNYVRPICLP 1395
+ G + EQ+ +SKIILH + NDIS+LK+ F++ V PI LP
Sbjct: 59 QIVAGELDMSVNEGSEQIITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVAPIALP 118
Query: 1396 HPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
T + T GWG E G PD LQ+V +P++S +CR + ++M
Sbjct: 119 EQGHTATGDVIVT--GWGTTSEGGNT-PDVLQKVTVPLVSDEDCRAD---YGADEILDSM 172
Query: 1456 FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPW 1515
CAG GG+D+C GDSGGPL + G L G+ S GYGCAR PGVYT+VS ++ W
Sbjct: 173 ICAGVPEGGKDSCQGDSGGPLAASD-TGSTYLAGIVSWGYGCARPGYPGVYTEVSYHVDW 231
Query: 1516 LYNN 1519
+ N
Sbjct: 232 IKAN 235
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 143 bits (360), Expect = 8e-34, Method: Compositional matrix adjust.
Identities = 94/266 (35%), Positives = 137/266 (51%), Gaps = 24/266 (9%)
Query: 1285 IVGGGNARLGSWPWQAAL----YKEGE--FQCGATLISDQWLLSAGHCFY-RAQDDYWVA 1337
+VGG +A G+WPW +L Y CG L++ W+L+A HCF + + W
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWRL 60
Query: 1338 RLGT--LRRGTKLP-SPYEQLRPISKIILHPQYVDAGFINDISILKMKTPF--SNYVRPI 1392
G + G+ P P Q R + +II+H +YV INDI+++K+ P ++ P
Sbjct: 61 IFGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPFIGPG 120
Query: 1393 CLPH-----PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLP 1447
CLP P P T C V GWG L E G TLQE ++ +I C +
Sbjct: 121 CLPQFKAGPPRAPQT----CWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYN- 175
Query: 1448 LYRVTENMFCAGFERGGRDACLGDSGGPLMCQE-PDGRWSLMGVTSNGYGCARANRPGVY 1506
R+ CAG+ RG D C GDSGGPLMC++ + + ++G+TS G GCARA RPGVY
Sbjct: 176 -GRIRSTNVCAGYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVY 234
Query: 1507 TKVSNYIPWLYNNMAASEYNMMRNET 1532
T Y+ W+ + + ++ M++ T
Sbjct: 235 TSTWPYLNWIASKIGSNALQMVQLGT 260
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 143 bits (360), Expect = 9e-34, Method: Composition-based stats.
Identities = 89/248 (35%), Positives = 132/248 (53%), Gaps = 23/248 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG A WPWQ +L + CG +LI QW+L+A HC D L T
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCLGPDVKD-----LAT 55
Query: 1342 LRRGTKLPSPY--EQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHP 1397
LR + Y +QL P+S+II+HPQ+ DI++L+++ P S+ V + LP
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHTVMLPPA 115
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPD-TLQEVQLPIISTAECRKRTLFLPLYR------ 1450
+ G C V GWG + + P L++V++PI+ C + L Y
Sbjct: 116 SETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAK-YHLGAYTGDDVRI 174
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVS 1510
+ ++M CAG + RD+C GDSGGPL+C+ +G W GV S GCA+ NRPG+YT+V+
Sbjct: 175 IRDDMLCAGNSQ--RDSCKGDSGGPLVCK-VNGTWLQAGVVSWDEGCAQPNRPGIYTRVT 231
Query: 1511 NYIPWLYN 1518
Y+ W+++
Sbjct: 232 YYLDWIHH 239
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 140 bits (354), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 88/243 (36%), Positives = 129/243 (53%), Gaps = 18/243 (7%)
Query: 1285 IVGGGNARLG-SWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG S P+Q +L F G +LI+ QW++SA HC Y+++ RLG
Sbjct: 1 IVGGYTCSAANSIPYQVSLNSGSHFCSGGSLINSQWVVSAAHCSYKSRIQ---VRLG--E 55
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P + R + P +
Sbjct: 56 HNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAA 115
Query: 1404 GTLCTVV-GWGQLFEIGRVFPDTLQ-EVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
GT C+++ GWG G +P LQ ++ P++S + C+ P ++T NM C GF
Sbjct: 116 GTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSS---YP-GQITGNMICVGFL 171
Query: 1462 RGGRDAC-LGDSGGPLMCQEPDGRWSLMGVTSNGYGC-ARANRPGVYTKVSNYIPWLYNN 1519
GG+D+C GDSGGP++C L G+ S GYGC A+ N+PGVYTKV NY+ W+
Sbjct: 172 EGGKDSCSQGDSGGPVVCSNGQ----LQGIVSWGYGCSAQKNKPGVYTKVCNYVNWIQQT 227
Query: 1520 MAA 1522
+AA
Sbjct: 228 IAA 230
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 140 bits (353), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 86/239 (35%), Positives = 132/239 (55%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+VGG +A+ G +PWQ L + + CG ++++++W+++A HC VA +
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEE 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDA--GFINDISILKMKTPF--SNYVRPICLP---HP 1397
EQ R + +II H Y A + +DI++L++ P ++YV PIC+ +
Sbjct: 61 ----TEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYT 116
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
N L G+ V GWG++F GR LQ +++P++ A C + T F +T NMFC
Sbjct: 117 NIFLKFGS-GYVSGWGRVFHKGRS-ALVLQYLRVPLVDRATCLRSTKF----TITNNMFC 170
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
AGF GGRD+C GDSGGP + E +G L G+ S G CA + G+YTKVS Y+ W+
Sbjct: 171 AGFHEGGRDSCQGDSGGPHV-TEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 140 bits (352), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 86/246 (34%), Positives = 138/246 (56%), Gaps = 20/246 (8%)
Query: 1283 SRIVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
+RIVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 14 TRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD 71
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 72 --RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD- 128
Query: 1400 PLTDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTEN 1454
+ TL T V G+G+ E GR L+ +++P + C+ + F+ +T+N
Sbjct: 129 -WAESTLMTQKTGIVSGFGRTHEKGRQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQN 182
Query: 1455 MFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
MFCAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++
Sbjct: 183 MFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLK 241
Query: 1515 WLYNNM 1520
W+ +M
Sbjct: 242 WIDRSM 247
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 140 bits (352), Expect = 8e-33, Method: Composition-based stats.
Identities = 86/249 (34%), Positives = 130/249 (52%), Gaps = 18/249 (7%)
Query: 1278 RSMRHSRIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWV 1336
R+ RI+GG ++ GS PW AA+Y F C +L+ W++SA HCF + D
Sbjct: 29 RTFLRPRIIGGSSSLPGSHPWLAAIYIGDSF-CAGSLVHTCWVVSAAHCFSHSPPRDSVS 87
Query: 1337 ARLGT--LRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMK------TPFSN 1387
LG R T + + I K I + Y V +D+ ++++K S
Sbjct: 88 VVLGQHFFNRTTDVTQTFG----IEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQ 143
Query: 1388 YVRPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLP 1447
+V+PICLP P + G C + GWG L E + +L+E +P+++ +C ++
Sbjct: 144 FVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGA 203
Query: 1448 LYRVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYT 1507
++ NM CAG+ DAC GDSGGPL C E +G L G+ S G GC R ++PGVYT
Sbjct: 204 --DISPNMLCAGYFDCKSDACQGDSGGPLAC-EKNGVAYLYGIISWGDGCGRLHKPGVYT 260
Query: 1508 KVSNYIPWL 1516
+V+NY+ W+
Sbjct: 261 RVANYVDWI 269
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 139 bits (351), Expect = 9e-33, Method: Compositional matrix adjust.
Identities = 85/239 (35%), Positives = 132/239 (55%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+VGG +A+ G +PWQ L + + CG ++++++W+++A HC VA
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAG----EH 56
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDA--GFINDISILKMKTPF--SNYVRPICLP---HP 1397
+ EQ R + +II H + A + +DI++L++ P ++YV PIC+ +
Sbjct: 57 NIEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYT 116
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
N L G+ V GWG++F GR LQ +++P++ A C + T F +T NMFC
Sbjct: 117 NIFLKFGS-GYVSGWGRVFHKGRA-ALVLQYLRVPLVDRATCLRSTKF----TITNNMFC 170
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
AGF GGRD+C GDSGGP + E +G L G+ S G CA + G+YTKVS Y+ W+
Sbjct: 171 AGFHEGGRDSCQGDSGGPHV-TEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 139 bits (350), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 88/246 (35%), Positives = 137/246 (55%), Gaps = 20/246 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++++ ++L+A HC ++A+ + R+G
Sbjct: 1 IVGGRDCAEGECPWQALLVNEENEGFCGGTILNEFYVLTAAHCLHQAKR--FTVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + H ++V + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEKD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E GR+ TL+ +++P + + C+ + F +T NMF
Sbjct: 115 AEATLMTQKTGIVSGFGRTHEKGRL-SSTLKMLEVPYVDRSTCKLSSSFT----ITPNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + GVYTKVSN++ W+
Sbjct: 170 CAGYDTQPEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWI 228
Query: 1517 YNNMAA 1522
M A
Sbjct: 229 DKIMKA 234
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 139 bits (350), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 87/239 (36%), Positives = 131/239 (54%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG NA+ G +PWQ L + + CG ++I+++W+++A HC VA
Sbjct: 1 IVGGENAKPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIEPGVKITVVAG----EY 56
Query: 1345 GTKLPSPYEQLRPISKIILHPQY--VDAGFINDISILKMKTPFS--NYVRPICLP---HP 1397
T+ P EQ R + + I H Y + +DI++L++ P + +YV PIC+ +
Sbjct: 57 NTEETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPICIADKEYT 116
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
N L G+ V GWG++F GR LQ +++P++ A C + T F + NMFC
Sbjct: 117 NIFLKFGS-GYVSGWGRVFNRGRS-ATILQYLKVPLVDRATCLRSTKF----TIYSNMFC 170
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
AGF GG+D+C GDSGGP + E +G L G+ S G CA + G+YTKVS Y+ W+
Sbjct: 171 AGFHEGGKDSCQGDSGGPHV-TEVEGTSFLTGIISWGEECAVKGKYGIYTKVSRYVNWI 228
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 139 bits (349), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 85/239 (35%), Positives = 132/239 (55%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+VGG +A+ G +PWQ L + + CG ++++++W+++A HC VA
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAG----EH 56
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDA--GFINDISILKMKTPF--SNYVRPICLP---HP 1397
+ EQ R + +II H + A + +DI++L++ P ++YV PIC+ +
Sbjct: 57 NIEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYT 116
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
N L G+ V GWG++F GR LQ +++P++ A C + T F +T NMFC
Sbjct: 117 NIFLKFGS-GYVSGWGRVFHKGRS-ALVLQYLRVPLVDRATCLRSTKF----TITNNMFC 170
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
AGF GGRD+C GDSGGP + E +G L G+ S G CA + G+YTKVS Y+ W+
Sbjct: 171 AGFHEGGRDSCQGDSGGPHV-TEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 139 bits (349), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 88/255 (34%), Positives = 140/255 (54%), Gaps = 31/255 (12%)
Query: 1283 SRIVGGGNARLGSWPWQAAL-YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
++I G A+ G+ PW A L + G+ CG +L+ W+++A HC +++ D T
Sbjct: 154 AQIFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLD----PEDPT 209
Query: 1342 LRRGTKL-PSPY---------------EQLRPISKIILHPQYVDAGFINDISILKM-KTP 1384
LR L PS + EQ + LHPQY F ND++++++ ++P
Sbjct: 210 LRDSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESP 269
Query: 1385 FSN-YVRPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRT 1443
N +V PICLP P +G + V GWG+ F + FP+TL E+++PI+ + C+K
Sbjct: 270 VLNAFVMPICLP--EGPQQEGAMVIVSGWGKQFL--QRFPETLMEIEIPIVDHSTCQKA- 324
Query: 1444 LFLPLYR-VTENMFCAGFERGGRDACLGDSGGPLMCQEPD-GRWSLMGVTSNGYGCARAN 1501
+ PL + VT +M CAG + GG+DAC GDSGGP++ + G+W L+G S G C + +
Sbjct: 325 -YAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKD 383
Query: 1502 RPGVYTKVSNYIPWL 1516
R GVY+ + + W+
Sbjct: 384 RYGVYSYIHHNKDWI 398
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 138 bits (347), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 85/239 (35%), Positives = 131/239 (54%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+VGG +A+ G +PWQ L + + CG ++++++W+++A HC VA +
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEE 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDA--GFINDISILKMKTPF--SNYVRPICLP---HP 1397
EQ R + +II H Y A + +DI++L++ P ++YV PIC+ +
Sbjct: 61 ----TEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYT 116
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
N L G+ V GWG++F GR LQ +++P++ A C + T F + NMFC
Sbjct: 117 NIFLKFGS-GYVSGWGRVFHKGRS-ALVLQYLRVPLVDRATCLRSTKF----TIYNNMFC 170
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
AGF GGRD+C GDSGGP + E +G L G+ S G CA + G+YTKVS Y+ W+
Sbjct: 171 AGFHEGGRDSCQGDSGGPHV-TEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 138 bits (347), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 88/253 (34%), Positives = 139/253 (54%), Gaps = 31/253 (12%)
Query: 1285 IVGGGNARLGSWPWQAAL-YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
I G A+ G+ PW A L + G+ CG +L+ W+++A HC +++ D + TLR
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLD----PKDPTLR 56
Query: 1344 RGTKL-PSPY---------------EQLRPISKIILHPQYVDAGFINDISILKM-KTPFS 1386
L PS + EQ + LHPQY F ND++++++ ++P
Sbjct: 57 DSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVL 116
Query: 1387 N-YVRPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLF 1445
N +V PICLP P +G + V GWG+ F + FP+TL E+++PI+ + C+K +
Sbjct: 117 NAFVMPICLP--EGPQQEGAMVIVSGWGKQFL--QRFPETLMEIEIPIVDHSTCQKA--Y 170
Query: 1446 LPLYR-VTENMFCAGFERGGRDACLGDSGGPLMCQEPD-GRWSLMGVTSNGYGCARANRP 1503
PL + VT +M CAG + GG+DAC GDSGGP++ + G+W L+G S G C + +R
Sbjct: 171 APLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRY 230
Query: 1504 GVYTKVSNYIPWL 1516
GVY+ + + W+
Sbjct: 231 GVYSYIHHNKDWI 243
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 137 bits (345), Expect = 5e-32, Method: Composition-based stats.
Identities = 87/239 (36%), Positives = 118/239 (49%), Gaps = 21/239 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG S Q +L G CG +L+S W++SA HC+ V R+
Sbjct: 1 IVGGYECTKHSQAHQVSL-NSGYHFCGGSLVSKDWVVSAAHCYKS------VLRVRLGEH 53
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLT 1402
++ EQ S +I HP Y NDI ++K+ P + YV + LP
Sbjct: 54 HIRVNEGTEQYISSSSVIRHPNYSSYNINNDIMLIKLTKPATLNQYVHAVALP--TECAA 111
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
D T+CTV GWG D LQ + LPI+S A+C + +T++MFCAG+
Sbjct: 112 DATMCTVSGWGNTMS-SVADGDKLQCLSLPILSHADCANSYPGM----ITQSMFCAGYLE 166
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D+C GDSGGP++C L GV S GYGCA + PGVY KV W+ + MA
Sbjct: 167 GGKDSCQGDSGGPVVCNG-----VLQGVVSWGYGCAERDHPGVYAKVCVLSGWVRDTMA 220
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In Complex
With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound "1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors:
Biaryl Pyrrolidin-2-Ones Incorporating Basic Heterocyclic
Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors:
Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors:
Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors:
Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine P4
Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors:
Pyrrolidin-2-Ones With Aminoindane And Phenylpyrrolidine
P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors:
Pyrrolidin-2-Ones With Aminoindane And Phenylpyrrolidine
P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors:
Pyrrolidin-2-Ones With Aminoindane And Phenylpyrrolidine
P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors:
Pyrrolidin-2-Ones With Aminoindane And Phenylpyrrolidine
P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 137 bits (344), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 85/244 (34%), Positives = 136/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E GR L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGRQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 137 bits (344), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 84/239 (35%), Positives = 131/239 (54%), Gaps = 18/239 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+VGG +A+ G +PWQ L + + CG ++++++W+++A HC VA +
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEE 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDA--GFINDISILKMKTPF--SNYVRPICLP---HP 1397
EQ R + +II H Y A + +DI++L++ P ++YV PIC+ +
Sbjct: 61 ----TEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYT 116
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
N L G+ V GWG++F GR LQ +++P++ A C + T F + NMFC
Sbjct: 117 NIFLKFGS-GYVSGWGRVFHKGRS-ALVLQYLRVPLVDRATCLRSTKF----TIYNNMFC 170
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
AGF GGRD+C GD+GGP + E +G L G+ S G CA + G+YTKVS Y+ W+
Sbjct: 171 AGFHEGGRDSCQGDAGGPHV-TEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 137 bits (344), Expect = 6e-32, Method: Composition-based stats.
Identities = 84/242 (34%), Positives = 127/242 (52%), Gaps = 18/242 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGT-- 1341
I+GG ++ GS PW AA+Y F C +L+ W++SA HCF + D LG
Sbjct: 1 IIGGSSSLPGSHPWLAAIYIGDSF-CAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMK------TPFSNYVRPICL 1394
R T + + I K I + Y V +D+ ++++K S +V+PICL
Sbjct: 60 FNRTTDVTQTFG----IEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICL 115
Query: 1395 PHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTEN 1454
P P + G C + GWG L E + +L+E +P+++ +C ++ ++ N
Sbjct: 116 PEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGA--DISPN 173
Query: 1455 MFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
M CAG+ DAC GDSGGPL C E +G L G+ S G GC R ++PGVYT+V+NY+
Sbjct: 174 MLCAGYFDCKSDACQGDSGGPLAC-EKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYVD 232
Query: 1515 WL 1516
W+
Sbjct: 233 WI 234
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 137 bits (344), Expect = 6e-32, Method: Composition-based stats.
Identities = 84/242 (34%), Positives = 127/242 (52%), Gaps = 18/242 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGT-- 1341
I+GG ++ GS PW AA+Y F C +L+ W++SA HCF + D LG
Sbjct: 1 IIGGSSSLPGSHPWLAAIYIGDSF-CAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMK------TPFSNYVRPICL 1394
R T + + I K I + Y V +D+ ++++K S +V+PICL
Sbjct: 60 FNRTTDVTQTFG----IEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICL 115
Query: 1395 PHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTEN 1454
P P + G C + GWG L E + +L+E +P+++ +C ++ ++ N
Sbjct: 116 PEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGA--DISPN 173
Query: 1455 MFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
M CAG+ DAC GDSGGPL C E +G L G+ S G GC R ++PGVYT+V+NY+
Sbjct: 174 MLCAGYFDCKSDACQGDSGGPLAC-EKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYVD 232
Query: 1515 WL 1516
W+
Sbjct: 233 WI 234
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 137 bits (344), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 85/244 (34%), Positives = 136/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E GR L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGRQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 136 bits (343), Expect = 7e-32, Method: Composition-based stats.
Identities = 84/240 (35%), Positives = 123/240 (51%), Gaps = 15/240 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG A + P+ A++ G CG L+++QW+LSA HC A D LG
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGA--H 58
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPLT 1402
P P ++L + + + HP Y +D+ +L++ K VRP+ + +
Sbjct: 59 SLSQPEPSKRLYDVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVA 118
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GTLC V GWG + GR PD+LQ V LP++ A C +RT +TE + CA E
Sbjct: 119 PGTLCDVAGWGIVNHAGRR-PDSLQHVLLPVLDRATCNRRTHHDG--AITERLMCA--ES 173
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPWLYNNMA 1521
RD+C GDSGGPL+C L GV S G C +PG+YT+V++Y W+ + +A
Sbjct: 174 NRRDSCKGDSGGPLVCGG-----VLEGVVSWGSRVCGNRKKPGIYTRVASYAAWIDSVLA 228
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 136 bits (343), Expect = 8e-32, Method: Compositional matrix adjust.
Identities = 85/244 (34%), Positives = 136/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E GR L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGRQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor 5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor 3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor 5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based Factor
Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor N-(2-(((5-Chloro-2-
Pyridinyl) Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor 1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-Oxo-
4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'- (Methylsulfon
Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5- Dih
2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5- Ox
Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With (R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 136 bits (343), Expect = 8e-32, Method: Compositional matrix adjust.
Identities = 85/244 (34%), Positives = 136/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E GR L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGRQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative Tak-44
Potent, Selective And Orally Active Factor Xa Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 136 bits (343), Expect = 8e-32, Method: Compositional matrix adjust.
Identities = 85/244 (34%), Positives = 136/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E GR L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGRQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 136 bits (343), Expect = 9e-32, Method: Compositional matrix adjust.
Identities = 85/244 (34%), Positives = 135/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTAAEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E GR L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGRQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed With
Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor 1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-2-
Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)
Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 136 bits (343), Expect = 9e-32, Method: Compositional matrix adjust.
Identities = 85/244 (34%), Positives = 136/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E GR L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGRQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 136 bits (342), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 89/254 (35%), Positives = 124/254 (48%), Gaps = 36/254 (14%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDY--WVARLGTL 1342
IVGG S PWQAALY FQCG L+ QW+L+A HC D+Y W+ R
Sbjct: 1 IVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCI---SDNYQLWLGRHNLF 57
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQY-----------VDAGFINDISILKMKTP---FSNY 1388
Q +S+ HP + D + +D+ +L++ P ++
Sbjct: 58 DDENT-----AQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDA 112
Query: 1389 VRPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPL 1448
V+ + LP + G+ C GWG + FPD LQ V L I+ EC+K +
Sbjct: 113 VKVVELPTEEPEV--GSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAH----V 166
Query: 1449 YRVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGY-GCARANRPGVYT 1507
+VT+ M C G GG+D C+GDSGGPLMC DG L GVTS GY C N+P V
Sbjct: 167 QKVTDFMLCVGHLEGGKDTCVGDSGGPLMC---DG--VLQGVTSWGYVPCGTPNKPSVAV 221
Query: 1508 KVSNYIPWLYNNMA 1521
+V +Y+ W+ + +A
Sbjct: 222 RVLSYVKWIEDTIA 235
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-1-
Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-1-
Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 135 bits (341), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 85/244 (34%), Positives = 136/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E GR L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGRQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 135 bits (340), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 84/244 (34%), Positives = 136/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E GR L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGRQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GD+GGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDAGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 135 bits (340), Expect = 2e-31, Method: Composition-based stats.
Identities = 83/241 (34%), Positives = 124/241 (51%), Gaps = 15/241 (6%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
RI+GG A + P+ A++ G CG L+++QW+LSA HC A D LG
Sbjct: 7 RILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGA-- 64
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPL 1401
P P ++L + + + HP +D+ +L++ K VRP+ + +
Sbjct: 65 HSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDV 124
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
GTLC V GWG + GR PD+LQ V LP++ A C +RT +TE + CA E
Sbjct: 125 APGTLCDVAGWGIVNHAGRR-PDSLQHVLLPVLDRATCNRRTHHDG--AITERLMCA--E 179
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPWLYNNM 1520
RD+C GDSGGPL+C L GV ++G C +PG+YT+V++Y W+ + +
Sbjct: 180 SNRRDSCKGDSGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVL 234
Query: 1521 A 1521
A
Sbjct: 235 A 235
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 135 bits (339), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 85/253 (33%), Positives = 128/253 (50%), Gaps = 35/253 (13%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDY--WVARLGTL 1342
IVGG S PW A+Y+ ++ CG L+ W+L+A HC+ D+Y W+ +
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQYLCGGVLLDPNWVLTAAHCY---DDNYKVWLGKNNLF 57
Query: 1343 RRGTKLPSPYEQLRPISKIILHP-----------QYVDAGFINDISILKMKTP--FSNYV 1389
+ P Q R +SK I HP ++++ + ND+ +L++ P ++ V
Sbjct: 58 KD-----EPSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDTV 112
Query: 1390 RPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
+PI LP L G+ C GWG + F D L V L ++ +C K +
Sbjct: 113 KPITLPTEEPKL--GSTCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAKAH----IE 166
Query: 1450 RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTK 1508
+VT+ M CAG GG+D C GDSGGPL+C DG L G+TS G+ C + PGVYTK
Sbjct: 167 KVTDAMLCAGEMDGGKDTCKGDSGGPLIC---DG--VLQGITSWGHTPCGEPDMPGVYTK 221
Query: 1509 VSNYIPWLYNNMA 1521
++ + W+ + MA
Sbjct: 222 LNKFTSWIKDTMA 234
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 134 bits (338), Expect = 3e-31, Method: Composition-based stats.
Identities = 83/240 (34%), Positives = 123/240 (51%), Gaps = 15/240 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG A + P+ A++ GE CG L+++QW+LSA HC A D LG
Sbjct: 1 ILGGREAEAHARPYMASVQVNGEHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGA--H 58
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPLT 1402
P P ++L + + + HP +D+ +L++ K VRP+ + +
Sbjct: 59 SLSQPEPSKRLYDVLRAVPHPDSRPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVE 118
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GTLC V GWG + GR PD LQ V LP++ A C +RT +T+ M CA E
Sbjct: 119 PGTLCDVAGWGIVSHAGRR-PDRLQHVLLPVLDRATCNRRTHHDG--AITQRMMCA--ES 173
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPWLYNNMA 1521
RD+C GDSGGPL+C L GV ++G C +PG+YT+V++Y W+ + +A
Sbjct: 174 NRRDSCKGDSGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 228
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 134 bits (338), Expect = 3e-31, Method: Composition-based stats.
Identities = 82/240 (34%), Positives = 123/240 (51%), Gaps = 15/240 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG A + P+ A++ G CG L+++QW+LSA HC A D LG
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGA--H 58
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPLT 1402
P P ++L + + + HP +D+ +L++ K VRP+ + +
Sbjct: 59 SLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVA 118
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GTLC V GWG + GR PD+LQ V LP++ A C +RT +TE + CA E
Sbjct: 119 PGTLCDVAGWGIVNHAGRR-PDSLQHVLLPVLDRATCNRRTHHDG--AITERLMCA--ES 173
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPWLYNNMA 1521
RD+C GDSGGPL+C L GV ++G C +PG+YT+V++Y W+ + +A
Sbjct: 174 NRRDSCKGDSGGPLVCGG-----VLEGVVTSGSAVCGNRKKPGIYTRVASYAAWIDSVLA 228
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 134 bits (338), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 84/244 (34%), Positives = 135/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E G L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGEQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 134 bits (338), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 84/244 (34%), Positives = 135/244 (55%), Gaps = 20/244 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IVGG + G PWQA L +E E CG T++S+ ++L+A HC Y+A+ + R+G
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKR--FKVRVGD-- 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
R T+ E + + +I H ++ + DI++L++KTP F V P CLP +
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD--W 114
Query: 1402 TDGTLCT-----VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ TL T V G+G+ E G L+ +++P + C+ + F+ +T+NMF
Sbjct: 115 AESTLMTQKTGIVSGFGRTHEKGEQ-STRLKMLEVPYVDRNSCKLSSSFI----ITQNMF 169
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG++ DAC GDSGGP + + D + + G+ S G GCAR + G+YTKV+ ++ W+
Sbjct: 170 CAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWI 228
Query: 1517 YNNM 1520
+M
Sbjct: 229 DRSM 232
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic Anhydride
Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 133 bits (335), Expect = 8e-31, Method: Composition-based stats.
Identities = 82/240 (34%), Positives = 123/240 (51%), Gaps = 15/240 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG A + P+ A++ G CG L+++QW+LSA HC A D LG
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGA--H 58
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPLT 1402
P P ++L + + + HP +D+ +L++ K VRP+ + +
Sbjct: 59 SLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVA 118
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GTLC V GWG + GR PD+LQ V LP++ A C +RT +TE + CA E
Sbjct: 119 PGTLCDVAGWGIVNHAGRR-PDSLQHVLLPVLDRATCNRRTHHDG--AITERLMCA--ES 173
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPWLYNNMA 1521
RD+C GDSGGPL+C L GV ++G C +PG+YT+V++Y W+ + +A
Sbjct: 174 NRRDSCKGDSGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 228
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 133 bits (334), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 90/247 (36%), Positives = 128/247 (51%), Gaps = 19/247 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG + G PWQ L G CG TLI+ W++SA HCF + ++ W + L
Sbjct: 1 IVGGKDCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKN--WRNLIAVL-- 56
Query: 1345 GTKLPSPY---EQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPH--- 1396
G S + EQ R ++++I+ YV +DI++L++ P +++V P+CLP
Sbjct: 57 GEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTF 116
Query: 1397 PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFL---PLYRVTE 1453
L V GWGQL + G LQ + +P + T +C +++ + P +TE
Sbjct: 117 SERTLAFVRFSLVSGWGQLLDRGAT-ALVLQVLNVPRLMTQDCLQQSRKVGDSP--NITE 173
Query: 1454 NMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYI 1513
MFCAG+ G +D+C GDSGGP G W L G+ S G GCA GVYT+VS YI
Sbjct: 174 YMFCAGYSDGSKDSCKGDSGGP-HATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYI 232
Query: 1514 PWLYNNM 1520
WL M
Sbjct: 233 EWLQKLM 239
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With Factors
B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With Factors
B And D
Length = 228
Score = 132 bits (332), Expect = 1e-30, Method: Composition-based stats.
Identities = 81/240 (33%), Positives = 123/240 (51%), Gaps = 15/240 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG A + P+ A++ G CG L+++QW+LSA HC A D LG
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGA--H 58
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPLT 1402
P P ++L + + + HP +D+ +L++ K VRP+ + +
Sbjct: 59 SLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVA 118
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GTLC V GWG + GR PD+LQ V LP++ A C +RT +TE + CA E
Sbjct: 119 PGTLCDVAGWGIVNHAGRR-PDSLQHVLLPVLDRATCNRRTHHDG--AITERLMCA--ES 173
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPWLYNNMA 1521
RD+C GD+GGPL+C L GV ++G C +PG+YT+V++Y W+ + +A
Sbjct: 174 NRRDSCKGDAGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 228
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 132 bits (332), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 92/255 (36%), Positives = 127/255 (49%), Gaps = 19/255 (7%)
Query: 1275 NLTRSMRHSRIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDY 1334
L+ RI GG A+ G +PWQ + G L+ D W+L+A H Y + D
Sbjct: 77 GLSARTTGGRIYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAVYEQKHDA 134
Query: 1335 WV--ARLGTLRRGTKLPSPYEQLRPISKIILHPQYV-DAGFINDISILKM--KTPFSNYV 1389
R+GTL+R SP+ + +H Y DAGF NDI+++K+ K ++ +
Sbjct: 135 SALDIRMGTLKR----LSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNI 190
Query: 1390 RPICLPHPNTP--LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLP 1447
PICLP + + T GWG L + G L V +PI+ +C P
Sbjct: 191 TPICLPRKEAESFMRTDDIGTASGWG-LTQRG-FLARNLMYVDIPIVDHQKCTAAYEKPP 248
Query: 1448 LYR--VTENMFCAGFERGGRDACLGDSGGPLMCQEPDG-RWSLMGVTSNG-YGCARANRP 1503
R VT NM CAG E GG+D+C GDSGG L+ + + RW + G+ S G C A +
Sbjct: 249 YPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQY 308
Query: 1504 GVYTKVSNYIPWLYN 1518
GVYTKV NYIPW+ N
Sbjct: 309 GVYTKVINYIPWIEN 323
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity Determinants
At The S1 Site Using An Artificial Ala190 Protease
(Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity Determinants
At The S1 Site Using An Artificial Ala190 Protease
(ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity Determinants
At The S1 Site Using An Artificial Ala190 Protease
(Ala190 Upa)
Length = 253
Score = 132 bits (332), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 86/250 (34%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +L+S W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
ICLP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + DAC GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDACQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex With
A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex With
A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex With
A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex With
A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex With
A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex With
A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 131 bits (330), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 85/251 (33%), Positives = 131/251 (52%), Gaps = 27/251 (10%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWV 1336
+I+GG + + PW AA+Y+ + CG +L+S W++SA HCF Y ++DY +
Sbjct: 23 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDY-I 81
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP--- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 82 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 139
Query: 1392 ---ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPL 1448
ICLP GT C + G+G+ ++P+ L+ + +IS EC++ P
Sbjct: 140 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQ-----PH 194
Query: 1449 Y---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGV 1505
Y VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGV
Sbjct: 195 YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGV 253
Query: 1506 YTKVSNYIPWL 1516
YT+VS+++PW+
Sbjct: 254 YTRVSHFLPWI 264
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic
Acid Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic
Acid Complex
Length = 253
Score = 131 bits (330), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 86/250 (34%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +LIS W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
ICLP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites Of
Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites Of
Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites Of
Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites Of
Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites Of
Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites Of
Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites Of
Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 131 bits (329), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +L+S W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
ICLP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A Multi-
Centered Short Hydrogen Bonding Network At The Active
Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 130 bits (327), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +L+S W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
ICLP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 130 bits (327), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +L+S W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
ICLP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 130 bits (327), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 85/260 (32%), Positives = 134/260 (51%), Gaps = 28/260 (10%)
Query: 1284 RIVGGGNARLGSWPWQAAL-YKEG----EFQCGATLISDQWLLSAGHCF----YRAQDDY 1334
+I+ G + +PW A + YK +F CG +LI+++++++A HC R
Sbjct: 22 KILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCVAGRVLRVVGAL 81
Query: 1335 WVARLGTLRRGTKLPSPYEQLR----------PISKIILHPQYVDAG--FINDISILKM- 1381
RLG T P Y +R I + I HP YVD +DI+++++
Sbjct: 82 NKVRLGEWNTATD-PDCYGAVRVCVPDKPIDLGIEETIQHPDYVDGSKDRYHDIALIRLN 140
Query: 1382 -KTPFSNYVRPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECR 1440
+ F+NY+RP+CLP PN + G TVVGWG+ E G+ + Q++ +P++ +C
Sbjct: 141 RQVEFTNYIRPVCLPQPNEEVQVGQRLTVVGWGRT-ETGQ-YSTIKQKLAVPVVHAEQCA 198
Query: 1441 KRTLFLPLYRVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARA 1500
K T RV + CAG E+ +D+C GDSGGPL+ + + ++ L G+ S G C
Sbjct: 199 K-TFGAAGVRVRSSQLCAGGEKA-KDSCGGDSGGPLLAERANQQFFLEGLVSFGATCGTE 256
Query: 1501 NRPGVYTKVSNYIPWLYNNM 1520
PG+YTKV Y W+ N+
Sbjct: 257 GWPGIYTKVGKYRDWIEGNI 276
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 130 bits (327), Expect = 7e-30, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +L+S W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
ICLP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 130 bits (326), Expect = 7e-30, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 130/250 (52%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +L+S W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
ICLP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 130 bits (326), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 90/245 (36%), Positives = 125/245 (51%), Gaps = 19/245 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWV--ARLGTL 1342
I GG A+ G +PWQ + G L+ D W+L+A H Y + D R+GTL
Sbjct: 1 IYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTL 58
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYV-DAGFINDISILKM--KTPFSNYVRPICLP--HP 1397
+R SP+ + +H Y DAGF NDI+++K+ K ++ + PICLP
Sbjct: 59 KR----LSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEA 114
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR--VTENM 1455
+ + + T GWG L + G L V +PI+ +C P R VT NM
Sbjct: 115 ESFMRTDDIGTASGWG-LTQRG-FLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANM 172
Query: 1456 FCAGFERGGRDACLGDSGGPLMCQEPDG-RWSLMGVTSNG-YGCARANRPGVYTKVSNYI 1513
CAG E GG+D+C GDSGG L+ + + RW + G+ S G C A + GVYTKV NYI
Sbjct: 173 LCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYI 232
Query: 1514 PWLYN 1518
PW+ N
Sbjct: 233 PWIEN 237
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For The
Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human Coagulation
Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide Exosite
Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide Exosite
Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor Viia/tissue
Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor ViiaTISSUE
FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl Ketone-factor
Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity Determinants
At The S1 Site Using An Artificial Ala190 Protease
(Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 129 bits (325), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 89/247 (36%), Positives = 127/247 (51%), Gaps = 19/247 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG G PWQ L G CG TLI+ W++SA HCF + ++ W + L
Sbjct: 1 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKN--WRNLIAVL-- 56
Query: 1345 GTKLPSPY---EQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPH--- 1396
G S + EQ R ++++I+ YV +DI++L++ P +++V P+CLP
Sbjct: 57 GEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTF 116
Query: 1397 PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFL---PLYRVTE 1453
L V GWGQL + G + L + +P + T +C +++ + P +TE
Sbjct: 117 SERTLAFVRFSLVSGWGQLLDRGATALE-LMVLNVPRLMTQDCLQQSRKVGDSP--NITE 173
Query: 1454 NMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYI 1513
MFCAG+ G +D+C GDSGGP G W L G+ S G GCA GVYT+VS YI
Sbjct: 174 YMFCAGYSDGSKDSCKGDSGGP-HATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYI 232
Query: 1514 PWLYNNM 1520
WL M
Sbjct: 233 EWLQKLM 239
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 129 bits (325), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 91/255 (35%), Positives = 128/255 (50%), Gaps = 19/255 (7%)
Query: 1275 NLTRSMRHSRIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDY 1334
L+ +I GG A+ G +PWQ + G L+ D W+L+A H Y + D
Sbjct: 152 GLSARTTGGQIYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAVYEQKHDA 209
Query: 1335 WV--ARLGTLRRGTKLPSPYEQLRPISKIILHPQYV-DAGFINDISILKM--KTPFSNYV 1389
R+GTL+R SP+ + +H Y DAGF NDI+++K+ K ++ +
Sbjct: 210 SALDIRMGTLKR----LSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNI 265
Query: 1390 RPICLP--HPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLP 1447
PICLP + + + T GWG L + G L V +PI+ +C P
Sbjct: 266 TPICLPRKEAESFMRTDDIGTASGWG-LTQRG-FLARNLMYVDIPIVDHQKCTAAYEKPP 323
Query: 1448 LYR--VTENMFCAGFERGGRDACLGDSGGPLMCQEPDG-RWSLMGVTSNG-YGCARANRP 1503
R VT NM CAG E GG+D+C GDSGG L+ + + RW + G+ S G C A +
Sbjct: 324 YPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQY 383
Query: 1504 GVYTKVSNYIPWLYN 1518
GVYTKV NYIPW+ N
Sbjct: 384 GVYTKVINYIPWIEN 398
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 129 bits (323), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 89/245 (36%), Positives = 125/245 (51%), Gaps = 19/245 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWV--ARLGTL 1342
I GG A+ G +PWQ + G L+ D W+L+A H Y + D R+GTL
Sbjct: 1 IYGGQKAKPGDFPWQVLIL--GGTTAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTL 58
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYV-DAGFINDISILKM--KTPFSNYVRPICLP--HP 1397
+R SP+ + +H Y DAGF NDI+++K+ K ++ + PICLP
Sbjct: 59 KR----LSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICLPRKEA 114
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR--VTENM 1455
+ + + T GWG L + G L V +PI+ +C P R VT NM
Sbjct: 115 ESFMRTDDIGTASGWG-LTQRG-FLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANM 172
Query: 1456 FCAGFERGGRDACLGDSGGPLMCQEPDG-RWSLMGVTSNG-YGCARANRPGVYTKVSNYI 1513
CAG E GG+D+C GD+GG L+ + + RW + G+ S G C A + GVYTKV NYI
Sbjct: 173 LCAGLESGGKDSCRGDAGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYI 232
Query: 1514 PWLYN 1518
PW+ N
Sbjct: 233 PWIEN 237
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 128 bits (322), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 85/251 (33%), Positives = 130/251 (51%), Gaps = 27/251 (10%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWV 1336
+I+GG + + PW AA+Y+ + CG +LIS W++SA HCF Y ++DY +
Sbjct: 15 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDY-I 73
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP--- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 74 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 131
Query: 1392 ---ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPL 1448
I LP GT C + G+G+ ++P+ L+ + +IS EC++ P
Sbjct: 132 IQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQ-----PH 186
Query: 1449 Y---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGV 1505
Y VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGV
Sbjct: 187 YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGV 245
Query: 1506 YTKVSNYIPWL 1516
YT+VS+++PW+
Sbjct: 246 YTRVSHFLPWI 256
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed By
Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide Inhibitor
Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide Inhibitor
Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide Inhibitor
Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 128 bits (322), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 129/250 (51%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +LIS W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
I LP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 128 bits (321), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 129/250 (51%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +LIS W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
I LP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 128 bits (321), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 129/250 (51%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +LIS W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
I LP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 128 bits (321), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 129/250 (51%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +LIS W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
I LP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As Orally
Bioavailable Inhibitors Of Urokinase-Type Plasminogen
Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As Orally
Bioavailable Inhibitors Of Urokinase-Type Plasminogen
Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As Orally
Bioavailable Inhibitors Of Urokinase-Type Plasminogen
Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As Orally
Bioavailable Inhibitors Of Urokinase-type Plasminogen
Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As Orally
Bioavailable Inhibitors Of Urokinase-Type Plasminogen
Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As Orally
Bioavailable Inhibitors Of Urokinase-Type Plasminogen
Activator
Length = 253
Score = 128 bits (321), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 129/250 (51%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +LIS W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
I LP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between Plasminogen
Activator Inhibitor-1 And Urokinase-Type Plasminogen
Activator
Length = 253
Score = 127 bits (319), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +LIS W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
I LP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GD+GGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDAGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With 2-
Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 127 bits (318), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 27/250 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE-----FQCGATLISDQWLLSAGHCF--YRAQDDYWVA 1337
I+GG + + PW AA+Y+ + CG +L+S W++SA HCF Y ++DY +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDY-IV 59
Query: 1338 RLGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFI--NDISILKMKTPFSNYVRP---- 1391
LG R + E + +ILH Y NDI++LK+++ +P
Sbjct: 60 YLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 1392 --ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY 1449
I LP GT C + G+G+ ++P+ L+ + +IS EC++ P Y
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQ-----PHY 172
Query: 1450 ---RVTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVY 1506
VT M CA + D+C GDSGGPL+C GR +L G+ S G GCA ++PGVY
Sbjct: 173 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSL-QGRMTLTGIVSWGRGCALKDKPGVY 231
Query: 1507 TKVSNYIPWL 1516
T+VS+++PW+
Sbjct: 232 TRVSHFLPWI 241
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 125 bits (313), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 88/254 (34%), Positives = 131/254 (51%), Gaps = 25/254 (9%)
Query: 1283 SRIVGGGNARLGSWPWQAALY--KEGEFQ--CGATLISDQWLLSAGHCFYRAQDDYWVAR 1338
SR+V G +A SW WQ +L K+G F CG +LI+ W+++AGHC ++ +
Sbjct: 10 SRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRT--YQVV 67
Query: 1339 LGTLRRGTKLPSPYEQLRPISK--IILHPQY----VDAGFINDISILKMK--TPFSNYVR 1390
LG R S EQ+ PI+ + +HP + V G NDI+++K+ + V+
Sbjct: 68 LGEYDRSVLQGS--EQVIPINAGDLFVHPLWNSNCVACG--NDIALVKLSRSAQLGDKVQ 123
Query: 1391 PICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR 1450
LP L + C + GWG+L+ G PD LQE LP++ C + +
Sbjct: 124 LANLPPAGDILPNEAPCYISGWGRLYT-GGPLPDKLQEALLPVVDYEHCSQYDWWG--IT 180
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTK 1508
V + M CAG + R C GDSGGPL C DG W + GVTS + +GC +P V+T+
Sbjct: 181 VKKTMVCAGGDT--RSGCDGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTR 238
Query: 1509 VSNYIPWLYNNMAA 1522
VS +I W+ +A+
Sbjct: 239 VSAFIDWINETIAS 252
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 124 bits (312), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 84/257 (32%), Positives = 117/257 (45%), Gaps = 17/257 (6%)
Query: 1280 MRHSRIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARL 1339
+R RIVGG A+LG PWQ A+ CG I W+L+A HC RA +
Sbjct: 317 IRRKRIVGGKRAQLGDLPWQVAIKDASGITCGGIYIGGCWILTAAHCL-RASKTHRYQIW 375
Query: 1340 GTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSN------YVRPIC 1393
T+ + + +II H Y + NDI++++MK + P C
Sbjct: 376 TTVVDWIHPDLKRIVIEYVDRIIFHENYNAGTYQNDIALIEMKKDGNKKDCELPRSIPAC 435
Query: 1394 LPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTE 1453
+P C V GWG+ + RVF EV+L + C K F +
Sbjct: 436 VPWSPYLFQPNDTCIVSGWGREKDNERVFSLQWGEVKL----ISNCSK---FYGNRFYEK 488
Query: 1454 NMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYI 1513
M CAG G DAC GDSGGPL+C + + + GV S G C + PGVYTKV+NY
Sbjct: 489 EMECAGTYDGSIDACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFPGVYTKVANYF 548
Query: 1514 PWLYNNMA---ASEYNM 1527
W+ ++ S+YN+
Sbjct: 549 DWISYHVGRPFISQYNV 565
Score = 43.5 bits (101), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 26/62 (41%), Positives = 31/62 (50%), Gaps = 1/62 (1%)
Query: 1042 KICDGIIDCWDFSDEYECEWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQCINLF 1101
K CDGI DC D SDE C+ C + C S VCI C+G DC G+DE C
Sbjct: 221 KACDGINDCGDQSDELCCKACQGKGFHC-KSGVCIPSQYQCNGEVDCITGEDEVGCAGFA 279
Query: 1102 PI 1103
+
Sbjct: 280 SV 281
Score = 38.9 bits (89), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 51/118 (43%), Gaps = 14/118 (11%)
Query: 1530 NETQMSRQHVCNGHRCPLGECLPKARVCNGYMECSDGKCE-------MNSSFRCGNGECV 1582
N T+ H C G L EC R GY + +D C M+ F+C NG+ +
Sbjct: 159 NSTECLHVH-CRGLETSLAECTFTKRRTMGYQDFADVVCYTQKADSPMDDFFQCVNGKYI 217
Query: 1583 SIGSKCNQLVDCADGSDE---KNCSCADF-LKSQFL--TRKICDGIIDCWDFSDEYEC 1634
S C+ + DC D SDE K C F KS ++ C+G +DC DE C
Sbjct: 218 SQMKACDGINDCGDQSDELCCKACQGKGFHCKSGVCIPSQYQCNGEVDCITGEDEVGC 275
Score = 37.4 bits (85), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 29/127 (22%), Positives = 54/127 (42%), Gaps = 6/127 (4%)
Query: 1484 RWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAASEYNMMRNETQMSRQHVCNGH 1543
R+ L ++ N C + G+ T ++ M ++ + TQ + + +
Sbjct: 150 RFKLSDLSINSTECLHVHCRGLETSLAECTFTKRRTMGYQDFADVVCYTQKADSPMDDFF 209
Query: 1544 RCPLGECLPKARVCNGYMECSDGKCEM------NSSFRCGNGECVSIGSKCNQLVDCADG 1597
+C G+ + + + C+G +C D E+ F C +G C+ +CN VDC G
Sbjct: 210 QCVNGKYISQMKACDGINDCGDQSDELCCKACQGKGFHCKSGVCIPSQYQCNGEVDCITG 269
Query: 1598 SDEKNCS 1604
DE C+
Sbjct: 270 EDEVGCA 276
Score = 30.4 bits (67), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 13/32 (40%), Positives = 17/32 (53%)
Query: 998 SFRCGNGECVSIGSKCNQLVDCADGSDEKNCS 1029
F C +G C+ +CN VDC G DE C+
Sbjct: 245 GFHCKSGVCIPSQYQCNGEVDCITGEDEVGCA 276
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With Ala-
Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With Ala-
Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With Suc-
Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With Suc-
Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 124 bits (310), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 82/241 (34%), Positives = 121/241 (50%), Gaps = 26/241 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+ G GS PWQ AL + CG L++++W+L+A HC + + + LG+
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHC----KMNEYTVHLGSDTL 56
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPLT 1402
G + Q SK HP Y +ND+ ++K+ + S+ V+ + LP P
Sbjct: 57 GDR----RAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEP-- 110
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR-VTEN-MFCAGF 1460
GT CTV GWG FP L V + +IS +C K +Y+ + EN M CAG
Sbjct: 111 PGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTK------VYKDLLENSMLCAGI 164
Query: 1461 ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNN 1519
++AC GDSGGPL+C R +L G+ S G + C + N PGVYT+V + W+ +
Sbjct: 165 PDSKKNACNGDSGGPLVC-----RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDT 219
Query: 1520 M 1520
M
Sbjct: 220 M 220
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 124 bits (310), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 86/253 (33%), Positives = 123/253 (48%), Gaps = 24/253 (9%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT-- 1341
++ G R G PWQ L + + CGA LI W+L+A HC ++ + RLG
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKL--LVRLGEYD 58
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
LRR K +E I ++ +HP Y + NDI++L + P S + PICLP
Sbjct: 59 LRRWEK----WELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGL 114
Query: 1400 PLTD----GTLCTVVGWG----QLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRV 1451
+ G V GWG + E R L +++P++ EC + + V
Sbjct: 115 AERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNM----V 170
Query: 1452 TENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSN 1511
+ENM CAG +DAC GDSGGP M G W L+G+ S G GC + GVYTKVS
Sbjct: 171 SENMLCAGILGDRQDACEGDSGGP-MVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSR 229
Query: 1512 YIPWLYNNMAASE 1524
Y+ W++ ++ E
Sbjct: 230 YLDWIHGHIRDKE 242
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 123 bits (309), Expect = 7e-28, Method: Compositional matrix adjust.
Identities = 84/242 (34%), Positives = 122/242 (50%), Gaps = 21/242 (8%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
I+ G + + + PWQAAL + + CGA L+ QWLL+A HC + + RLG
Sbjct: 1 IINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHC----RKKVFRVRLGHYS 56
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPF--SNYVRPICLPHPNTPL 1401
S + + + K I HP Y G ND+ ++K+ + VRPI + + P
Sbjct: 57 LSPVYESGQQMFQGV-KSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINVSS-HCP- 113
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
+ GT C V GWG FP LQ + + ++S C ++ + MFCAG +
Sbjct: 114 SAGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAYP----RQIDDTMFCAG-D 168
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNNM 1520
+ GRD+C GDSGGP++C SL G+ S G Y CAR NRPGVYT + + W+ +
Sbjct: 169 KAGRDSCQGDSGGPVVCNG-----SLQGLVSWGDYPCARPNRPGVYTNLCKFTKWIQETI 223
Query: 1521 AA 1522
A
Sbjct: 224 QA 225
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid: Structure
Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine Pancreatic
Elastase Based On The X-Ray Crystal Structures Of
Complexes With Trifluoroacetyl-Dipeptide-Anilide
Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine Pancreatic
Elastase Based On The X-Ray Crystal Structures Of
Complexes With Trifluoroacetyl-Dipeptide-Anilide
Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala With
Porcine Pancreatic Elastase At 1.65 Angstroms Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)pyrrolidin-2-
One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)pyrrolidin-2-
One Soaked In Ph 9 Buffer For Two Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 % BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With Beta-Casomorphin-
7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At Ph
5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme Intermediate
In The Hydrolysis Of An Ester Substrate By Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi And
Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme Intermediate
In The Hydrolysis Of An Ester Substrate By Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 123 bits (309), Expect = 8e-28, Method: Composition-based stats.
Identities = 85/251 (33%), Positives = 130/251 (51%), Gaps = 23/251 (9%)
Query: 1285 IVGGGNARLGSWPWQAAL-YKEGE---FQCGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
+VGG A+ SWP Q +L Y+ G CG TLI W+++A HC D R+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCV----DRELTFRVV 56
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQY----VDAGFINDISILKM--KTPFSNYVRPICL 1394
+ EQ + KI++HP + V AG+ DI++L++ ++YV+ L
Sbjct: 57 VGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGY--DIALLRLAQSVTLNSYVQLGVL 114
Query: 1395 PHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTEN 1454
P T L + + C + GWG G++ TLQ+ LP + A C + + V +
Sbjct: 115 PRAGTILANNSPCYITGWGLTRTNGQL-AQTLQQAYLPTVDYAICSSSSYWGS--TVKNS 171
Query: 1455 MFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNY 1512
M CAG + G R C GDSGGPL C +G++++ GVTS + GC +P V+T+VS Y
Sbjct: 172 MVCAGGD-GVRSGCQGDSGGPLHCL-VNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAY 229
Query: 1513 IPWLYNNMAAS 1523
I W+ N +A++
Sbjct: 230 ISWINNVIASN 240
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 123 bits (308), Expect = 9e-28, Method: Compositional matrix adjust.
Identities = 80/239 (33%), Positives = 114/239 (47%), Gaps = 31/239 (12%)
Query: 1297 PWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRRGTKLPSPYEQLR 1356
PW A+Y+ ++QCG L+ W+L+A HC Y + W+ + L P +Q R
Sbjct: 16 PWHVAVYRFNKYQCGGVLLDRNWVLTAAHC-YNDKYQVWLGKNNFLED-----EPSDQHR 69
Query: 1357 PISKIILHPQY-----------VDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLTD 1403
+SK I HP + + + ND+ +L++ P ++ V+PI LP L
Sbjct: 70 LVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTEEPKL-- 127
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
G+ C GWG I +PD LQ V L ++ +C K +VT+ M CAG G
Sbjct: 128 GSTCLASGWGSTTPIKFKYPDDLQCVNLKLLPNEDCDKAHEM----KVTDAMLCAGEMDG 183
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNNMA 1521
G C DSGGPL+C DG L G+TS G C P VYTK+ + W+ MA
Sbjct: 184 GSYTCEHDSGGPLIC---DG--ILQGITSWGPEPCGEPTEPSVYTKLIKFSSWIRETMA 237
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 123 bits (308), Expect = 9e-28, Method: Compositional matrix adjust.
Identities = 85/249 (34%), Positives = 122/249 (48%), Gaps = 24/249 (9%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT-- 1341
++ G R G PWQ L + + CGA LI W+L+A HC ++ + RLG
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKL--LVRLGEYD 58
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
LRR K +E I ++ +HP Y + NDI++L + P S + PICLP
Sbjct: 59 LRRWEK----WELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGL 114
Query: 1400 PLTD----GTLCTVVGWG----QLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRV 1451
+ G V GWG + E R L +++P++ EC + + V
Sbjct: 115 AERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNM----V 170
Query: 1452 TENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSN 1511
+ENM CAG +DAC GDSGGP M G W L+G+ S G GC + GVYTKVS
Sbjct: 171 SENMLCAGILGDRQDACEGDSGGP-MVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSR 229
Query: 1512 YIPWLYNNM 1520
Y+ W++ ++
Sbjct: 230 YLDWIHGHI 238
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 123 bits (308), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 82/241 (34%), Positives = 121/241 (50%), Gaps = 26/241 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+ G GS PWQ AL + CG L++++W+L+A HC + + + LG+
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHC----KMNEYTVHLGSDTL 56
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPLT 1402
G + Q SK HP Y +ND+ ++K+ + S+ V+ + LP P
Sbjct: 57 GDR----RAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEP-- 110
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR-VTEN-MFCAGF 1460
GT CTV GWG FP L V + +IS +C K +Y+ + EN M CAG
Sbjct: 111 PGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTK------VYKDLLENSMLCAGI 164
Query: 1461 ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNN 1519
++AC GDSGGPL+C R +L G+ S G + C + N PGVYT+V + W+ +
Sbjct: 165 PDSKKNACNGDSGGPLVC-----RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDT 219
Query: 1520 M 1520
M
Sbjct: 220 M 220
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed With
Xenon And Bromide, Cryoprotected With Dry Paraffin Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed With
Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent Peptidyl
Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase Inhibit
Second Crystal Structure Of Covalent Serpin-Proteinase
Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase (ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample Cryoprotection
And Diffraction Phasing At Long Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 123 bits (308), Expect = 1e-27, Method: Composition-based stats.
Identities = 85/251 (33%), Positives = 129/251 (51%), Gaps = 23/251 (9%)
Query: 1285 IVGGGNARLGSWPWQAAL-YKEGE---FQCGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
+VGG A+ SWP Q +L Y+ G CG TLI W+++A HC D R+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCV----DRELTFRVV 56
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQY----VDAGFINDISILKM--KTPFSNYVRPICL 1394
EQ + KI++HP + V AG+ DI++L++ ++YV+ L
Sbjct: 57 VGEHNLNQNDGTEQYVGVQKIVVHPYWNTDDVAAGY--DIALLRLAQSVTLNSYVQLGVL 114
Query: 1395 PHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTEN 1454
P T L + + C + GWG G++ TLQ+ LP + A C + + V +
Sbjct: 115 PRAGTILANNSPCYITGWGLTRTNGQL-AQTLQQAYLPTVDYAICSSSSYWGS--TVKNS 171
Query: 1455 MFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNY 1512
M CAG + G R C GDSGGPL C +G++++ GVTS + GC +P V+T+VS Y
Sbjct: 172 MVCAGGD-GVRSGCQGDSGGPLHCL-VNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAY 229
Query: 1513 IPWLYNNMAAS 1523
I W+ N +A++
Sbjct: 230 ISWINNVIASN 240
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 122 bits (306), Expect = 2e-27, Method: Composition-based stats.
Identities = 85/251 (33%), Positives = 130/251 (51%), Gaps = 23/251 (9%)
Query: 1285 IVGGGNARLGSWPWQAAL-YKEGE---FQCGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
+VGG A+ SWP Q +L Y+ G CG TLI W+++A HC D R+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCV----DRELTFRVV 56
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQY----VDAGFINDISILKM--KTPFSNYVRPICL 1394
+ EQ + KI++HP + V AG+ DI++L++ ++YV+ L
Sbjct: 57 VGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGY--DIALLRLAQSVTLNSYVQLGVL 114
Query: 1395 PHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTEN 1454
P T L + + C + GWG G++ TLQ+ LP + A C + + V +
Sbjct: 115 PRAGTILRNNSPCYITGWGLTRTNGQL-AQTLQQAYLPTVDYAICSSSSYWGS--TVKNS 171
Query: 1455 MFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNY 1512
M CAG + G R C GDSGGPL C +G++++ GVTS + GC +P V+T+VS Y
Sbjct: 172 MVCAGGD-GVRSGCQGDSGGPLHCL-VNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAY 229
Query: 1513 IPWLYNNMAAS 1523
I W+ N +A++
Sbjct: 230 ISWINNVIASN 240
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 122 bits (306), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 82/245 (33%), Positives = 126/245 (51%), Gaps = 17/245 (6%)
Query: 1285 IVGGGNARLGSWPWQAAL--YKEGEFQ--CGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
+VGG +AR SWPWQ +L K ++ CG TLI+ ++L+A HC + R+
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCISNTR----TYRVA 56
Query: 1341 TLRRGTKLPSPYEQL-RPISKIILHPQYVDAGFINDISILKMK--TPFSNYVRPICLPHP 1397
+ ++ L + I +H ++ NDI+++K+ S+ ++ CLP
Sbjct: 57 VGKNNLEVEDEEGSLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQVACLPEK 116
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
++ L C V GWG+L+ G + D LQ+ P++ A C + + +RV + M C
Sbjct: 117 DSLLPKDYPCYVTGWGRLWTNGPI-ADKLQQGLQPVVDHATCSRIDWWG--FRVKKTMVC 173
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG--YGCARANRPGVYTKVSNYIPW 1515
AG + G AC GDSGGPL CQ +G W + G+ S G GC +P VYT+VS YI W
Sbjct: 174 AGGD-GVISACNGDSGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYTRVSAYIDW 232
Query: 1516 LYNNM 1520
+ M
Sbjct: 233 INEKM 237
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 122 bits (306), Expect = 2e-27, Method: Composition-based stats.
Identities = 80/242 (33%), Positives = 121/242 (50%), Gaps = 22/242 (9%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
++V GG S P+QAALY G CG LI W+L+A HC + LG +
Sbjct: 1 KLVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC----KKPNLQVFLG--K 54
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
+ ++ + + ++HP Y A DI +L++ P S ++P+ L +
Sbjct: 55 HNLRQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQ 114
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
T T C ++GWG+ + FPDT+Q + ++S EC P ++T+NM CAG E
Sbjct: 115 T--TSCHILGWGKTADGD--FPDTIQCAYIHLVSREECEHA---YP-GQITQNMLCAGDE 166
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNNM 1520
+ G+D+C GDSGGPL+C + L G+ S G C +PGVYT V Y W+ +
Sbjct: 167 KYGKDSCQGDSGGPLVCGD-----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTI 221
Query: 1521 AA 1522
A
Sbjct: 222 QA 223
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 121 bits (304), Expect = 3e-27, Method: Composition-based stats.
Identities = 79/227 (34%), Positives = 115/227 (50%), Gaps = 16/227 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG +A G +P+ ++ + G CG +L++ +L+A HC + R G+L R
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKT--PFSNYVRPICLPHPNTPLT 1402
+ + +S + +HP Y +G ND++ILK+ T P + L +
Sbjct: 61 TSGGIT-----SSLSSVRVHPSY--SGNNNDLAILKLSTSIPSGGNIGYARLAASGSDPV 113
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
G+ TV GWG E G P L +V +PI+S A CR + +T MFCAG
Sbjct: 114 AGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQ---YGTSAITNQMFCAGVSS 170
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKV 1509
GG+D+C GDSGGP++ D +L+G S G GCAR N GVY V
Sbjct: 171 GGKDSCQGDSGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASV 213
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 121 bits (304), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 78/241 (32%), Positives = 120/241 (49%), Gaps = 22/241 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+V GG S P+QAALY G CG LI W+L+A HC + ++ + +R
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC-KKPNLQVFLGKHNLRQR 59
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLT 1402
+ ++ + + ++HP Y A DI +L++ P S ++P LP
Sbjct: 60 ESS-----QEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSA 112
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
+ T C ++GWG+ + FPDT+Q + ++S EC ++T+NM CAG E+
Sbjct: 113 NTTSCHILGWGKTAD--GDFPDTIQCAYIHLVSREECEHAYPG----QITQNMLCAGDEK 166
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNNMA 1521
G+D+C GDSGGPL+C + L G+ S G C +PGVYT V Y W+ +
Sbjct: 167 YGKDSCQGDSGGPLVCGD-----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 221
Query: 1522 A 1522
A
Sbjct: 222 A 222
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A Para-Amidobenzylanmine
P1 Group Carry A High Binding Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1 Group
Length = 223
Score = 120 bits (302), Expect = 5e-27, Method: Composition-based stats.
Identities = 82/241 (34%), Positives = 121/241 (50%), Gaps = 22/241 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+V GG S P+QAALY G CG LI W+L+A HC + LG
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC----KKPNLQVFLGKHNL 56
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLT 1402
G + S ++ + + ++HP Y A DI +L++ P S ++P+ L + T
Sbjct: 57 GQQESS--QEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQT 114
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
T C ++GWG+ + FPDT+Q + ++S EC P ++T+NM CAG E+
Sbjct: 115 --TSCHILGWGKTADGD--FPDTIQCAYIHLVSREECEHA---YP-GQITQNMLCAGDEK 166
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNNMA 1521
G+D+C GDSGGPL+C + L G+ S G C +PGVYT V Y W+ +
Sbjct: 167 YGKDSCQGDSGGPLVCGD-----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 221
Query: 1522 A 1522
A
Sbjct: 222 A 222
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 120 bits (301), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 83/245 (33%), Positives = 122/245 (49%), Gaps = 23/245 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEF----QCGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
I+GG A+ S P+ A L E+ +CG LI + ++L+A HC LG
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHC----SGSKIQVTLG 56
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPF--SNYVRPICLPHPN 1398
K +Q+ P+ KII HP Y NDI +LK+K+ S+ V+P+ LP N
Sbjct: 57 A--HNIKEQEKMQQIIPVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNLPRRN 114
Query: 1399 TPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCA 1458
+ G +C V GWG+L +G+ + DTLQEV+L + +C +L Y N CA
Sbjct: 115 VKVKPGDVCYVAGWGKLGPMGK-YSDTLQEVELTVQEDQKCES---YLKNYFDKANEICA 170
Query: 1459 GFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYN 1518
G + R + GDSGGPL+C++ G+ S YG + P +TKVS ++ W+
Sbjct: 171 GDPKIKRASFRGDSGGPLVCKK-----VAAGIVS--YGQNDGSTPRAFTKVSTFLSWIKK 223
Query: 1519 NMAAS 1523
M S
Sbjct: 224 TMKKS 228
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6 Subunit
Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6 Subunit
Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 120 bits (300), Expect = 8e-27, Method: Composition-based stats.
Identities = 86/250 (34%), Positives = 128/250 (51%), Gaps = 25/250 (10%)
Query: 1288 GGNARLGSWPWQAALY--KEGEFQ--CGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
G +A SW WQ +L K+G F CG +LI+ W+++AGHC ++ Y V LG
Sbjct: 2 GEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRT-YQVV-LGEYD 59
Query: 1344 RGTKLPSPYEQLRPIS--KIILHPQY----VDAGFINDISILKMK--TPFSNYVRPICLP 1395
R S EQ+ PI+ + +HP + V G NDI+++K+ + V+ LP
Sbjct: 60 RSVLEGS--EQVIPINAGDLFVHPLWNSNCVACG--NDIALVKLSRSAQLGDKVQLANLP 115
Query: 1396 HPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
L + C + GWG+L+ G PD LQ+ LP + C + + V + M
Sbjct: 116 PAGDILPNEAPCYISGWGRLY-TGGPLPDKLQQALLPTVDYEHCSQWDWWG--ITVKKTM 172
Query: 1456 FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNYI 1513
CAG + R C GDSGGPL C DG W + GVTS + +GC +P V+T+VS +I
Sbjct: 173 VCAGGDT--RSGCNGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFI 230
Query: 1514 PWLYNNMAAS 1523
W+ +A++
Sbjct: 231 DWIDETIASN 240
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 120 bits (300), Expect = 8e-27, Method: Composition-based stats.
Identities = 78/227 (34%), Positives = 114/227 (50%), Gaps = 16/227 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG +A G +P+ ++ + G CG +L++ +L+A HC + R G+L R
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKT--PFSNYVRPICLPHPNTPLT 1402
+ + +S + +HP Y +G ND++ILK+ T P + L +
Sbjct: 61 TSGGIT-----SSLSSVRVHPSY--SGNNNDLAILKLSTSIPSGGNIGYARLAASGSDPV 113
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
G+ TV GWG E G P L +V +PI+S A CR + +T MFCAG
Sbjct: 114 AGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQ---YGTSAITNQMFCAGVSS 170
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKV 1509
GG+D+C GD GGP++ D +L+G S G GCAR N GVY V
Sbjct: 171 GGKDSCQGDXGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASV 213
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To Atomic
Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 119 bits (299), Expect = 1e-26, Method: Composition-based stats.
Identities = 79/229 (34%), Positives = 115/229 (50%), Gaps = 22/229 (9%)
Query: 1286 VGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRRG 1345
VGG +A G +P+ ++ + G CG +L++ +L+A HC + R G+L R
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSRT 61
Query: 1346 TKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSN-----YVRPICLPHPNTP 1400
+ + +S + +HP Y +G ND++ILK+ T + Y R L +
Sbjct: 62 SGGIT-----SSLSSVRVHPSY--SGNNNDLAILKLSTSIPSGGNIGYAR---LAASGSD 111
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF 1460
G+ TV GWG E G P L +V +PI+S A CR + +T MFCAG
Sbjct: 112 PVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQ---YGTSAITNQMFCAGV 168
Query: 1461 ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKV 1509
GG+D+C GDSGGP++ D +L+G S G GCAR N GVY V
Sbjct: 169 SSGGKDSCQGDSGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASV 213
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 119 bits (297), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 82/250 (32%), Positives = 118/250 (47%), Gaps = 31/250 (12%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+VGG N S PWQ A+Y + E CG L+ W+L+A HC Y Q + W+ + +
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQKEHICGGVLLDRNWVLTAAHC-YVDQYEVWLGKNKLFQE 59
Query: 1345 GTKLPSPYEQLRPISKIILHPQY-----------VDAGFINDISILKMKTP--FSNYVRP 1391
P Q R +SK HP + A F +D+ +L++ P ++ V+P
Sbjct: 60 -----EPSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKPADITDVVKP 114
Query: 1392 ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRV 1451
I LP G+ C GWG + PD LQ V + ++ C K + L +V
Sbjct: 115 IALPTKEP--KPGSKCLASGWGSITPTRWQKPDDLQCVFITLLPNENCAK----VYLQKV 168
Query: 1452 TENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVS 1510
T+ M CAG GG+D C DSGGPL+C DG L G TS G C + P +YT +
Sbjct: 169 TDVMLCAGEMGGGKDTCRDDSGGPLIC---DG--ILQGTTSYGPVPCGKPGVPAIYTNLI 223
Query: 1511 NYIPWLYNNM 1520
+ W+ + M
Sbjct: 224 KFNSWIKDTM 233
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 118 bits (295), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 81/253 (32%), Positives = 125/253 (49%), Gaps = 26/253 (10%)
Query: 1291 ARLGSWPWQAALYK--------EGEFQCGATLISDQWLLSAGHCF--YRAQDDYWVARLG 1340
A G +PW A+ K E + CG +LI+ +L+ HC Y++ D R G
Sbjct: 137 AEYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLTGAHCVNSYQSNLDAIKIRAG 196
Query: 1341 ---TLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPF--SNYVRPICLP 1395
TL +LP Q R I ++I+H + +ND+++L + P ++ + ICLP
Sbjct: 197 EWDTLTEKERLPY---QERKIRQVIIHSNFNPKTVVNDVALLLLDRPLVQADNIGTICLP 253
Query: 1396 HPNTPLTDGTLCTVVGWGQL-FEIGRVFPDTLQEVQLPIISTAECRK--RTLFLPLYRVT 1452
+ + D T C GWG+ F + + L+++QLP + +C+ R L L V
Sbjct: 254 Q-QSQIFDSTECFASGWGKKEFGSRHRYSNILKKIQLPTVDRDKCQADLRNTRLGLKFVL 312
Query: 1453 ENMF-CAGFERGGRDACLGDSGGPLMCQEP--DGRWSLMGVTSNGYGCARANRPGVYTKV 1509
+ F CAG E+G +D C GD G PL C +P R+ MG+ + G GC N PGVY V
Sbjct: 313 DQTFVCAGGEQG-KDTCTGDGGSPLFCPDPRNPSRYMQMGIVAWGIGCGDENVPGVYANV 371
Query: 1510 SNYIPWLYNNMAA 1522
+++ W+ M A
Sbjct: 372 AHFRNWIDQEMQA 384
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 116 bits (291), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 76/250 (30%), Positives = 123/250 (49%), Gaps = 20/250 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYR---AQDDYWVARLGT 1341
I+GG S P+ A++ G CG LI QW+L+A HC YR Q V +
Sbjct: 3 IIGGKEVSPHSRPFMASIQYGGHHVCGGVLIDPQWVLTAAHCQYRFTKGQSPTVVLGAHS 62
Query: 1342 LRR--GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHP 1397
L + +K ++ P S++ PQ NDI ++K++T + +V+ + +
Sbjct: 63 LSKNEASKQTLEIKKFIPFSRVTSDPQS------NDIMLVKLQTAAKLNKHVKMLHI-RS 115
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
T L GT C V GWG DTL+EV + ++S C ++ + +T++M C
Sbjct: 116 KTSLRSGTKCKVTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFITKDMVC 175
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVS-NYIPWL 1516
AG +G +D+C GD+GGPL+C + + S G+ C A +PG+YT ++ Y W+
Sbjct: 176 AGDAKGQKDSCKGDAGGPLIC-----KGVFHAIVSGGHECGVATKPGIYTLLTKKYQTWI 230
Query: 1517 YNNMAASEYN 1526
+N+ N
Sbjct: 231 KSNLVPPHTN 240
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 115 bits (289), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 74/243 (30%), Positives = 121/243 (49%), Gaps = 22/243 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
++GG + P+ A LY G F CG TLI+ +W+++A HC + +LG +
Sbjct: 1 VLGGDECDINEHPFLAFLYSHGYF-CGLTLINQEWVVTAAHC----DSTNFQMQLGVHSK 55
Query: 1345 GTKLPSPYEQLR-PISKIILHPQYVDAGFINDISILKMKTPFSN--YVRPICLPHPNTPL 1401
K+ + EQ R P K I + + DI ++K+ P SN ++ P+ LP + P
Sbjct: 56 --KVLNEDEQTRNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLP--SNPP 111
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
+ G++C ++GWG + +PD + ++ C+ LP + CAG
Sbjct: 112 SVGSVCRIMGWGSITIPNETYPDVPYCANINLVDYEVCQGAYNGLP----AKTTLCAGVL 167
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNNM 1520
GG+D C+GDSGGPL+C G+ S G + C + +PG+YT V +Y W+ N+
Sbjct: 168 EGGKDTCVGDSGGPLICNG-----QFQGIVSYGAHSCGQGPKPGIYTNVFDYTDWIQRNI 222
Query: 1521 AAS 1523
A +
Sbjct: 223 AGN 225
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North Atlantic
Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 114 bits (285), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 83/244 (34%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 1285 IVGGGNARLGSWPWQAAL-YKEGE---FQCGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
+VGG A+ SWPWQ +L YK G CG +LI W+++A HC A+ W LG
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCVDSART--WRVVLG 58
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQY----VDAGFINDISILKMKTPFS--NYVRPICL 1394
T EQ+ ++ + +H + V G+ DI++L++ T S + V+ L
Sbjct: 59 EHNLNTN--EGKEQIMTVNSVFIHSGWNSDDVAGGY--DIALLRLNTQASLNSAVQLAAL 114
Query: 1395 PHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTEN 1454
P N L + C + GWG+ G D+L++ LP + A C + + T
Sbjct: 115 PPSNQILPNNNPCYITGWGKT-STGGPLSDSLKQAWLPSVDHATCSSSGWWGSTVKTT-- 171
Query: 1455 MFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNY 1512
M CAG G C GDSGGPL CQ +G + + GVTS + GC + +P V+T+VS Y
Sbjct: 172 MVCAG--GGANSGCNGDSGGPLNCQV-NGSYYVHGVTSFVSSSGCNASKKPTVFTRVSAY 228
Query: 1513 IPWL 1516
I W+
Sbjct: 229 ISWM 232
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic System
Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic System
Of Mouse Brain
Length = 225
Score = 112 bits (279), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 76/232 (32%), Positives = 119/232 (51%), Gaps = 24/232 (10%)
Query: 1295 SWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRRGTKLPSPYEQ 1354
S PWQAAL++ CG L+ D+W+L+A HC + + RLG ++ P ++
Sbjct: 11 SQPWQAALFQGERLICGGVLVGDRWVLTAAHC----KKQKYSVRLGDHSLQSR-DQPEQE 65
Query: 1355 LRPISKIILHPQYVDAG---FINDISILKMKTP--FSNYVRPICLPHPNTPLTDGTLCTV 1409
++ +++ I HP Y ++ +DI +++++ + V+P+ L N G C +
Sbjct: 66 IQ-VAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQL--ANLCPKVGQKCII 122
Query: 1410 VGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACL 1469
GWG + FP+TL ++ I S +C + ++TE M CAG G D C
Sbjct: 123 SGWGTVTSPQENFPNTLNCAEVKIYSQNKCERAYPG----KITEGMVCAGSSNGA-DTCQ 177
Query: 1470 GDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPWLYNNM 1520
GDSGGPL+C DG L G+TS G C + +PGVYTK+ Y W+ M
Sbjct: 178 GDSGGPLVC---DGM--LQGITSWGSDPCGKPEKPGVYTKICRYTTWIKKTM 224
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 111 bits (278), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 79/243 (32%), Positives = 123/243 (50%), Gaps = 18/243 (7%)
Query: 1283 SRIVGGGNARLGSWPWQAAL--YKEGEFQ--CGATLISDQWLLSAGHCFYRAQDDYWVAR 1338
+R+VGG +A SWPWQ +L ++ ++ CG TLI+ +L+A HC R
Sbjct: 12 ARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCISNTL----TYR 67
Query: 1339 LGTLRRGTKLPSPYEQLR-PISKIILHPQYVDAGFINDISILKMK--TPFSNYVRPICLP 1395
+ + ++ L + I +H ++ NDI+++K+ + ++ CLP
Sbjct: 68 VALGKNNLEVEDEAGSLYVGVDTIFVHEKWNSFLVRNDIALIKLAETVELGDTIQVACLP 127
Query: 1396 HPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
+ L C V GWG+L+ G + + Q +Q P++ A C +R + V E M
Sbjct: 128 SEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQ-PVVDYATCSQRDWWGT--TVKETM 184
Query: 1456 FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG--CARANRPGVYTKVSNYI 1513
CAG + G AC GDSGGPL CQ DG+W + G+ S G G C +P V+T+VS YI
Sbjct: 185 VCAGGD-GVISACNGDSGGPLNCQA-DGQWDVRGIVSFGSGLSCNTFKKPTVFTRVSAYI 242
Query: 1514 PWL 1516
W+
Sbjct: 243 DWI 245
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 110 bits (274), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 84/256 (32%), Positives = 127/256 (49%), Gaps = 30/256 (11%)
Query: 1281 RHSRIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFY----RAQDDYWV 1336
+ RI+GG A++G++PWQ G + G L+ D+W+L+A H Y AQ +
Sbjct: 86 QRQRIIGGQKAKMGNFPWQVFTNIHG--RGGGALLGDRWILTAAHTLYPKEHEAQSN--- 140
Query: 1337 ARLGTLRRGTKLPSPYEQL-----RPISKIILHPQYVD---AGFINDISILKMK--TPFS 1386
A L T + E+L PI ++ +HP Y F DI++L+++
Sbjct: 141 ASLDVFLGHTNV----EELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLG 196
Query: 1387 NYVRPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFL 1446
+ PICLP +T G + V G+G + E ++ D L+ V+LP+ + C
Sbjct: 197 PNLLPICLPDNDTFYDLGLMGYVSGFGVMEE--KIAHD-LRFVRLPVANPQACENWLRGK 253
Query: 1447 PLYRV-TENMFCAGFERGGRDACLGDSGGPLMCQEPD-GRWSLMGVTSNGYGCARANRPG 1504
V ++NMFCAG +DAC GDSGG ++P+ RW G+ S G GC+R G
Sbjct: 254 NRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--G 311
Query: 1505 VYTKVSNYIPWLYNNM 1520
YTKV NY+ W+ M
Sbjct: 312 FYTKVLNYVDWIKKEM 327
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme Component
B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 109 bits (273), Expect = 1e-23, Method: Composition-based stats.
Identities = 77/243 (31%), Positives = 120/243 (49%), Gaps = 15/243 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ--CGATLISDQWLLSAGHCFYRAQDDYWVARLGTL 1342
IVGG AR +PWQ ++ ++ CG ++I+D+W++ A HC + + L
Sbjct: 1 IVGGIEARPYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCM--QGEAPALVSLVVG 58
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILK--MKTPFSNYVRPICLPHP-NT 1399
+ S Q + I ++ Y A ND+S++K + F V PIC P P N
Sbjct: 59 EHDSSAASTVRQTHDVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAPDPAND 118
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ + C+ GWG + G P L+ V L I + A C +Y ++M CA
Sbjct: 119 YVYRKSQCS--GWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTSDTIY---DDMICAT 173
Query: 1460 FERG--GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLY 1517
G RD+C GDSGGPL ++ G +SL+G+ S G GCA + PGVY++V + W+
Sbjct: 174 DNTGMTDRDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCA-SGYPGVYSRVGFHAGWIT 232
Query: 1518 NNM 1520
+ +
Sbjct: 233 DTI 235
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 109 bits (272), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 83/256 (32%), Positives = 127/256 (49%), Gaps = 30/256 (11%)
Query: 1281 RHSRIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFY----RAQDDYWV 1336
+ RI+GG A++G++PWQ G + G L+ D+W+L+A H Y AQ +
Sbjct: 86 QRQRIIGGQKAKMGNFPWQVFTNIHG--RGGGALLGDRWILTAAHTLYPKEHEAQSN--- 140
Query: 1337 ARLGTLRRGTKLPSPYEQL-----RPISKIILHPQYVD---AGFINDISILKMK--TPFS 1386
A L T + E+L PI ++ +HP Y F DI++L+++
Sbjct: 141 ASLDVFLGHTNV----EELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLG 196
Query: 1387 NYVRPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFL 1446
+ PICLP +T G + V G+G + E ++ D L+ V+LP+ + C
Sbjct: 197 PNLLPICLPDNDTFYDLGLMGYVSGFGVMEE--KIAHD-LRFVRLPVANPQACENWLRGK 253
Query: 1447 PLYRV-TENMFCAGFERGGRDACLGDSGGPLMCQEPD-GRWSLMGVTSNGYGCARANRPG 1504
V ++NMFCAG +DAC GD+GG ++P+ RW G+ S G GC+R G
Sbjct: 254 NRMDVFSQNMFCAGHPSLKQDACQGDAGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--G 311
Query: 1505 VYTKVSNYIPWLYNNM 1520
YTKV NY+ W+ M
Sbjct: 312 FYTKVLNYVDWIKKEM 327
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 108 bits (271), Expect = 2e-23, Method: Composition-based stats.
Identities = 73/230 (31%), Positives = 110/230 (47%), Gaps = 13/230 (5%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
+VGG A G +P+ L +E E CG L + +L+A HC + ++ + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGV- 59
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
L S +K++ P + + D +++K+ P + +P T
Sbjct: 60 --VDLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPIN---QPTLKIATTTAYNQ 114
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF-ER 1462
GT TV GWG E G L + +P +S A CR + F+ V M CAG+ +
Sbjct: 115 GTF-TVAGWGANREGGSQ-QRYLLKANVPFVSDAACRSSSSFI---LVANEMICAGYPDT 169
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNY 1512
GG D C GDSGGP+ ++ W +G+ S GYGCAR PGVYT+VS +
Sbjct: 170 GGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTF 219
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 108 bits (271), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 83/256 (32%), Positives = 127/256 (49%), Gaps = 30/256 (11%)
Query: 1281 RHSRIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFY----RAQDDYWV 1336
+ +I+GG A++G++PWQ G + G L+ D+W+L+A H Y AQ +
Sbjct: 154 QRQQIIGGQKAKMGNFPWQVFTNIHG--RGGGALLGDRWILTAAHTLYPKEHEAQSN--- 208
Query: 1337 ARLGTLRRGTKLPSPYEQL-----RPISKIILHPQYVD---AGFINDISILKMK--TPFS 1386
A L T + E+L PI ++ +HP Y F DI++L+++
Sbjct: 209 ASLDVFLGHTNV----EELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLG 264
Query: 1387 NYVRPICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFL 1446
+ PICLP +T G + V G+G + E ++ D L+ V+LP+ + C
Sbjct: 265 PNLLPICLPDNDTFYDLGLMGYVSGFGVMEE--KIAHD-LRFVRLPVANPQACENWLRGK 321
Query: 1447 PLYRV-TENMFCAGFERGGRDACLGDSGGPLMCQEPD-GRWSLMGVTSNGYGCARANRPG 1504
V ++NMFCAG +DAC GDSGG ++P+ RW G+ S G GC+R G
Sbjct: 322 NRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--G 379
Query: 1505 VYTKVSNYIPWLYNNM 1520
YTKV NY+ W+ M
Sbjct: 380 FYTKVLNYVDWIKKEM 395
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 108 bits (270), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 119/241 (49%), Gaps = 21/241 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+ G + S PWQAAL E E C L+ QW+LSA HCF Q+ Y + LG L
Sbjct: 1 IINGEDCSPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCF---QNSYTIG-LG-LHS 55
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPF--SNYVRPICLPHPNTPLT 1402
P Q+ S + HP+Y ND+ ++K+ S+ +R I + P T
Sbjct: 56 LEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISIAS-QCP-T 113
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
G C V GWG L GR+ P LQ V + ++S C K L+ PLY +MFCAG +
Sbjct: 114 AGNSCLVSGWG-LLANGRM-PTVLQCVNVSVVSEEVCSK--LYDPLYH--PSMFCAGGGQ 167
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPWLYNNMA 1521
+D+C GDSGGPL+C L G+ S G C + PGVYT + + W+ +
Sbjct: 168 DQKDSCNGDSGGPLICNG-----YLQGLVSFGKAPCGQVGVPGVYTNLCKFTEWIEKTVQ 222
Query: 1522 A 1522
A
Sbjct: 223 A 223
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 108 bits (270), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 83/252 (32%), Positives = 125/252 (49%), Gaps = 30/252 (11%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFY----RAQDDYWVARLG 1340
I+GG A++G++PWQ G + G L+ D+W+L+A H Y AQ + A L
Sbjct: 1 IIGGQKAKMGNFPWQVFTNIHG--RGGGALLGDRWILTAAHTLYPKEHEAQSN---ASLD 55
Query: 1341 TLRRGTKLPSPYEQL-----RPISKIILHPQYVD---AGFINDISILKMK--TPFSNYVR 1390
T + E+L PI ++ +HP Y F DI++L+++ +
Sbjct: 56 VFLGHTNV----EELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLL 111
Query: 1391 PICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR 1450
PICLP +T G + V G+G + E ++ D L+ V+LP+ + C
Sbjct: 112 PICLPDNDTFYDLGLMGYVSGFGVMEE--KIAHD-LRFVRLPVANPQACENWLRGKNRMD 168
Query: 1451 V-TENMFCAGFERGGRDACLGDSGGPLMCQEPD-GRWSLMGVTSNGYGCARANRPGVYTK 1508
V ++NMFCAG +DAC GDSGG ++P+ RW G+ S G GC+R G YTK
Sbjct: 169 VFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTK 226
Query: 1509 VSNYIPWLYNNM 1520
V NY+ W+ M
Sbjct: 227 VLNYVDWIKKEM 238
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 107 bits (266), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 80/242 (33%), Positives = 116/242 (47%), Gaps = 25/242 (10%)
Query: 1285 IVGGGNARLGSWPWQAA---LYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
I+GG A+ S P+ A L ++ +CG L+ ++L+A HC Q LG
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHC----QGSSINVTLGA 56
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNT 1399
K +Q P+ + I HP Y F NDI +L++ K ++ VRP+ LP
Sbjct: 57 --HNIKEQERTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLPSSKA 114
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY-RVTENMFCA 1458
+ G LC+V GWG + TLQEV L + +C + LF Y R TE C
Sbjct: 115 QVKPGQLCSVAGWG--YVSMSTLATTLQEVLLTVQKDCQCER--LFHGNYSRATE--ICV 168
Query: 1459 GFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYN 1518
G + + GDSGGPL+C++ G+ S YG + PGVY KVS+++PW+
Sbjct: 169 GDPKKTQTGFKGDSGGPLVCKD-----VAQGILS--YGNKKGTPPGVYIKVSHFLPWIKR 221
Query: 1519 NM 1520
M
Sbjct: 222 TM 223
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 107 bits (266), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 83/253 (32%), Positives = 114/253 (45%), Gaps = 33/253 (13%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG S PWQ + G CG L+ QW+L+A HC V LG R
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCIRNKS----VILLG--RH 54
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFI------------NDISILKMKTP--FSNYVR 1390
P Q+ +S HP Y D + +D+ +L++ P ++ V+
Sbjct: 55 SLFHPEDTGQVFQVSHSFPHPLY-DMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVK 113
Query: 1391 PICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR 1450
+ LP L GT C GWG + + P LQ V L +IS C + + +
Sbjct: 114 VMDLPTQEPAL--GTTCYASGWGSIEPEEFLTPKKLQCVDLHVISNDVCAQ----VHPQK 167
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGY-GCARANRPGVYTKV 1509
VT+ M CAG GG+ C GDSGGPL+C L G+TS G CA RP +YTKV
Sbjct: 168 VTKFMLCAGRWTGGKSTCSGDSGGPLVCNG-----VLQGITSWGSEPCALPERPSLYTKV 222
Query: 1510 SNYIPWLYNNMAA 1522
+Y W+ + + A
Sbjct: 223 VHYRKWIKDTIVA 235
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To Pmsf
Length = 222
Score = 107 bits (266), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 74/243 (30%), Positives = 123/243 (50%), Gaps = 30/243 (12%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG +A +G +P+Q +L G +CGA+++ + +L+A HC V L L R
Sbjct: 1 IVGGKDAPVGKYPYQVSLRLSGSHRCGASILDNNNVLTAAHC---------VDGLSNLNR 51
Query: 1345 -----GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHP 1397
GT S + + +++ Y D ND++++ + P F++ V+PI L
Sbjct: 52 LKVHVGTNYLSESGDVYDVEDAVVNKNYDDFLLRNDVALVHLTNPIKFNDLVQPIKLSTN 111
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
+ L + CT+ GWG +G P+ LQE++L + +C + +RV ++ C
Sbjct: 112 DEDL-ESNPCTLTGWGST-RLGGNTPNALQEIELIVHPQKQCERDQ-----WRVIDSHIC 164
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLY 1517
+R G AC GDSGGPL+ + +G+ S G CA P VYT+VS+++ W+
Sbjct: 165 TLTKR-GEGACHGDSGGPLVANG-----AQIGIVSFGSPCALG-EPDVYTRVSSFVSWIN 217
Query: 1518 NNM 1520
N+
Sbjct: 218 ANL 220
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 106 bits (264), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 81/252 (32%), Positives = 115/252 (45%), Gaps = 37/252 (14%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG S PWQ A+ E + CG LI W+++A HC+ ++Y V LG R
Sbjct: 1 IVGGYKCEKNSQPWQVAVINE--YLCGGVLIDPSWVITAAHCY---SNNYQVL-LG--RN 52
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFIND-----------ISILKMKTP--FSNYVRP 1391
P+ Q R + + HP Y+ ND + +L + P + V+
Sbjct: 53 NLFKDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPADITGGVKV 112
Query: 1392 ICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR- 1450
I LP + G+ C GWG V LQ V + ++S +C + Y+
Sbjct: 113 IDLPTKEPKV--GSTCLASGWGSTNPSEMVVSHDLQCVNIHLLSNEKC------IETYKD 164
Query: 1451 -VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTK 1508
VT+ M CAG GG+D C GDSGGPL+C DG L G+TS G CA+ P +Y K
Sbjct: 165 NVTDVMLCAGEMEGGKDTCAGDSGGPLIC---DG--VLQGITSGGATPCAKPKTPAIYAK 219
Query: 1509 VSNYIPWLYNNM 1520
+ + W+ M
Sbjct: 220 LIKFTSWIKKVM 231
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 105 bits (262), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 79/242 (32%), Positives = 116/242 (47%), Gaps = 25/242 (10%)
Query: 1285 IVGGGNARLGSWPWQAA---LYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
I+GG A+ S P+ A L ++ +CG L+ ++L+A HC Q LG
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHC----QGSSINVTLGA 56
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNT 1399
K +Q P+ + I HP Y F N+I +L++ K ++ VRP+ LP
Sbjct: 57 --HNIKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSKA 114
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLY-RVTENMFCA 1458
+ G LC+V GWG + TLQEV L + +C + LF Y R TE C
Sbjct: 115 QVKPGQLCSVAGWG--YVSMSTLATTLQEVLLTVQKDCQCER--LFHGNYSRATE--ICV 168
Query: 1459 GFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYN 1518
G + + GDSGGPL+C++ G+ S YG + PGVY KVS+++PW+
Sbjct: 169 GDPKKTQTGFKGDSGGPLVCKD-----VAQGILS--YGNKKGTPPGVYIKVSHFLPWIKR 221
Query: 1519 NM 1520
M
Sbjct: 222 TM 223
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 105 bits (262), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 46/271 (16%)
Query: 1284 RIVGGGNARLGSWPWQAAL----YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARL 1339
R+ G +L S PW A L + E F CG +IS++++L+A HC + Q+D + RL
Sbjct: 118 RVSNGYEVKLSSRPWMALLRYQQFGESRFLCGGAMISERYILTAAHCVHGLQNDLYEIRL 177
Query: 1340 GTLR-----------RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFS 1386
G R R K P + I K ++H +Y ++DI++LK+ PF
Sbjct: 178 GEHRISTEEDCRQQGRKKKCAPPVVNVG-IEKHLIHEKYDARHIMHDIALLKLNRSVPFQ 236
Query: 1387 NYVRPICLPHPNTPLTDGTLCT---VVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRT 1443
+++PICLP + + V GWG E G D L + +P+ + C +
Sbjct: 237 KHIKPICLPITDELKEKAEQISTYFVTGWGTT-ENGSS-SDVLLQANVPLQPRSACSQA- 293
Query: 1444 LFLPLYR--VTENMFCAGFERGG--RDACLGDSGGPLMCQEPD---GRWS----LMGVTS 1492
YR V + C G GG +D+C GDSGGPL Q P G ++ G+ S
Sbjct: 294 -----YRRAVPLSQLCVG---GGDLQDSCKGDSGGPL--QAPAQYLGEYAPKMVEFGIVS 343
Query: 1493 NG-YGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G C + + PG+YT V Y+ W+ + MA+
Sbjct: 344 QGVVTCGQISLPGLYTNVGEYVQWITDTMAS 374
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 105 bits (261), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 74/244 (30%), Positives = 111/244 (45%), Gaps = 16/244 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG S P+ L + + C LI+ W+L+A HC + + R
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLNKRSQVILGAHSITRE 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPLT 1402
P +Q+ + K +P Y A D+ +L++ K + YV + LP +
Sbjct: 61 -----EPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVK 115
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT+C V GWG+ + DTL+EV++ II C R + + NM CAG R
Sbjct: 116 PGTMCQVAGWGRTHNSAS-WSDTLREVEITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLR 174
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGY--GCARANRPGVYTKVS-NYIPWLYNN 1519
GGRD+C GDSG PL+C+ GVTS G C PGVY +S ++ W+
Sbjct: 175 GGRDSCNGDSGSPLLCEG-----VFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIMT 229
Query: 1520 MAAS 1523
+ +
Sbjct: 230 IKGA 233
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 104 bits (259), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 74/237 (31%), Positives = 108/237 (45%), Gaps = 16/237 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG S P+ L + + C LI+ W+L+A HC + + R
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLNKRSQVILGAHSITRE 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTPLT 1402
P +Q+ + K +P Y A D+ +L++ K + YV + LP +
Sbjct: 61 -----EPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVK 115
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
GT+C V GWG+ + DTL+EV + II C R + + NM CAG R
Sbjct: 116 PGTMCQVAGWGRTHNSAS-WSDTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLR 174
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGY--GCARANRPGVYTKVS-NYIPWL 1516
GGRD+C GDSG PL+C+ GVTS G C PGVY +S ++ W+
Sbjct: 175 GGRDSCNGDSGSPLLCEG-----VFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWI 226
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 103 bits (258), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 77/244 (31%), Positives = 120/244 (49%), Gaps = 29/244 (11%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ---CGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
I+GG A+ S P+ A L + + CG L+ + ++L+A HC + + A
Sbjct: 1 IIGGHEAKPHSRPYMAFLLFKTSGKSHICGGFLVREDFVLTAAHCLGSSINVTLGAHNIM 60
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNT 1399
R T +Q+ P+ + I HP Y D NDI +LK+ K ++ V PI LP
Sbjct: 61 ERERT------QQVIPVRRPIPHPDYNDETLANDIMLLKLTRKADITDKVSPINLPRSLA 114
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFP--DTLQEVQLPIISTAECRKRTL-FLPLYRVTENMF 1456
+ G +C+V GWG+L G P D LQEV L + S +C R ++P ++
Sbjct: 115 EVKPGMMCSVAGWGRL---GVNMPSTDKLQEVDLEVQSEEKCIARFKNYIPFTQI----- 166
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
CAG +++ GDSGGPL+C G+ S YG P VYT++S+++ W+
Sbjct: 167 CAGDPSKRKNSFSGDSGGPLVCNG-----VAQGIVS--YGRNDGTTPDVYTRISSFLSWI 219
Query: 1517 YNNM 1520
++ M
Sbjct: 220 HSTM 223
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 103 bits (256), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/242 (30%), Positives = 119/242 (49%), Gaps = 18/242 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
++GG + + A + F CG TLI+ +W+++A HC D+ + +LG +
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHC---DSTDFQM-QLGVHSK 56
Query: 1345 GTKLPSPYEQLR-PISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
K+ + EQ R P K I + + DI ++K+ P SN L P++P +
Sbjct: 57 --KVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPLSLPSSPPSV 114
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRK-RTLFLPLYRVTENMFCAGFER 1462
G++C ++GWG + + FPD + ++ A C+ L YR CAG +
Sbjct: 115 GSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEYRT----LCAGIVQ 170
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D C GDSGGPL+C G+ S G + C + +PG+YT V +Y W+ N+A
Sbjct: 171 GGKDTCGGDSGGPLICNG-----QFQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRNIA 225
Query: 1522 AS 1523
+
Sbjct: 226 GN 227
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 103 bits (256), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 72/242 (29%), Positives = 117/242 (48%), Gaps = 18/242 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
++GG + + A + F CG TLI+ +W+++A HC + +LG +
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHC----DSTNFQMQLGVHSK 56
Query: 1345 GTKLPSPYEQLR-PISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
K+ + EQ R P K I + + DI ++K+ P SN L P++P +
Sbjct: 57 --KVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPLSLPSSPPSV 114
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRK-RTLFLPLYRVTENMFCAGFER 1462
G++C ++GWG + + FPD + ++ A C+ L YR CAG +
Sbjct: 115 GSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEYRT----LCAGIVQ 170
Query: 1463 GGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNNMA 1521
GG+D C GDSGGPL+C G+ S G + C + +PG+YT V +Y W+ N+A
Sbjct: 171 GGKDTCGGDSGGPLICNG-----QFQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRNIA 225
Query: 1522 AS 1523
+
Sbjct: 226 GN 227
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal Plasma
Length = 237
Score = 102 bits (254), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 79/247 (31%), Positives = 113/247 (45%), Gaps = 33/247 (13%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG S PWQ A+Y +G FQCG L+ QW+L+A HC DDY ++ R
Sbjct: 1 IIGGWECEKHSKPWQVAVYHQGHFQCGGVLVHPQWVLTAAHCM---SDDY---QIWLGRH 54
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFI------------NDISILKMKTP--FSNYVR 1390
Q +S L PQ+ D + +D+ +L++ P ++ V+
Sbjct: 55 NLSKDEDTAQFHQVSDSFLDPQF-DLSLLKKKYLRPYDDISHDLMLLRLAQPARITDAVK 113
Query: 1391 PICLPHPNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR 1450
+ LP L G+ C GWG + TLQ V+L + S +C + P +
Sbjct: 114 ILDLPTQEPKL--GSTCYTSGWGLISTFTNRGSGTLQCVELRLQSNEKCARA---YP-EK 167
Query: 1451 VTENMFCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKV 1509
+TE + CA CLGDSGG L+C DG G+TS GY CA N V+TKV
Sbjct: 168 MTEFVLCATHRDDSGSICLGDSGGALIC---DG--VFQGITSWGYSECADFNDNFVFTKV 222
Query: 1510 SNYIPWL 1516
+ W+
Sbjct: 223 MPHKKWI 229
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 102 bits (253), Expect = 2e-21, Method: Composition-based stats.
Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 12/229 (5%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
+VGG A G +P+ L +E E CG L + +L+A HC + ++ + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGV- 59
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
L S +K++ P + + D +++K+ P + +P T
Sbjct: 60 --VDLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPIN---QPTLKIATTTAYNQ 114
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
GT TV GWG E G L + +P +S A CR + F+ V M CAG++
Sbjct: 115 GTF-TVAGWGANREGGSQ-QRYLLKANVPFVSDAACRSSSSFI---LVANEMICAGYDTK 169
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNY 1512
D C GDSGGP+ ++ W +G+ S G GCAR + GVYT+VS +
Sbjct: 170 QEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTF 218
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 101 bits (252), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 78/255 (30%), Positives = 124/255 (48%), Gaps = 30/255 (11%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
RI+GG +A + ++PWQ G LI++ W+L+A H ++ +G+
Sbjct: 82 RIIGGSDADIKNFPWQVFFDNP---WAGGALINEYWVLTAAHVVEGNREP--TMYVGSTS 136
Query: 1344 RGTKLPSPYEQLRPISKIILHPQY----VDAG---FINDISILKMKTP--FSNYVRPICL 1394
T + + L P + +HP + V G F NDI+++++K P V PICL
Sbjct: 137 VQTSRLAKSKMLTP-EHVFIHPGWKLLAVPEGRTNFDNDIALVRLKDPVKMGPTVSPICL 195
Query: 1395 PHPNTP--LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLP----- 1447
P ++ L DG L + GWG+ + R L+ +LP+ +C++ + P
Sbjct: 196 PGTSSDYNLMDGDLGLISGWGRTEKRDRAV--RLKAARLPVAPLRKCKEVKVEKPTADAE 253
Query: 1448 LYRVTENMFCAGFERGGRDACLGDSGGPLMCQEPDG--RWSLMGVTSNGYGCARANRPGV 1505
Y T NM CAG E+G D+C GDSGG Q+P+ ++ G+ S G C G+
Sbjct: 254 AYVFTPNMICAGGEKG-MDSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQCGTY---GL 309
Query: 1506 YTKVSNYIPWLYNNM 1520
YT+V NY+ W+ M
Sbjct: 310 YTRVKNYVDWIMKTM 324
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme Component
A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme Component
A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme Component
A From Eisenia Fetida
Length = 241
Score = 100 bits (250), Expect = 5e-21, Method: Composition-based stats.
Identities = 79/246 (32%), Positives = 118/246 (47%), Gaps = 17/246 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG---EFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
++GG NA G +PWQ + ++ CGA+L+S LSA HC + G
Sbjct: 1 VIGGTNASPGEFPWQLSQQRQSGSWSHSCGASLLSSTSALSASHCVDGVLPNNIRVIAGL 60
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYV--DAGFINDISILKMKTPFS--NYVRPICLPHP 1397
++ + Q + +H Y A + NDI+IL + T S ++ LP
Sbjct: 61 WQQSD---TSGTQTANVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQAAVLPAN 117
Query: 1398 NTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
N GT C + GWG+ + PD LQ+ +P+I+TA+C + + + +N C
Sbjct: 118 NNNDYAGTTCVISGWGRTDGTNNL-PDILQKSSIPVITTAQCTAAMVGVGGANIWDNHIC 176
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVT----SNGYGCARANRPGVYTKVSNYI 1513
G AC GDSGGPL C PDG ++GVT S+G G + P VYT+VS Y+
Sbjct: 177 VQDPAGNTGACNGDSGGPLNC--PDGGTRVVGVTSWVVSSGLGACLPDYPSVYTRVSAYL 234
Query: 1514 PWLYNN 1519
W+ +N
Sbjct: 235 GWIGDN 240
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 100 bits (248), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 69/239 (28%), Positives = 102/239 (42%), Gaps = 29/239 (12%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHC------FYRAQDDYWVAR 1338
++GG + + A +Y G CG TLI+ +W+L+A HC Y + V
Sbjct: 1 VIGGDECNINEHRFLALVYANGSL-CGGTLINQEWVLTARHCDRGNMRIYLGMHNLKVLN 59
Query: 1339 LGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPN 1398
LRR P K D + DI ++++ P N L P+
Sbjct: 60 KDALRR-----------FPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLPS 108
Query: 1399 TPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCA 1458
P + G++C ++GWG + PD + I+ A C+ L CA
Sbjct: 109 NPPSVGSVCRIMGWGTITSPNATLPDVPHCANINILDYAVCQAAYKGL-----AATTLCA 163
Query: 1459 GFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTS-NGYGCARANRPGVYTKVSNYIPWL 1516
G GG+D C GDSGGPL+C G+ S G CA+ +PG+YTKV +Y W+
Sbjct: 164 GILEGGKDTCKGDSGGPLICNG-----QFQGILSVGGNPCAQPRKPGIYTKVFDYTDWI 217
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 99.8 bits (247), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 77/254 (30%), Positives = 113/254 (44%), Gaps = 26/254 (10%)
Query: 1284 RIVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
RI+GG GS+PWQA + GATLI++QWLL+ + A+ +
Sbjct: 102 RIMGGSLDAKGSFPWQAKMISHHNLTSGATLINEQWLLTTAKNLRLGHKNDTKAK--DIA 159
Query: 1344 RGTKLPSPYEQLRPISKIILHP--QYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPL 1401
+L +Q I K+I HP VD G I LK K P + V PICLP + +
Sbjct: 160 PTLRLYVGKKQEVEIEKVIFHPDNSTVDIGLIK----LKQKVPVNERVMPICLPSKDY-V 214
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAEC----------RKRTLFLPLYR- 1450
G + V GWG+ + F + L+ V LP+ +C K+T P+
Sbjct: 215 NVGLVGYVSGWGRNANLN--FTEHLKYVMLPVADQEKCVQYYEGSTVPEKKTPKSPVGVQ 272
Query: 1451 --VTENMFCAGFERGGRDACLGDSGGPLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYT 1507
+ E+ FCAG + D C GD+G + D W G+ S C R GVY
Sbjct: 273 PILNEHTFCAGLSKYQEDTCYGDAGSAFAVHDKDDDTWYAAGILSFDKSC-RTAEYGVYV 331
Query: 1508 KVSNYIPWLYNNMA 1521
+V++ + W+ +A
Sbjct: 332 RVTSILDWIQTTIA 345
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor Protease
Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor Protease
Active Site Selectivity
Length = 224
Score = 99.8 bits (247), Expect = 1e-20, Method: Composition-based stats.
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+VGG A G +P+ L CG L + +L+A HC + ++ + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGV-- 54
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
L S +K++ P + + D +++K+ P + +P T G
Sbjct: 55 -VDLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPIN---QPTLKIATTTAYNQG 110
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T TV GWG E G L + +P +S A CR + F+ V M CAG++
Sbjct: 111 TF-TVAGWGANREGGSQ-QRYLLKANVPFVSDAACRSSSSFI---LVANEMICAGYDTKQ 165
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNY 1512
D C GDSGGP+ ++ W +G+ S G GCAR + GVYT+VS +
Sbjct: 166 EDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTF 213
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 99.4 bits (246), Expect = 1e-20, Method: Composition-based stats.
Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 29/245 (11%)
Query: 1285 IVGGGNARLGSWPWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQD-----DYWVAR 1338
+VGG G+ PW +L ++G+ CG +L+ +QW+L+A CF + W
Sbjct: 1 VVGG---HPGNSPWTVSLRNRQGQHFCGGSLVKEQWILTARQCFSSCHMPLTGYEVW--- 54
Query: 1339 LGTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMK--TPFSNYVRPICLPH 1396
LGTL + + P Q P++K++ P + + +LK++ + V ICLP
Sbjct: 55 LGTLFQNPQHGEPSLQRVPVAKMVCGPSG------SQLVLLKLERSVTLNQRVALICLPP 108
Query: 1397 PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQL-PIISTAECRKRTLFLPLYRVTENM 1455
+ GT C + GWG+ G DT+ V L +IS EC + RV E+
Sbjct: 109 EWYVVPPGTKCEIAGWGETKGTGN---DTVLNVALLNVISNQECNIKHR----GRVRESE 161
Query: 1456 FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPW 1515
C AC GD GGPL C + W L G+ CAR+ P V+T+VS ++ W
Sbjct: 162 MCTEGLLAPVGACEGDYGGPLACFTHNS-WVLEGIIIPNRVCARSRWPAVFTRVSVFVDW 220
Query: 1516 LYNNM 1520
++ M
Sbjct: 221 IHKVM 225
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 99.0 bits (245), Expect = 2e-20, Method: Composition-based stats.
Identities = 72/236 (30%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG S P+ A+L + G CG L+ +W+L+A HC + +A+L +
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQR-----MAQLRLVLG 55
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDA-GFINDISILKM--KTPFSNYVRPICLPHPNTPL 1401
L SP I I HP+Y ND+++L++ K S +RP+ LP +
Sbjct: 56 LHTLDSPGLTFH-IKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQVV 114
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
GT C++ GWG + GR+ L+E+ L ++ T C + ++ +M C +
Sbjct: 115 AAGTRCSMAGWGLTHQGGRL-SRVLRELDLQVLDTRMCNNSRFWNG--SLSPSMVCLAAD 171
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTS-NGYGCARANRPGVYTKVSNYIPWL 1516
+ C GDSGGPL+C + GR L GV S + C +P V T V+ Y+ W+
Sbjct: 172 SKDQAPCKGDSGGPLVCGK--GR-VLAGVLSFSSRVCTDIFKPPVATAVAPYVSWI 224
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 99.0 bits (245), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 16/241 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
++GG + A + F C TLI+++W+L+A HC + + +LG +
Sbjct: 1 VIGGDECNINEHRSLVAFFNSTGFFCSGTLINEEWVLTAAHC----DNTNFQMKLGVHSK 56
Query: 1345 GTKLPSPYEQLR-PISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
K+ + EQ R P K I + D DI ++K+ + SN + L P++P +
Sbjct: 57 --KVLNEDEQTRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHIVPLSLPSSPPSV 114
Query: 1404 GTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG 1463
G++C ++GWG + I +PD + ++ A C+ P CAG G
Sbjct: 115 GSVCHIMGWGSITPIKVTYPDVPYCAYINLLDDAVCQAG---YPELLTEYRTLCAGILEG 171
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWLYNNMAA 1522
G+D C GDSGGPL+C G+ S G + C + +PGVYTKV +Y W+ + +A
Sbjct: 172 GKDTCGGDSGGPLICNG-----QFQGIVSFGAHPCGQGLKPGVYTKVFDYNHWIQSIIAG 226
Query: 1523 S 1523
+
Sbjct: 227 N 227
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 98.6 bits (244), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 16/227 (7%)
Query: 1300 AALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRRGTKLPSPYEQLR-PI 1358
L+ F CG TLI+ W+++A HC + + G + K+ + EQ R P
Sbjct: 16 VVLFNSNGFLCGGTLINQDWVVTAAHC----DSNNFQLLFGVHSK--KILNEDEQTRDPK 69
Query: 1359 SKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDGTLCTVVGWGQLFEI 1418
K + D DI ++K+ + SN L P++P + G++C ++GWG+
Sbjct: 70 EKFFCPNRKKDDEVDKDIMLIKLDSSVSNSEHIAPLSLPSSPPSVGSVCRIMGWGKTIPT 129
Query: 1419 GRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACLGDSGGPLMC 1478
++PD + I+ A CR + +V CAG +GGRD C DSGGPL+C
Sbjct: 130 KEIYPDVPHCANINILDHAVCRTAYSW---RQVANTTLCAGILQGGRDTCHFDSGGPLIC 186
Query: 1479 QEPDGRWSLMGVTS-NGYGCARANRPGVYTKVSNYIPWLYNNMAASE 1524
G+ S G+ C + PGVYTKV +Y+ W+ + +A ++
Sbjct: 187 NG-----IFQGIVSWGGHPCGQPGEPGVYTKVFDYLDWIKSIIAGNK 228
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 98.6 bits (244), Expect = 3e-20, Method: Composition-based stats.
Identities = 72/235 (30%), Positives = 110/235 (46%), Gaps = 20/235 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG A SWP QAAL+ + + CG +LIS +W+L+A HC A V +R
Sbjct: 1 IVGGVEAVPNSWPHQAALFIDDMYFCGGSLISPEWILTAAHCMDGAGFVDVVLGAHNIRE 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
+ + +H Y NDI+++++ P + + P+T + G
Sbjct: 61 DEATQVTIQS----TDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGLPSTDVGVG 116
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR-VTENMFCAGFERG 1463
T+ T GWG + D L++V +PI+S A+C +Y VT+ C G
Sbjct: 117 TVVTPTGWGLPSDSALGISDVLRQVDVPIMSNADCDA------VYGIVTDGNICID-STG 169
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNG--YGCARANRPGVYTKVSNYIPWL 1516
G+ C GDSGGPL + G+TS G GC A P +T+V+ ++ W+
Sbjct: 170 GKGTCNGDSGGPL-----NYNGLTYGITSFGAAAGC-EAGYPDAFTRVTYFLDWI 218
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 97.4 bits (241), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 76/242 (31%), Positives = 112/242 (46%), Gaps = 23/242 (9%)
Query: 1285 IVGGGNARLGSWPWQA--ALYKEG--EFQCGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
I+GG S P+ A K G + CG L+ D+++L+A HC R+ LG
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHCKGRSM----TVTLG 56
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPN 1398
K +Q+ P++K I HP Y NDI +LK+ + VRP+ LP N
Sbjct: 57 A--HNIKAKEETQQIIPVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPRRN 114
Query: 1399 TPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCA 1458
+ G C V GWG++ G FP TL EV+L + C + F Y N C
Sbjct: 115 AHVKPGDECYVAGWGKVTPDGE-FPKTLHEVKLTVQKDQVCESQ--FQSSYN-RANEICV 170
Query: 1459 GFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYN 1518
G + + GDSGGPL+C+ + G+ S YG + P V+T+V +++ W+
Sbjct: 171 GDSKIKGASFRGDSGGPLVCKR-----AAAGIVS--YGQTDGSAPQVFTRVLSFVSWIKK 223
Query: 1519 NM 1520
M
Sbjct: 224 TM 225
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 97.1 bits (240), Expect = 7e-20, Method: Composition-based stats.
Identities = 71/236 (30%), Positives = 114/236 (48%), Gaps = 16/236 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG S P+ A+L + G CG L+ +W+L+A HC + +A+L +
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQR-----MAQLRLVLG 55
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDA-GFINDISILKM--KTPFSNYVRPICLPHPNTPL 1401
L SP I I HP+Y N++++L++ K S +RP+ LP +
Sbjct: 56 LHTLDSPGLTFH-IKAAIQHPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSKRQVV 114
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
GT C++ GWG + GR+ L+E+ L ++ T C + ++ +M C +
Sbjct: 115 AAGTRCSMAGWGLTHQGGRL-SRVLRELDLQVLDTRMCNNSRFWNG--SLSPSMVCLAAD 171
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTS-NGYGCARANRPGVYTKVSNYIPWL 1516
+ C GDSGGPL+C + GR L GV S + C +P V T V+ Y+ W+
Sbjct: 172 SKDQAPCKGDSGGPLVCGK--GR-VLAGVLSFSSRVCTDIFKPPVATAVAPYVSWI 224
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 97.1 bits (240), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 71/243 (29%), Positives = 113/243 (46%), Gaps = 16/243 (6%)
Query: 1285 IVGGGNARLGSWPWQAALY--KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTL 1342
I+GG + + ALY + CG TLI+ +W+L+A HC D R+
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHC------DRKNFRIKLG 54
Query: 1343 RRGTKLPSPYEQLR-PISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPL 1401
K+P+ EQ R P K + DI ++++ +P N P++P
Sbjct: 55 MHSKKVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSKHIAPFSLPSSPP 114
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFE 1461
+ G++C ++GWG++ +PD V + ++ CR L T CAG
Sbjct: 115 SVGSVCRIMGWGRISPTEGTYPDVPHCVNINLLEYEMCRAPYPEFEL-PATSRTLCAGIL 173
Query: 1462 RGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPWLYNNM 1520
GG+D C GDSGGPL+C G+ S G CA+ ++P YTKV +++ W+ N +
Sbjct: 174 EGGKDTCKGDSGGPLICNG-----QFQGIASWGDDPCAQPHKPAAYTKVFDHLDWIENII 228
Query: 1521 AAS 1523
A +
Sbjct: 229 AGN 231
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of The
Porcine Alpha Trypsin
Length = 98
Score = 97.1 bits (240), Expect = 8e-20, Method: Composition-based stats.
Identities = 46/105 (43%), Positives = 67/105 (63%), Gaps = 9/105 (8%)
Query: 1419 GRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACLGDSGGPLMC 1478
G +P LQ ++ P++S + C+ P ++T NM C GF +GG+D+C GDSGGP++C
Sbjct: 3 GSSYPSLLQCLKAPVLSNSSCKSS---YP-GQITGNMICVGFLQGGKDSCQGDSGGPVVC 58
Query: 1479 QEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
L G+ S GYGCA+ N+PGVYTKV NY+ W+ +AA+
Sbjct: 59 NG-----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN 98
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 97.1 bits (240), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 19/225 (8%)
Query: 1298 WQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDY--WVARLGTLRRGTKLPSPYEQ 1354
W +L + CG +LI + W+L+A CF R DY W+ RG + +Q
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDE---KCKQ 69
Query: 1355 LRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLTDGTLCTVVGW 1412
+ +S+++ P+ +D+ ++K+ P ++V I LP+ + + + T C+V GW
Sbjct: 70 VLNVSQLVYGPEG------SDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGW 123
Query: 1413 GQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACLGDS 1472
G I + L+ L I+ +C + + E+ CAG E+ G C GD
Sbjct: 124 GYTGLIN--YDGLLRVAHLYIMGNEKCSQH--HRGKVTLNESEICAGAEKIGSGPCEGDY 179
Query: 1473 GGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLY 1517
GGPL+C++ R ++GV G GCA NRPG++ +V+ Y W++
Sbjct: 180 GGPLVCEQHKMR-MVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIH 223
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With The
Sema Domain Of The Met Receptor
Length = 234
Score = 97.1 bits (240), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 19/225 (8%)
Query: 1298 WQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDY--WVARLGTLRRGTKLPSPYEQ 1354
W +L + CG +LI + W+L+A CF R DY W+ RG + +Q
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDE---KCKQ 69
Query: 1355 LRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLTDGTLCTVVGW 1412
+ +S+++ P+ +D+ ++K+ P ++V I LP+ + + + T C+V GW
Sbjct: 70 VLNVSQLVYGPEG------SDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGW 123
Query: 1413 GQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACLGDS 1472
G I + L+ L I+ +C + + E+ CAG E+ G C GD
Sbjct: 124 GYTGLIN--YDGLLRVAHLYIMGNEKCSQH--HRGKVTLNESEICAGAEKIGSGPCEGDY 179
Query: 1473 GGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLY 1517
GGPL+C++ R ++GV G GCA NRPG++ +V+ Y W++
Sbjct: 180 GGPLVCEQHKMR-MVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIH 223
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 96.3 bits (238), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 74/241 (30%), Positives = 113/241 (46%), Gaps = 22/241 (9%)
Query: 1285 IVGGGNARLGSWPWQAALY---KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
I+GG A+ S P+ A L ++ +CG LI D ++L+A HC+ + + LG
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHCWGSSIN----VTLGA 56
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNT 1399
K P +Q P+ + I HP Y F NDI +L++ K + V+P+ LP
Sbjct: 57 --HNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKA 114
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ G C+V GWGQ +G+ TLQEV++ + +C L Y + C G
Sbjct: 115 QVKPGQTCSVAGWGQTAPLGK-HSHTLQEVKMTVQEDRKCESD---LRHYYDSTIELCVG 170
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
+ + GDSGGPL+C + G+ S YG P TKVS+++ W+
Sbjct: 171 DPEIKKTSFKGDSGGPLVCNK-----VAQGIVS--YGRNNGMPPRACTKVSSFVHWIKKT 223
Query: 1520 M 1520
M
Sbjct: 224 M 224
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A Resolution
Length = 98
Score = 96.3 bits (238), Expect = 1e-19, Method: Composition-based stats.
Identities = 46/105 (43%), Positives = 66/105 (62%), Gaps = 9/105 (8%)
Query: 1419 GRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACLGDSGGPLMC 1478
G +P LQ ++ P++S + C+ P ++T NM C GF GG+D+C GDSGGP++C
Sbjct: 3 GSSYPSLLQCLKAPVLSDSSCKSS---YP-GQITGNMICVGFLEGGKDSCQGDSGGPVVC 58
Query: 1479 QEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
L G+ S GYGCA+ N+PGVYTKV NY+ W+ +AA+
Sbjct: 59 NG-----QLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN 98
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Ppack-Bound
Form)
Length = 234
Score = 96.3 bits (238), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 68/246 (27%), Positives = 112/246 (45%), Gaps = 24/246 (9%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGE--FQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTL 1342
+VGG + P+ ALY C LI+ +W+L+A HC R R+
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHCDRRN------IRIKLG 54
Query: 1343 RRGTKLPSPYEQLR-PISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ + EQ+R P K G DI +++++ P +S ++ P+ LP +
Sbjct: 55 MHSKNIRNEDEQIRVPRGKYFCLNTKFPNGLDKDIMLIRLRRPVTYSTHIAPVSLPSRSR 114
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ G+ C ++GWG++ +PD + I+ C ++P CAG
Sbjct: 115 GV--GSRCRIMGWGKISTT--TYPDVPHCTNIFIVKHKWCEPLYPWVP---ADSRTLCAG 167
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGY-GCARANRPGVYTKVSNYIPWLYN 1518
+GGRD C GDSGGPL+C + G+ + G C + +P VYTKV +Y W+ +
Sbjct: 168 ILKGGRDTCHGDSGGPLICNG-----EMHGIVAGGSEPCGQHLKPAVYTKVFDYNNWIQS 222
Query: 1519 NMAASE 1524
+A +
Sbjct: 223 IIAGNR 228
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 96.3 bits (238), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 74/241 (30%), Positives = 113/241 (46%), Gaps = 22/241 (9%)
Query: 1285 IVGGGNARLGSWPWQAALY---KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
I+GG A+ S P+ A L ++ +CG LI D ++L+A HC+ + + LG
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHCWGSSIN----VTLGA 56
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNT 1399
K P +Q P+ + I HP Y F NDI +L++ K + V+P+ LP
Sbjct: 57 --HNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKA 114
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAG 1459
+ G C+V GWGQ +G+ TLQEV++ + +C L Y + C G
Sbjct: 115 QVKPGQTCSVAGWGQTAPLGK-HSHTLQEVKMTVQEDRKCESD---LRHYYDSTIELCVG 170
Query: 1460 FERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNN 1519
+ + GDSGGPL+C + G+ S YG P TKVS+++ W+
Sbjct: 171 DPEIKKTSFKGDSGGPLVCNK-----VAQGIVS--YGRNNGMPPRACTKVSSFVHWIKKT 223
Query: 1520 M 1520
M
Sbjct: 224 M 224
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 95.1 bits (235), Expect = 3e-19, Method: Composition-based stats.
Identities = 71/229 (31%), Positives = 103/229 (44%), Gaps = 18/229 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+VGG A G +P+ L CG L + +L+A HC + ++ + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGV-- 54
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
L S +K++ P Y G D +++K+ P + +P T G
Sbjct: 55 -VDLQSSSAVKVRSTKVLQAPGYNGTG--KDWALIKLAQPIN---QPTLKIATTTAYNQG 108
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF-ERG 1463
T TV GWG E G L + +P +S A CR V CAG+ + G
Sbjct: 109 TF-TVAGWGANREGGSQ-QRYLLKANVPFVSDAACRSA---YGNELVANEEICAGYPDTG 163
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNY 1512
G D C GDSGGP+ ++ W +G+ S GYGCAR PGVYT+VS +
Sbjct: 164 GVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTF 212
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin At
1.7 Angstroms Resolution
Length = 223
Score = 95.1 bits (235), Expect = 3e-19, Method: Composition-based stats.
Identities = 72/232 (31%), Positives = 107/232 (46%), Gaps = 24/232 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLG---T 1341
+VGG A G +P+ L CG L + +L+A HC + ++ + G
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPL 1401
L+ G + ++R +K++ P Y G D +++K+ P + +P T
Sbjct: 57 LQSGAAV-----KVRS-TKVLQAPGYNGTG--KDWALIKLAQPIN---QPTLKIATTTAY 105
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF- 1460
GT TV GWG E G L + +P +S A CR V CAG+
Sbjct: 106 NQGTF-TVAGWGANREGGSQ-QRYLLKANVPFVSDAACRSA---YGNELVANEEICAGYP 160
Query: 1461 ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNY 1512
+ GG D C GDSGGP+ ++ W +G+ S GYGCAR PGVYT+VS +
Sbjct: 161 DTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTF 212
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 95.1 bits (235), Expect = 3e-19, Method: Composition-based stats.
Identities = 71/229 (31%), Positives = 103/229 (44%), Gaps = 18/229 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+VGG A G +P+ L CG L + +L+A HC + ++ + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGV-- 54
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
L S +K++ P Y G D +++K+ P + +P T G
Sbjct: 55 -VDLQSSSAVKVRSTKVLQAPGYNGTG--KDWALIKLAQPIN---QPTLKIATTTAYNQG 108
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF-ERG 1463
T TV GWG E G L + +P +S A CR V CAG+ + G
Sbjct: 109 TF-TVAGWGANREGGSQ-QRYLLKANVPFVSDAACRSA---YGNELVANEEICAGYPDTG 163
Query: 1464 GRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNY 1512
G D C GDSGGP+ ++ W +G+ S GYGCAR PGVYT+VS +
Sbjct: 164 GVDPCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTF 212
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 94.4 bits (233), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 75/242 (30%), Positives = 111/242 (45%), Gaps = 23/242 (9%)
Query: 1285 IVGGGNARLGSWPWQA--ALYKEG--EFQCGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
I+GG S P+ A K G + CG L+ D+++L+A HC R+ LG
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHCKGRSM----TVTLG 56
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPN 1398
K +Q+ P++K I HP Y NDI +LK+ + VRP+ LP N
Sbjct: 57 A--HNIKAKEETQQIIPVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPRRN 114
Query: 1399 TPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCA 1458
+ G C V GWG++ G FP TL EV+L + C + F Y N C
Sbjct: 115 AHVKPGDECYVAGWGKVTPDGE-FPKTLHEVKLTVQKDQVCESQ--FQSSYN-RANEICV 170
Query: 1459 GFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYN 1518
G + + DSGGPL+C+ + G+ S YG + P V+T+V +++ W+
Sbjct: 171 GDSKIKGASFEEDSGGPLVCKR-----AAAGIVS--YGQTDGSAPQVFTRVLSFVSWIKK 223
Query: 1519 NM 1520
M
Sbjct: 224 TM 225
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 93.6 bits (231), Expect = 7e-19, Method: Composition-based stats.
Identities = 76/242 (31%), Positives = 112/242 (46%), Gaps = 26/242 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKE---GEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
I+GG +R S P+ A L + G+ +CG L+ + ++L+A HC+ + A
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQ 60
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPI--CLPHPNT 1399
R T +Q + I HPQY NDI +L++ LP
Sbjct: 61 RRENT------QQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQE 114
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAEC-RKRTLFLPLYRVTENMFCA 1458
L GTLCTV GWG++ R DTL+EVQL + +C R + P ++ C
Sbjct: 115 GLRPGTLCTVAGWGRVSM--RRGTDTLREVQLRVQRDRQCLRIFGSYDPRRQI-----CV 167
Query: 1459 GFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYN 1518
G R + A GDSGGPL+C G+ S YG + P V+T+VS+++PW+
Sbjct: 168 GDRRERKAAFKGDSGGPLLCNN-----VAHGIVS--YGKSSGVPPEVFTRVSSFLPWIRT 220
Query: 1519 NM 1520
M
Sbjct: 221 TM 222
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G And
Chymase With Therapeutic Efficacy In Animals Models Of
Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 93.6 bits (231), Expect = 9e-19, Method: Composition-based stats.
Identities = 76/242 (31%), Positives = 112/242 (46%), Gaps = 26/242 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKE---GEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
I+GG +R S P+ A L + G+ +CG L+ + ++L+A HC+ + A
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQ 60
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPI--CLPHPNT 1399
R T +Q + I HPQY NDI +L++ LP
Sbjct: 61 RRENT------QQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQE 114
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAEC-RKRTLFLPLYRVTENMFCA 1458
L GTLCTV GWG++ R DTL+EVQL + +C R + P ++ C
Sbjct: 115 GLRPGTLCTVAGWGRVSM--RRGTDTLREVQLRVQRDRQCLRIFGSYDPRRQI-----CV 167
Query: 1459 GFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYN 1518
G R + A GDSGGPL+C G+ S YG + P V+T+VS+++PW+
Sbjct: 168 GDRRERKAAFKGDSGGPLLCNN-----VAHGIVS--YGKSSGVPPEVFTRVSSFLPWIRT 220
Query: 1519 NM 1520
M
Sbjct: 221 TM 222
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 93.6 bits (231), Expect = 9e-19, Method: Composition-based stats.
Identities = 69/228 (30%), Positives = 102/228 (44%), Gaps = 17/228 (7%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
+VGG A G +P+ L CG L + +L+A HC + ++ + G +
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGV-- 54
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDG 1404
L S +K++ P Y G D +++K+ P + +P T G
Sbjct: 55 -VDLQSSSAVKVRSTKVLQAPGYNGTG--KDWALIKLAQPIN---QPTLKIATTTAYNQG 108
Query: 1405 TLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGG 1464
T TV GWG E G L + +P +S A CR V CAG++ GG
Sbjct: 109 TF-TVAGWGANREGGSQ-QRYLLKANVPFVSDAACRSA---YGNELVANEEICAGYDTGG 163
Query: 1465 RDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNY 1512
D C GDSGGP+ ++ W +G+ S G GCAR + GVYT+VS +
Sbjct: 164 VDTCQGDSGGPMFRKDNADEWIQVGIVSWGEGCARKGKYGVYTEVSTF 211
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The Complex
Formed By Porcine Kallikrein A And The Bovine Pancreatic
Trypsin Inhibitor. Crystallization, Patterson Search,
Structure Determination, Refinement, Structure And
Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its Comparison
With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its Comparison
With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 92.4 bits (228), Expect = 2e-18, Method: Composition-based stats.
Identities = 56/154 (36%), Positives = 87/154 (56%), Gaps = 24/154 (15%)
Query: 1372 FINDISILKMKTP--FSNYVRPICLPHPNTPLTDGTLCTVVGWGQL------FEIGRVFP 1423
+ +D+ +L++++P ++ V+ + LP L G+ C GWG + FE FP
Sbjct: 6 YSHDLMLLRLQSPAKITDAVKVLELPTQEPEL--GSTCEASGWGSIEPGPDDFE----FP 59
Query: 1424 DTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACLGDSGGPLMCQEPDG 1483
D +Q VQL ++ C +VTE+M CAG+ GG+D C+GDSGGPL+C +G
Sbjct: 60 DEIQCVQLTLLQNTFCADAHP----DKVTESMLCAGYLPGGKDTCMGDSGGPLIC---NG 112
Query: 1484 RWSLMGVTSNGYG-CARANRPGVYTKVSNYIPWL 1516
W G+TS G+ C AN+P +YTK+ Y+ W+
Sbjct: 113 MWQ--GITSWGHTPCGSANKPSIYTKLIFYLDWI 144
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 89.0 bits (219), Expect = 2e-17, Method: Composition-based stats.
Identities = 43/101 (42%), Positives = 65/101 (64%), Gaps = 7/101 (6%)
Query: 1423 PDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACLGDSGGPLMCQEPD 1482
P+ LQ+ LPI+S A+C+K ++T+ M CAG G D+C+GDSGGPL+CQ+ D
Sbjct: 6 PEKLQQAALPIVSEADCKKSWG----SKITDVMTCAG--ASGVDSCMGDSGGPLVCQK-D 58
Query: 1483 GRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
G W+L G+ S G G + PGVY++V+ +PW+ + A+
Sbjct: 59 GVWTLAGIVSWGSGVCSTSTPGVYSRVTALMPWVQQILEAN 99
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 87.4 bits (215), Expect = 6e-17, Method: Composition-based stats.
Identities = 71/244 (29%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 1285 IVGGGNARLGSWPWQAALY---KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT 1341
IVGG A+ S P+ A+L G CG TLI ++L+A HC LG
Sbjct: 1 IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIPQRLVNVVLGA 60
Query: 1342 LRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNT 1399
+ P +Q ++++ L+ Y +NDI ++++ +P S V + LP +
Sbjct: 61 --HNVRTQEPTQQHFSVAQVFLN-NYDAENKLNDILLIQLSSPANLSASVATVQLPQQDQ 117
Query: 1400 PLTDGTLCTVVGWGQLFEIGRVFP--DTLQEVQLPIISTAECRKRTLFLPLYRVTENMFC 1457
P+ GT C +GWG+ +G P LQE+ + ++ T CR + C
Sbjct: 118 PVPHGTQCLAMGWGR---VGAHDPPAQVLQELNVTVV-TFFCRPHNI------------C 161
Query: 1458 AGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNG-YGCARANRPGVYTKVSNYIPWL 1516
R C GDSGGPL+C DG + G+ S +GCA P +T+V+ Y+ W+
Sbjct: 162 TFVPRRKAGICFGDSGGPLIC---DG--IIQGIDSFVIWGCATRLFPDFFTRVALYVDWI 216
Query: 1517 YNNM 1520
+ +
Sbjct: 217 RSTL 220
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At 1.9-Angstroms
Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At 1.9-Angstroms
Resolution
Length = 224
Score = 87.0 bits (214), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 78/242 (32%), Positives = 108/242 (44%), Gaps = 33/242 (13%)
Query: 1285 IVGGGNARLGSWPWQAAL----YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
I+GG + S P+ A L K CG LIS Q++L+A HC R A
Sbjct: 1 IIGGVESIPHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHCKGREITVILGAHDV 60
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPN 1398
R T +Q + K I+H Y ++DI +LK+ K + V + LP P+
Sbjct: 61 RKREST------QQKIKVEKQIIHESYNSVPNLHDIMLLKLEKKVELTPAVNVVPLPSPS 114
Query: 1399 TPLTDGTLCTVVGWGQLFEIGRVFPD--TLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
+ G +C GWG+ G P TL+EV+L I+ C YR E F
Sbjct: 115 DFIHPGAMCWAAGWGK---TGVRDPTSYTLREVELRIMDEKACVD-------YRYYEYKF 164
Query: 1457 --CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
C G R A +GDSGGPL+C G+ S YG A P ++T+VS Y+P
Sbjct: 165 QVCVGSPTTLRAAFMGDSGGPLLCAG-----VAHGIVS--YGHPDAKPPAIFTRVSTYVP 217
Query: 1515 WL 1516
W+
Sbjct: 218 WI 219
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 86.7 bits (213), Expect = 1e-16, Method: Composition-based stats.
Identities = 42/101 (41%), Positives = 64/101 (63%), Gaps = 7/101 (6%)
Query: 1423 PDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACLGDSGGPLMCQEPD 1482
P+ LQ+ LPI+S A+C+K ++T+ M CAG G D+C+GDSGGPL+CQ+ D
Sbjct: 6 PEKLQQAALPIVSEADCKKSWG----SKITDVMTCAG--ASGVDSCMGDSGGPLVCQK-D 58
Query: 1483 GRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
G W+L G+ S G G + P VY++V+ +PW+ + A+
Sbjct: 59 GVWTLAGIVSWGSGVCSTSTPAVYSRVTALMPWVQQILEAN 99
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin With
The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 86.7 bits (213), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 55/147 (37%), Positives = 80/147 (54%), Gaps = 15/147 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQDDYW-----V 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D + +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI+++K+K P FS+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWGQLFE 1417
LP T L G V GWG L E
Sbjct: 120 LPDRETAASLLQAGYKGRVTGWGNLKE 146
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 83.6 bits (205), Expect = 9e-16, Method: Composition-based stats.
Identities = 71/238 (29%), Positives = 104/238 (43%), Gaps = 31/238 (13%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG AR +WP+ +L G CGATLI+ +++SA HC LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMK--TPFSNYVRPICLPHPNTPLT 1402
+ P+ Q+ + + I Y +NDI IL++ + V+ LP L
Sbjct: 61 SRREPT--RQVFAVQR-IFEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLG 117
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
+G C +GWG L R LQE+ + ++ T+ CR R+ L R
Sbjct: 118 NGVQCLAMGWG-LLGRNRGIASVLQELNVTVV-TSLCR-RSNVCTLVR------------ 162
Query: 1463 GGRDA--CLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNYIPWL 1516
GR A C GDSG PL+C + G+ S G GCA P + V+ ++ W+
Sbjct: 163 -GRQAGVCFGDSGSPLVCNG-----LIHGIASFVRG-GCASGLYPDAFAPVAQFVNWI 213
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 83.6 bits (205), Expect = 9e-16, Method: Composition-based stats.
Identities = 45/130 (34%), Positives = 72/130 (55%), Gaps = 8/130 (6%)
Query: 1288 GGNARLGSWPWQAALYKEGEFQ-CGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRRGT 1346
G +A GSWPWQ +L + F CG +LIS+ W+++A HC + D V G +G+
Sbjct: 1 GEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSD---VVVAGEFDQGS 57
Query: 1347 KLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPLTDG 1404
+ Q+ I+++ +P++ NDI++LK+ TP FS V +CLP+ + G
Sbjct: 58 DEENI--QVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLPNVDDDFPPG 115
Query: 1405 TLCTVVGWGQ 1414
T+C GWG+
Sbjct: 116 TVCATTGWGK 125
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 83.2 bits (204), Expect = 1e-15, Method: Composition-based stats.
Identities = 71/238 (29%), Positives = 104/238 (43%), Gaps = 31/238 (13%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG AR +WP+ +L G CGATLI+ +++SA HC LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMK--TPFSNYVRPICLPHPNTPLT 1402
+ P+ Q+ + + I Y +NDI IL++ + V+ LP L
Sbjct: 61 SRREPT--RQVFAVQR-IFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLG 117
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
+G C +GWG L R LQE+ + ++ T+ CR R+ L R
Sbjct: 118 NGVQCLAMGWG-LLGRNRGIASVLQELNVTVV-TSLCR-RSNVCTLVR------------ 162
Query: 1463 GGRDA--CLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNYIPWL 1516
GR A C GDSG PL+C + G+ S G GCA P + V+ ++ W+
Sbjct: 163 -GRQAGVCFGDSGSPLVCNG-----LIHGIASFVRG-GCASGLYPDAFAPVAQFVNWI 213
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 83.2 bits (204), Expect = 1e-15, Method: Composition-based stats.
Identities = 71/238 (29%), Positives = 104/238 (43%), Gaps = 31/238 (13%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG AR +WP+ +L G CGATLI+ +++SA HC LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMK--TPFSNYVRPICLPHPNTPLT 1402
+ P+ Q+ + + I Y +NDI IL++ + V+ LP L
Sbjct: 61 SRREPT--RQVFAVQR-IFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLG 117
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
+G C +GWG L R LQE+ + ++ T+ CR R+ L R
Sbjct: 118 NGVQCLAMGWG-LLGRNRGIASVLQELNVTVV-TSLCR-RSNVCTLVR------------ 162
Query: 1463 GGRDA--CLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNYIPWL 1516
GR A C GDSG PL+C + G+ S G GCA P + V+ ++ W+
Sbjct: 163 -GRQAGVCFGDSGSPLVCNG-----LIHGIASFVRG-GCASGLYPDAFAPVAQFVNWI 213
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl 101,
146
Length = 218
Score = 83.2 bits (204), Expect = 1e-15, Method: Composition-based stats.
Identities = 71/238 (29%), Positives = 104/238 (43%), Gaps = 31/238 (13%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG AR +WP+ +L G CGATLI+ +++SA HC LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMK--TPFSNYVRPICLPHPNTPLT 1402
+ P+ Q+ + + I Y +NDI IL++ + V+ LP L
Sbjct: 61 SRREPT--RQVFAVQR-IFEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLG 117
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
+G C +GWG L R LQE+ + ++ T+ CR R+ L R
Sbjct: 118 NGVQCLAMGWG-LLGRNRGIASVLQELNVTVV-TSLCR-RSNVCTLVR------------ 162
Query: 1463 GGRDA--CLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNYIPWL 1516
GR A C GDSG PL+C + G+ S G GCA P + V+ ++ W+
Sbjct: 163 -GRQAGVCFGDSGSPLVCNG-----LIHGIASFVRG-GCASGLYPDAFAPVAQFVNWI 213
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex With
Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G And
Chymase With Therapeutic Efficacy In Animals Models Of
Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors Of
Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 83.2 bits (204), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 116/248 (46%), Gaps = 33/248 (13%)
Query: 1285 IVGGGNARLGSWPWQAALY-----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARL 1339
I+GG + S P+ A L +F CG LI ++L+A HC R+ L
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKF-CGGFLIRRNFVLTAAHCAGRSI----TVTL 55
Query: 1340 GTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNT 1399
G T+ +++L I K HP+Y + +DI +LK+K S + LP P+
Sbjct: 56 GA-HNITEEEDTWQKLEVI-KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQ 113
Query: 1400 P--LTDGTLCTVVGWGQLFEIGRVFP--DTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
+ G +C V GWG+ G + P DTLQEV+L ++ C F N+
Sbjct: 114 KNFVPPGRMCRVAGWGR---TGVLKPGSDTLQEVKLRLMDPQACSHFRDF------DHNL 164
Query: 1456 -FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
C G R + A GDSGGPL+C + G+ S YG + A P V+T++S+Y P
Sbjct: 165 QLCVGNPRKTKSAFKGDSGGPLLCAG-----AAQGIVS--YGRSDAKPPAVFTRISHYQP 217
Query: 1515 WLYNNMAA 1522
W+ + A
Sbjct: 218 WINQILQA 225
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of Human
Fibrinogen Bound To Bovine Thrombin At 2.3 Angstroms
Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues 7-
19). Three Complexes, One With Epsilon-Thrombin And Two
With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 83.2 bits (204), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 54/143 (37%), Positives = 77/143 (53%), Gaps = 15/143 (10%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHC-FYRAQD-----DYWV 1336
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC Y D D +
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 1337 ARLGTLRRGTKLPSPYEQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPIC 1393
R+G R T+ E++ + KI +HP+Y DI++LK+K P S+Y+ P+C
Sbjct: 61 VRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVC 119
Query: 1394 LPHPNTP---LTDGTLCTVVGWG 1413
LP T L G V GWG
Sbjct: 120 LPDKQTAAKLLHAGFKGRVTGWG 142
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 82.4 bits (202), Expect = 2e-15, Method: Composition-based stats.
Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 8/133 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ-CGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IV G +A GSWPWQ +L + F CG +LIS+ W+++A HC + D V G
Sbjct: 1 IVNGEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSD---VVVAGEFD 57
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
+G+ + Q+ I+++ +P++ NDI++LK+ TP FS V + LP+ +
Sbjct: 58 QGSDEENI--QVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVSLPNVDDDF 115
Query: 1402 TDGTLCTVVGWGQ 1414
GT+C GWG+
Sbjct: 116 PPGTVCATTGWGK 128
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 82.0 bits (201), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 116/248 (46%), Gaps = 33/248 (13%)
Query: 1285 IVGGGNARLGSWPWQAALY-----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARL 1339
I+GG + S P+ A L +F CG LI ++L+A HC R+ L
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKF-CGGFLIRRNFVLTAAHCAGRSI----TVTL 55
Query: 1340 GTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPN- 1398
G T+ +++L I K HP+Y + +DI +LK+K S + LP P+
Sbjct: 56 GA-HNITEEEDTWQKLEVI-KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQ 113
Query: 1399 -TPLTDGTLCTVVGWGQLFEIGRVFP--DTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
+ G +C V GWG+ G + P DTLQEV+L ++ C F N+
Sbjct: 114 FNFVPPGRMCRVAGWGR---TGVLKPGSDTLQEVKLRLMDPQACSHFRDF------DHNL 164
Query: 1456 -FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
C G R + A GDSGGPL+C + G+ S YG + A P V+T++S+Y P
Sbjct: 165 QLCVGNPRKTKSAFKGDSGGPLLCAG-----AAQGIVS--YGRSDAKPPAVFTRISHYQP 217
Query: 1515 WLYNNMAA 1522
W+ + A
Sbjct: 218 WINQILQA 225
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 82.0 bits (201), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 116/248 (46%), Gaps = 33/248 (13%)
Query: 1285 IVGGGNARLGSWPWQAALY-----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARL 1339
I+GG ++ S P+ A L +F CG LI ++L+A HC R+ L
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGPSKF-CGGFLIRRNFVLTAAHCAGRSI----TVTL 55
Query: 1340 GTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPN- 1398
G T+ +++L I K HP+Y + +DI +LK+K S + LP P+
Sbjct: 56 GA-HNITEEEDTWQKLEVI-KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQ 113
Query: 1399 -TPLTDGTLCTVVGWGQLFEIGRVFP--DTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
+ G +C V GWG+ G + P DTLQEV+L ++ C F N+
Sbjct: 114 FNFVPPGRMCRVAGWGR---TGVLKPGSDTLQEVKLRLMDPQACSHFRDF------DHNL 164
Query: 1456 -FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
C G R + A GDSGGPL+C G+ S YG + A P V+T++S+Y P
Sbjct: 165 QLCVGNPRKTKSAFKGDSGGPLLCAG-----VAQGIVS--YGRSDAKPPAVFTRISHYRP 217
Query: 1515 WLYNNMAA 1522
W+ + A
Sbjct: 218 WINQILQA 225
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 81.3 bits (199), Expect = 4e-15, Method: Composition-based stats.
Identities = 70/238 (29%), Positives = 103/238 (43%), Gaps = 31/238 (13%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
IVGG AR +WP+ +L G CGATLI+ +++SA HC LG
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMK--TPFSNYVRPICLPHPNTPLT 1402
+ P+ Q+ + + I Y +NDI IL++ + V+ LP L
Sbjct: 61 SRREPT--RQVFAVQR-IFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLG 117
Query: 1403 DGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFER 1462
+G C +GWG L R LQE+ + ++ T+ CR R+ L R
Sbjct: 118 NGVQCLAMGWG-LLGRNRGIASVLQELNVTVV-TSLCR-RSNVCTLVR------------ 162
Query: 1463 GGRDA--CLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNYIPWL 1516
GR A C GD G PL+C + G+ S G GCA P + V+ ++ W+
Sbjct: 163 -GRQAGVCFGDXGSPLVCNG-----LIHGIASFVRG-GCASGLYPDAFAPVAQFVNWI 213
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of Human
Fibrinogen Bound To Bovine Thrombin At 2.3 Angstroms
Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues 7-
19). Three Complexes, One With Epsilon-Thrombin And Two
With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 81.3 bits (199), Expect = 4e-15, Method: Composition-based stats.
Identities = 43/103 (41%), Positives = 58/103 (56%), Gaps = 8/103 (7%)
Query: 1418 IGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERG-GR--DACLGDSGG 1474
+ V P LQ V LP++ C+ T R+T+NMFCAG++ G G+ DAC GDSGG
Sbjct: 2 VAEVQPSVLQVVNLPLVERPVCKASTRI----RITDNMFCAGYKPGEGKRGDACEGDSGG 57
Query: 1475 PLMCQEP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
P + + P + RW MG+ S G GC R + G YT V W+
Sbjct: 58 PFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 100
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 80.9 bits (198), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 115/248 (46%), Gaps = 33/248 (13%)
Query: 1285 IVGGGNARLGSWPWQAALY-----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARL 1339
I+GG + S P+ A L +F CG LI ++L+A HC R+ L
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKF-CGGFLIRRNFVLTAAHCAGRSI----TVTL 55
Query: 1340 GTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPN- 1398
G T+ +++L I K HP+Y + +DI +LK+K S + LP P+
Sbjct: 56 GA-HNITEEEDTWQKLEVI-KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQ 113
Query: 1399 -TPLTDGTLCTVVGWGQLFEIGRVFP--DTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
+ G +C V GWG+ G + P DTLQEV+L ++ C F N+
Sbjct: 114 FNFVPPGRMCRVAGWGR---TGVLKPGSDTLQEVKLRLMDPQACSHFRDF------DHNL 164
Query: 1456 -FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
C G R + A GDSGGPL+C G+ S YG + A P V+T++S+Y P
Sbjct: 165 QLCVGNPRKTKSAFKGDSGGPLLCAG-----VAQGIVS--YGRSDAKPPAVFTRISHYRP 217
Query: 1515 WLYNNMAA 1522
W+ + A
Sbjct: 218 WINQILQA 225
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 80.9 bits (198), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 115/248 (46%), Gaps = 33/248 (13%)
Query: 1285 IVGGGNARLGSWPWQAALY-----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARL 1339
I+GG + S P+ A L +F CG LI ++L+A HC R+ L
Sbjct: 3 IIGGTECKPHSRPYMAYLEIVTSNGPSKF-CGGFLIRRNFVLTAAHCAGRSI----TVTL 57
Query: 1340 GTLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPN- 1398
G T+ +++L I K HP+Y + +DI +LK+K S + LP P+
Sbjct: 58 GA-HNITEEEDTWQKLEVI-KQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQ 115
Query: 1399 -TPLTDGTLCTVVGWGQLFEIGRVFP--DTLQEVQLPIISTAECRKRTLFLPLYRVTENM 1455
+ G +C V GWG+ G + P DTLQEV+L ++ C F N+
Sbjct: 116 FNFVPPGRMCRVAGWGR---TGVLKPGSDTLQEVKLRLMDPQACSHFRDF------DHNL 166
Query: 1456 -FCAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIP 1514
C G R + A GDSGGPL+C G+ S YG + A P V+T++S+Y P
Sbjct: 167 QLCVGNPRKTKSAFKGDSGGPLLCAG-----VAQGIVS--YGRSDAKPPAVFTRISHYRP 219
Query: 1515 WLYNNMAA 1522
W+ + A
Sbjct: 220 WINQILQA 227
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin With
The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 80.5 bits (197), Expect = 8e-15, Method: Composition-based stats.
Identities = 43/98 (43%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 1423 PDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQ 1479
P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSGGP + +
Sbjct: 3 PSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMK 58
Query: 1480 EP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
P + RW MG+ S G GC R + G YT V W+
Sbjct: 59 SPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 96
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid Acid
Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-Leucil-
Phenylalanine Aldehyde Bound At The Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE Complex
Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of Inhibited
Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly Equilibrating
Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly Equilibrating
Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral Intermediate
Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated With
(2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation Of
Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 80.5 bits (197), Expect = 8e-15, Method: Composition-based stats.
Identities = 47/132 (35%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQ-CGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
IV G A GSWPWQ +L + F CG +LI++ W+++A HC D V G
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD---VVVAGEFD 57
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTP--FSNYVRPICLPHPNTPL 1401
+G+ S Q I+K+ + +Y NDI++LK+ T FS V +CLP +
Sbjct: 58 QGSS--SEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDF 115
Query: 1402 TDGTLCTVVGWG 1413
GT C GWG
Sbjct: 116 AAGTTCVTTGWG 127
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 80.5 bits (197), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 107/238 (44%), Gaps = 25/238 (10%)
Query: 1285 IVGGGNARLGSWPWQAAL---YKEGEFQ-CGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
I+GG R + P+ A L E C LI ++++A HC R+ A
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHLSACSGFLIRRNFVMTAAHCAGRSITVLLGAHNK 60
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLP--HPN 1398
++ T +++L + K HP+Y D +NDI +LK+K + + LP +
Sbjct: 61 KVKEDT-----WQKLE-VEKQFPHPKYDDRLVLNDIMLLKLKEKANLTLGVGTLPISAKS 114
Query: 1399 TPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCA 1458
+ G +C VGWG+ + DTLQEV++ I+ C+ F E C
Sbjct: 115 NSIPPGRVCRAVGWGRT-NVNEPPSDTLQEVKMRILDPQACKHFEDFH-----QEPQLCV 168
Query: 1459 GFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
G + R+ GDSGGPL+C G+ S Y A P V+T++S+Y PW+
Sbjct: 169 GNPKKIRNVYKGDSGGPLLCAG-----IAQGIAS--YVLRNAKPPSVFTRISHYRPWI 219
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 80.1 bits (196), Expect = 1e-14, Method: Composition-based stats.
Identities = 43/98 (43%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 1423 PDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF--ERGGR-DACLGDSGGPLMCQ 1479
P LQ V LPI+ C+ T R+T+NMFCAG+ + G R DAC GDSGGP + +
Sbjct: 3 PSVLQVVNLPIVERPVCKDSTRI----RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMK 58
Query: 1480 EP-DGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWL 1516
P + RW MG+ S G GC R + G YT V W+
Sbjct: 59 SPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 96
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid Acid
Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-Leucil-
Phenylalanine Aldehyde Bound At The Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE Complex
Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of Inhibited
Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly Equilibrating
Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly Equilibrating
Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral Intermediate
Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated With
(2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation Of
Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 77.0 bits (188), Expect = 7e-14, Method: Composition-based stats.
Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 7/101 (6%)
Query: 1423 PDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACLGDSGGPLMCQEPD 1482
PD LQ+ LP++S C+K ++ + M CAG G +C+GDSGGPL+C++ +
Sbjct: 4 PDRLQQASLPLLSNTNCKKYWG----TKIKDAMICAG--ASGVSSCMGDSGGPLVCKK-N 56
Query: 1483 GRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
G W+L+G+ S G + PGVY +V+ + W+ +AA+
Sbjct: 57 GAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN 97
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 77.0 bits (188), Expect = 8e-14, Method: Composition-based stats.
Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 7/101 (6%)
Query: 1423 PDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRDACLGDSGGPLMCQEPD 1482
PD LQ+ LP++S C+K ++ + M CAG G +C+GDSGGPL+C++ +
Sbjct: 3 PDRLQQASLPLLSNTNCKKYWG----TKIKDAMICAG--ASGVSSCMGDSGGPLVCKK-N 55
Query: 1483 GRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAAS 1523
G W+L+G+ S G + PGVY +V+ + W+ +AA+
Sbjct: 56 GAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLAAN 96
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 76.6 bits (187), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 30/247 (12%)
Query: 1285 IVGGGNARLGSWPWQAAL----YKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLG 1340
I+ G A G +P+QA L + CG +LI ++W+L+A HC + A
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCVHDAVSV------- 53
Query: 1341 TLRRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM-KTPFSNYVRPICLP---H 1396
+ G+ + E + +II H + ++ND++++K+ +++ ++PI LP
Sbjct: 54 VVYLGSAVQYEGEAVVNSERIISHSMFNPDTYLNDVALIKIPHVEYTDNIQPIRLPSGEE 113
Query: 1397 PNTPLTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMF 1456
N + TV GWGQ LQ +I C + P + E+
Sbjct: 114 LNNKF-ENIWATVSGWGQ----SNTDTVILQYTYNLVIDNDRCAQE---YPPGIIVESTI 165
Query: 1457 CAGFERGGRDACLGDSGGPLMCQEPDGRWSLMGVTS--NGYGCARANRPGVYTKVSNYIP 1514
C G G+ C GDSGGP + + + L+GV S +G GC + +P +++V++Y+
Sbjct: 166 C-GDTSDGKSPCFGDSGGPFVLSDKN---LLIGVVSFVSGAGC-ESGKPVGFSRVTSYMD 220
Query: 1515 WLYNNMA 1521
W+ N
Sbjct: 221 WIQQNTG 227
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 72.0 bits (175), Expect = 2e-12, Method: Composition-based stats.
Identities = 68/241 (28%), Positives = 105/241 (43%), Gaps = 37/241 (15%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT--L 1342
IVGG AR +P+ A++ +G +CG LI +++++A CF LG L
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGSHECGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTP 1400
RR + + +S+ PQ +ND+ +L++ + ++ V + LP N
Sbjct: 61 RRRERQSRQTFSISSMSENGYDPQQN----LNDLMLLQLDREANLTSSVTILPLPLQNAT 116
Query: 1401 LTDGTLCTVVGWGQLFEIGRV--FPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCA 1458
+ GT C V GWG GR+ FP + V + + +CR N C
Sbjct: 117 VEAGTRCQVAGWGSQRSGGRLSRFP---RFVNVTVTPEDQCRP------------NNVCT 161
Query: 1459 GF--ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPW 1515
G RGG C GD G PL+C+ GV S G C R P +T+V+ + W
Sbjct: 162 GVLTRRGG--ICNGDGGTPLVCEG-----LAHGVASFSLGPCGRG--PDFFTRVALFRDW 212
Query: 1516 L 1516
+
Sbjct: 213 I 213
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 70.1 bits (170), Expect = 9e-12, Method: Composition-based stats.
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 37/241 (15%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT--L 1342
IVGG AR +P+ A++ +G CG LI +++++A CF LG L
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTP 1400
RR + + +S+ PQ +ND+ +L++ + ++ V + LP N
Sbjct: 61 RRRERQSRQTFSISSMSENGYDPQQN----LNDLMLLQLDREANLTSSVTILPLPLQNAT 116
Query: 1401 LTDGTLCTVVGWGQLFEIGRV--FPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCA 1458
+ GT C V GWG GR+ FP + V + + +CR N C
Sbjct: 117 VEAGTRCQVAGWGSQRSGGRLSRFP---RFVNVTVTPEDQCRP------------NNVCT 161
Query: 1459 GF--ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPW 1515
G RGG C GD G PL+C+ GV S G C R P +T+V+ + W
Sbjct: 162 GVLTRRGG--ICNGDGGTPLVCEG-----LAHGVASFSLGPCGRG--PDFFTRVALFRDW 212
Query: 1516 L 1516
+
Sbjct: 213 I 213
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 70.1 bits (170), Expect = 9e-12, Method: Composition-based stats.
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 37/241 (15%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGT--L 1342
IVGG AR +P+ A++ +G CG LI +++++A CF LG L
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 1343 RRGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKM--KTPFSNYVRPICLPHPNTP 1400
RR + + +S+ PQ +ND+ +L++ + ++ V + LP N
Sbjct: 61 RRRERQSRQTFSISSMSENGYDPQQN----LNDLMLLQLDREANLTSSVTILPLPLQNAT 116
Query: 1401 LTDGTLCTVVGWGQLFEIGRV--FPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCA 1458
+ GT C V GWG GR+ FP + V + + +CR N C
Sbjct: 117 VEAGTRCQVAGWGSQRSGGRLSRFP---RFVNVTVTPEDQCRP------------NNVCT 161
Query: 1459 GF--ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYG-CARANRPGVYTKVSNYIPW 1515
G RGG C GD G PL+C+ GV S G C R P +T+V+ + W
Sbjct: 162 GVLTRRGG--ICNGDQGTPLVCEG-----LAHGVASFSLGPCGRG--PDFFTRVALFRDW 212
Query: 1516 L 1516
+
Sbjct: 213 I 213
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of The
Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A Resolution
Length = 125
Score = 67.8 bits (164), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/130 (33%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF-YRAQDDYWVARLGTLR 1343
IVGG S P+Q +L F CG +LI+ QW++SA HC+ R Q RLG
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQ-----VRLG--E 52
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTD 1403
+ EQ +KII HP + NDI ++K+ +P + R + P +
Sbjct: 53 HNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAA 112
Query: 1404 GTLCTVVGWG 1413
GT C + GWG
Sbjct: 113 GTECLISGWG 122
>pdb|3M0C|C Chain C, The X-Ray Crystal Structure Of Pcsk9 In Complex With The Ldl
Receptor
Length = 791
Score = 66.6 bits (161), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 61/182 (33%), Positives = 82/182 (45%), Gaps = 30/182 (16%)
Query: 993 CEMNSSFRCGNGECVSIGSKCNQLVDCADGSDEKN-------CSCADFLKSQFLTRKI-- 1043
CE N F+C +G+C+S C+ +C DGSDE C DF + R I
Sbjct: 24 CERNE-FQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQ 82
Query: 1044 ---CDGIIDCWDFSDEYEC--EWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQCI 1098
CDG +DC + SDE C + CS ++ C + + CI R +CD +DC G DE C
Sbjct: 83 FWRCDGQVDCDNGSDEQGCPPKTCSQDEFRCHDGK-CISRQFVCDSDRDCLDGSDEASC- 140
Query: 1099 NLFPIETRSPSSTYLRNAMQGRSDVPIRVHQRTDNNPKHVLQDGEDSYLQNT--LYPVYH 1156
P+ T P+S Q S I DN+P +DG D + Q LY
Sbjct: 141 ---PVLTCGPAS------FQCNSSTCIPQLWACDNDPD--CEDGSDEWPQRCRGLYVFQG 189
Query: 1157 DS 1158
DS
Sbjct: 190 DS 191
Score = 48.1 bits (113), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 18/166 (10%)
Query: 948 PSSFNFNQVNGIPILTKVYTKVSKTNSTSK--ERNQTEFHLSVNRSECEMNSSFRCGNGE 1005
P+SF N IP L + + + +R + + + S C F C +GE
Sbjct: 147 PASFQCNSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSA-FEFHCLSGE 205
Query: 1006 CVSIGSKCNQLVDCADGSDEKNCSCADFLKSQFLT--------RKICDGIIDCWDFSDEY 1057
C+ +C+ DC D SDE+NC+ A +F + CD DC D SDE
Sbjct: 206 CIHSSWRCDGGPDCKDKSDEENCAVATCRPDEFQCSDGNCIHGSRQCDREYDCKDMSDEV 265
Query: 1058 EC---EWC-SPGQYICPNSRVCIERTRLCDGIKDCPLGDDE--KQC 1097
C C P ++ C +S CI ++C+ +DC DE K+C
Sbjct: 266 GCVNVTLCEGPNKFKC-HSGECITLDKVCNMARDCRDWSDEPIKEC 310
Score = 47.0 bits (110), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 52/114 (45%), Gaps = 20/114 (17%)
Query: 1541 NGHRCPLGECLPKARVCNGYMECSDGKCEMNSS----------FRCGN--GECVSIGSKC 1588
N +C G+C+ VC+G EC DG E + F CG C+ +C
Sbjct: 27 NEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQFWRC 86
Query: 1589 NQLVDCADGSDEKNCSCADFLKSQF-------LTRK-ICDGIIDCWDFSDEYEC 1634
+ VDC +GSDE+ C + +F ++R+ +CD DC D SDE C
Sbjct: 87 DGQVDCDNGSDEQGCPPKTCSQDEFRCHDGKCISRQFVCDSDRDCLDGSDEASC 140
Score = 45.4 bits (106), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 61/158 (38%), Gaps = 36/158 (22%)
Query: 999 FRCGNGECVSIGSKCNQLVDCADGSDEKNCSCADFLKSQFLTRKICDGIIDCWDFSDEYE 1058
FRC +G+C+S C+ DC DGSDE +C LT
Sbjct: 111 FRCHDGKCISRQFVCDSDRDCLDGSDEASCP--------VLT------------------ 144
Query: 1059 CEWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDE--KQCINLFPIE-TRSPSSTYLRN 1115
C P + C NS CI + CD DC G DE ++C L+ + SP S + +
Sbjct: 145 ---CGPASFQC-NSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFH 200
Query: 1116 AMQGRSDVPIRVHQRTDNNPKHVLQDGEDSYLQNTLYP 1153
+ G I R D P + E++ T P
Sbjct: 201 CLSGEC---IHSSWRCDGGPDCKDKSDEENCAVATCRP 235
Score = 44.3 bits (103), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 31/99 (31%), Positives = 44/99 (44%), Gaps = 16/99 (16%)
Query: 1550 CLPKARVCNGYMECSDGKCEMNS--------SFRCGNGECVSIGSKCNQLVDCADGSDEK 1601
C+P+ C+G ++C +G E FRC +G+C+S C+ DC DGSDE
Sbjct: 79 CIPQFWRCDGQVDCDNGSDEQGCPPKTCSQDEFRCHDGKCISRQFVCDSDRDCLDGSDEA 138
Query: 1602 NCSCADFLKSQFLTRK--------ICDGIIDCWDFSDEY 1632
+C + F CD DC D SDE+
Sbjct: 139 SCPVLTCGPASFQCNSSTCIPQLWACDNDPDCEDGSDEW 177
Score = 43.9 bits (102), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 41/128 (32%), Positives = 55/128 (42%), Gaps = 21/128 (16%)
Query: 997 SSFRCGNGECVSIGSKCNQLVDCADGSDE---------------KNCSCADF--LKSQFL 1039
+SF+C + C+ C+ DC DGSDE CS +F L + +
Sbjct: 148 ASFQCNSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLSGECI 207
Query: 1040 TRKI-CDGIIDCWDFSDEYECE--WCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQ 1096
CDG DC D SDE C C P ++ C + CI +R CD DC DE
Sbjct: 208 HSSWRCDGGPDCKDKSDEENCAVATCRPDEFQCSDGN-CIHGSRQCDREYDCKDMSDEVG 266
Query: 1097 CINLFPIE 1104
C+N+ E
Sbjct: 267 CVNVTLCE 274
Score = 43.5 bits (101), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 42/149 (28%), Positives = 60/149 (40%), Gaps = 48/149 (32%)
Query: 1534 MSRQHVCNGHR----------CPL------------GECLPKARVCNGYMECSDG----- 1566
+SRQ VC+ R CP+ C+P+ C+ +C DG
Sbjct: 119 ISRQFVCDSDRDCLDGSDEASCPVLTCGPASFQCNSSTCIPQLWACDNDPDCEDGSDEWP 178
Query: 1567 -KC------EMNSS------FRCGNGECVSIGSKCNQLVDCADGSDEKNCSCADFLKSQF 1613
+C + +SS F C +GEC+ +C+ DC D SDE+NC+ A +F
Sbjct: 179 QRCRGLYVFQGDSSPCSAFEFHCLSGECIHSSWRCDGGPDCKDKSDEENCAVATCRPDEF 238
Query: 1614 LT--------RKICDGIIDCWDFSDEYEC 1634
+ CD DC D SDE C
Sbjct: 239 QCSDGNCIHGSRQCDREYDCKDMSDEVGC 267
Score = 43.1 bits (100), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 18/116 (15%)
Query: 988 VNRSECEMNSSFRCGNGECVSIGSKCNQLVDCADGSDE--KNCSCADFLKSQFLTRKICD 1045
VN + CE + F+C +GEC+++ CN DC D SDE K C + L + +C+
Sbjct: 268 VNVTLCEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIKECGTNECLDNNGGCSHVCN 327
Query: 1046 GIIDCWDFSDEYECEWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQ-CINL 1100
D YEC +CP+ + + R C+ I +C D Q C+NL
Sbjct: 328 ------DLKIGYEC--------LCPDGFQLVAQRR-CEDIDECQDPDTCSQLCVNL 368
Score = 42.0 bits (97), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/80 (36%), Positives = 39/80 (48%), Gaps = 13/80 (16%)
Query: 1567 KCEMNSSFRCGNGECVSIGSKCNQLVDCADGSDEKN-------CSCADFLKSQFLTRKI- 1618
+CE N F+C +G+C+S C+ +C DGSDE C DF + R I
Sbjct: 23 RCERNE-FQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIP 81
Query: 1619 ----CDGIIDCWDFSDEYEC 1634
CDG +DC + SDE C
Sbjct: 82 QFWRCDGQVDCDNGSDEQGC 101
Score = 41.2 bits (95), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 18/103 (17%)
Query: 1544 RCPLGECLPKARVCNGYMECSDGK----------CEMNSSFRCGNGECVSIGSKCNQLVD 1593
+C G C+ +R C+ +C D CE + F+C +GEC+++ CN D
Sbjct: 239 QCSDGNCIHGSRQCDREYDCKDMSDEVGCVNVTLCEGPNKFKCHSGECITLDKVCNMARD 298
Query: 1594 CADGSDE--KNCSCADFLKSQFLTRKICDGIIDCWDFSDEYEC 1634
C D SDE K C + L + +C+ D YEC
Sbjct: 299 CRDWSDEPIKECGTNECLDNNGGCSHVCN------DLKIGYEC 335
Score = 32.0 bits (71), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 11/109 (10%)
Query: 1524 EYNM--MRNETQMSRQHVCNG---HRCPLGECLPKARVCNGYMECSDGKCEMNSSFRCGN 1578
EY+ M +E +C G +C GEC+ +VCN +C D E CG
Sbjct: 255 EYDCKDMSDEVGCVNVTLCEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIK--ECGT 312
Query: 1579 GECVSIGSKCNQLVDCADGSDEKNCSCADFLKSQFLTRKICDGIIDCWD 1627
EC+ C+ + C D C C D Q + ++ C+ I +C D
Sbjct: 313 NECLDNNGGCSHV--CNDLKIGYECLCPDGF--QLVAQRRCEDIDECQD 357
>pdb|1N7D|A Chain A, Extracellular Domain Of The Ldl Receptor
Length = 699
Score = 65.1 bits (157), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 61/182 (33%), Positives = 82/182 (45%), Gaps = 30/182 (16%)
Query: 993 CEMNSSFRCGNGECVSIGSKCNQLVDCADGSDEKN-------CSCADFLKSQFLTRKI-- 1043
CE N F+C +G+C+S C+ +C DGSDE C DF + R I
Sbjct: 6 CERNE-FQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQ 64
Query: 1044 ---CDGIIDCWDFSDEYEC--EWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQCI 1098
CDG +DC + SDE C + CS ++ C + + CI R +CD +DC G DE C
Sbjct: 65 FWRCDGQVDCDNGSDEQGCPPKTCSQDEFRCHDGK-CISRQFVCDSDRDCLDGSDEASC- 122
Query: 1099 NLFPIETRSPSSTYLRNAMQGRSDVPIRVHQRTDNNPKHVLQDGEDSYLQNT--LYPVYH 1156
P+ T P+S Q S I DN+P +DG D + Q LY
Sbjct: 123 ---PVLTCGPAS------FQCNSSTCIPQLWACDNDPD--CEDGSDEWPQRCRGLYVFQG 171
Query: 1157 DS 1158
DS
Sbjct: 172 DS 173
Score = 46.6 bits (109), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 18/166 (10%)
Query: 948 PSSFNFNQVNGIPILTKVYTKVSKTNSTSK--ERNQTEFHLSVNRSECEMNSSFRCGNGE 1005
P+SF N IP L + + + +R + + + S C F C +GE
Sbjct: 129 PASFQCNSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSA-FEFHCLSGE 187
Query: 1006 CVSIGSKCNQLVDCADGSDEKNCSCADFLKSQFLT--------RKICDGIIDCWDFSDEY 1057
C+ +C+ DC D SDE+NC+ A +F + CD DC D SDE
Sbjct: 188 CIHSSWRCDGGPDCKDKSDEENCAVATCRPDEFQCSDGNCIHGSRQCDREYDCKDMSDEV 247
Query: 1058 EC---EWC-SPGQYICPNSRVCIERTRLCDGIKDCPLGDDE--KQC 1097
C C P ++ C +S CI ++C+ +DC DE K+C
Sbjct: 248 GCVNVTLCEGPNKFKC-HSGECITLDKVCNMARDCRDWSDEPIKEC 292
Score = 45.4 bits (106), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 52/114 (45%), Gaps = 20/114 (17%)
Query: 1541 NGHRCPLGECLPKARVCNGYMECSDGKCEMNSS----------FRCGN--GECVSIGSKC 1588
N +C G+C+ VC+G EC DG E + F CG C+ +C
Sbjct: 9 NEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQFWRC 68
Query: 1589 NQLVDCADGSDEKNCSCADFLKSQF-------LTRK-ICDGIIDCWDFSDEYEC 1634
+ VDC +GSDE+ C + +F ++R+ +CD DC D SDE C
Sbjct: 69 DGQVDCDNGSDEQGCPPKTCSQDEFRCHDGKCISRQFVCDSDRDCLDGSDEASC 122
Score = 44.7 bits (104), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 61/158 (38%), Gaps = 36/158 (22%)
Query: 999 FRCGNGECVSIGSKCNQLVDCADGSDEKNCSCADFLKSQFLTRKICDGIIDCWDFSDEYE 1058
FRC +G+C+S C+ DC DGSDE +C LT
Sbjct: 93 FRCHDGKCISRQFVCDSDRDCLDGSDEASCP--------VLT------------------ 126
Query: 1059 CEWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDE--KQCINLFPIE-TRSPSSTYLRN 1115
C P + C NS CI + CD DC G DE ++C L+ + SP S + +
Sbjct: 127 ---CGPASFQC-NSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFH 182
Query: 1116 AMQGRSDVPIRVHQRTDNNPKHVLQDGEDSYLQNTLYP 1153
+ G I R D P + E++ T P
Sbjct: 183 CLSGEC---IHSSWRCDGGPDCKDKSDEENCAVATCRP 217
Score = 43.1 bits (100), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/99 (31%), Positives = 44/99 (44%), Gaps = 16/99 (16%)
Query: 1550 CLPKARVCNGYMECSDGKCEMNS--------SFRCGNGECVSIGSKCNQLVDCADGSDEK 1601
C+P+ C+G ++C +G E FRC +G+C+S C+ DC DGSDE
Sbjct: 61 CIPQFWRCDGQVDCDNGSDEQGCPPKTCSQDEFRCHDGKCISRQFVCDSDRDCLDGSDEA 120
Query: 1602 NCSCADFLKSQFLTRK--------ICDGIIDCWDFSDEY 1632
+C + F CD DC D SDE+
Sbjct: 121 SCPVLTCGPASFQCNSSTCIPQLWACDNDPDCEDGSDEW 159
Score = 42.4 bits (98), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 41/128 (32%), Positives = 55/128 (42%), Gaps = 21/128 (16%)
Query: 997 SSFRCGNGECVSIGSKCNQLVDCADGSDE---------------KNCSCADF--LKSQFL 1039
+SF+C + C+ C+ DC DGSDE CS +F L + +
Sbjct: 130 ASFQCNSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLSGECI 189
Query: 1040 TRKI-CDGIIDCWDFSDEYECE--WCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQ 1096
CDG DC D SDE C C P ++ C + CI +R CD DC DE
Sbjct: 190 HSSWRCDGGPDCKDKSDEENCAVATCRPDEFQCSDGN-CIHGSRQCDREYDCKDMSDEVG 248
Query: 1097 CINLFPIE 1104
C+N+ E
Sbjct: 249 CVNVTLCE 256
Score = 42.0 bits (97), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 42/149 (28%), Positives = 60/149 (40%), Gaps = 48/149 (32%)
Query: 1534 MSRQHVCNGHR----------CPL------------GECLPKARVCNGYMECSDG----- 1566
+SRQ VC+ R CP+ C+P+ C+ +C DG
Sbjct: 101 ISRQFVCDSDRDCLDGSDEASCPVLTCGPASFQCNSSTCIPQLWACDNDPDCEDGSDEWP 160
Query: 1567 -KC------EMNSS------FRCGNGECVSIGSKCNQLVDCADGSDEKNCSCADFLKSQF 1613
+C + +SS F C +GEC+ +C+ DC D SDE+NC+ A +F
Sbjct: 161 QRCRGLYVFQGDSSPCSAFEFHCLSGECIHSSWRCDGGPDCKDKSDEENCAVATCRPDEF 220
Query: 1614 LT--------RKICDGIIDCWDFSDEYEC 1634
+ CD DC D SDE C
Sbjct: 221 QCSDGNCIHGSRQCDREYDCKDMSDEVGC 249
Score = 41.6 bits (96), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 18/116 (15%)
Query: 988 VNRSECEMNSSFRCGNGECVSIGSKCNQLVDCADGSDE--KNCSCADFLKSQFLTRKICD 1045
VN + CE + F+C +GEC+++ CN DC D SDE K C + L + +C+
Sbjct: 250 VNVTLCEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIKECGTNECLDNNGGCSHVCN 309
Query: 1046 GIIDCWDFSDEYECEWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQ-CINL 1100
D YEC +CP+ + + R C+ I +C D Q C+NL
Sbjct: 310 ------DLKIGYEC--------LCPDGFQLVAQRR-CEDIDECQDPDTCSQLCVNL 350
Score = 40.8 bits (94), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 29/80 (36%), Positives = 39/80 (48%), Gaps = 13/80 (16%)
Query: 1567 KCEMNSSFRCGNGECVSIGSKCNQLVDCADGSDEKN-------CSCADFLKSQFLTRKI- 1618
+CE N F+C +G+C+S C+ +C DGSDE C DF + R I
Sbjct: 5 RCERNE-FQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIP 63
Query: 1619 ----CDGIIDCWDFSDEYEC 1634
CDG +DC + SDE C
Sbjct: 64 QFWRCDGQVDCDNGSDEQGC 83
Score = 39.7 bits (91), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 18/103 (17%)
Query: 1544 RCPLGECLPKARVCNGYMECSDGK----------CEMNSSFRCGNGECVSIGSKCNQLVD 1593
+C G C+ +R C+ +C D CE + F+C +GEC+++ CN D
Sbjct: 221 QCSDGNCIHGSRQCDREYDCKDMSDEVGCVNVTLCEGPNKFKCHSGECITLDKVCNMARD 280
Query: 1594 CADGSDE--KNCSCADFLKSQFLTRKICDGIIDCWDFSDEYEC 1634
C D SDE K C + L + +C+ D YEC
Sbjct: 281 CRDWSDEPIKECGTNECLDNNGGCSHVCN------DLKIGYEC 317
Score = 30.8 bits (68), Expect = 7.2, Method: Compositional matrix adjust.
Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 11/109 (10%)
Query: 1524 EYNM--MRNETQMSRQHVCNG---HRCPLGECLPKARVCNGYMECSDGKCEMNSSFRCGN 1578
EY+ M +E +C G +C GEC+ +VCN +C D E CG
Sbjct: 237 EYDCKDMSDEVGCVNVTLCEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIK--ECGT 294
Query: 1579 GECVSIGSKCNQLVDCADGSDEKNCSCADFLKSQFLTRKICDGIIDCWD 1627
EC+ C+ + C D C C D Q + ++ C+ I +C D
Sbjct: 295 NECLDNNGGCSHV--CNDLKIGYECLCPDGF--QLVAQRRCEDIDECQD 339
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 55.8 bits (133), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 18/111 (16%)
Query: 1297 PWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQD-DYWVARLGTLRRGTKLPSPYEQL 1355
PW + + + C LISDQW+L+A HCF D W +G + S + +
Sbjct: 244 PWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPK------SQWGKE 297
Query: 1356 RPISKIILHP---------QYVDAGFINDISILKM--KTPFSNYVRPICLP 1395
I K ++ P Q + + +DI++LK+ K S + RPICLP
Sbjct: 298 FLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLP 348
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3- And
C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3- And
C5- Convertase Of Human Complement
Length = 509
Score = 55.8 bits (133), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 18/111 (16%)
Query: 1297 PWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQD-DYWVARLGTLRRGTKLPSPYEQL 1355
PW + + + C LISDQW+L+A HCF D W +G + S + +
Sbjct: 236 PWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPK------SQWGKE 289
Query: 1356 RPISKIILHP---------QYVDAGFINDISILKM--KTPFSNYVRPICLP 1395
I K ++ P Q + + +DI++LK+ K S + RPICLP
Sbjct: 290 FLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLP 340
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 55.5 bits (132), Expect = 3e-07, Method: Composition-based stats.
Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 24/237 (10%)
Query: 1287 GGGNARLGSWPWQAALYK---EGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLR 1343
GG + PW A+ E CG ++S ++L+A HC + + + V +
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESLTCGGAILSQWFVLTAAHCVFDQKPETIVIQY---- 57
Query: 1344 RGTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFS---NYVRPICLPHPNTP 1400
T L + P + Y NDI+IL++ P +P LP
Sbjct: 58 ESTNLWEDPGKSDPYVSHVYLSFYRQETMENDIAILELSRPLKLDGLKSKPAKLPDIEFR 117
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGF 1460
G+ V G+G + D L+ QL ++ EC RT + P++ ++ +FCA
Sbjct: 118 PKTGSDVLVSGYGDGQTMDPKDHD-LKSAQLTVVDLDEC--RTKYGPIF-LSLQVFCA-- 171
Query: 1461 ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARAN-RPGVYTKVSNYIPWL 1516
++ G GD+G P + Q+ +L+GV + Y R P V+TKV +Y+ W+
Sbjct: 172 QKVGVSLESGDAGDPTVQQD-----TLVGVAA--YFPKRPEGAPEVFTKVGSYVSWI 221
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The Complex
Formed By Porcine Kallikrein A And The Bovine Pancreatic
Trypsin Inhibitor. Crystallization, Patterson Search,
Structure Determination, Refinement, Structure And
Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its Comparison
With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its Comparison
With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 53.5 bits (127), Expect = 9e-07, Method: Composition-based stats.
Identities = 23/56 (41%), Positives = 32/56 (57%), Gaps = 5/56 (8%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDY--WVAR 1338
I+GG S PWQ A+Y FQCG L++ +W+L+A HC D+Y W+ R
Sbjct: 1 IIGGRECEKNSHPWQVAIYHYSSFQCGGVLVNPKWVLTAAHC---KNDNYEVWLGR 53
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 51.6 bits (122), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 22/45 (48%), Positives = 31/45 (68%), Gaps = 2/45 (4%)
Query: 1285 IVGGGNARLGSWPWQAALYKEG--EFQCGATLISDQWLLSAGHCF 1327
IV G +A +G PWQ L+++ E CGA+LISD+W+L+A HC
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 47.8 bits (112), Expect = 5e-05, Method: Composition-based stats.
Identities = 27/71 (38%), Positives = 39/71 (54%), Gaps = 6/71 (8%)
Query: 1353 EQLRPISKIILHPQY-VDAGFINDISILKMKTP--FSNYVRPICLPHPNTP---LTDGTL 1406
E++ + KI +HP+Y DI+++K+K P FS+Y+ P+CLP T L G
Sbjct: 3 EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYK 62
Query: 1407 CTVVGWGQLFE 1417
V GWG L E
Sbjct: 63 GRVTGWGNLKE 73
>pdb|1F5Y|A Chain A, Nmr Structure Of A Concatemer Of The First And Second
Ligand-Binding Modules Of The Human Ldl Receptor
Length = 85
Score = 47.0 bits (110), Expect = 9e-05, Method: Composition-based stats.
Identities = 29/80 (36%), Positives = 39/80 (48%), Gaps = 13/80 (16%)
Query: 1567 KCEMNSSFRCGNGECVSIGSKCNQLVDCADGSDEKN-------CSCADFLKSQFLTRKI- 1618
+CE N F+C +G+C+S C+ +C DGSDE C DF + R I
Sbjct: 7 RCERNE-FQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIP 65
Query: 1619 ----CDGIIDCWDFSDEYEC 1634
CDG +DC + SDE C
Sbjct: 66 QFWRCDGQVDCDNGSDEQGC 85
Score = 46.2 bits (108), Expect = 2e-04, Method: Composition-based stats.
Identities = 29/79 (36%), Positives = 38/79 (48%), Gaps = 13/79 (16%)
Query: 993 CEMNSSFRCGNGECVSIGSKCNQLVDCADGSDEKN-------CSCADFLKSQFLTRKI-- 1043
CE N F+C +G+C+S C+ +C DGSDE C DF + R I
Sbjct: 8 CERNE-FQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQ 66
Query: 1044 ---CDGIIDCWDFSDEYEC 1059
CDG +DC + SDE C
Sbjct: 67 FWRCDGQVDCDNGSDEQGC 85
Score = 44.7 bits (104), Expect = 4e-04, Method: Composition-based stats.
Identities = 25/75 (33%), Positives = 35/75 (46%), Gaps = 12/75 (16%)
Query: 1541 NGHRCPLGECLPKARVCNGYMECSDGKCEMNSS----------FRCGN--GECVSIGSKC 1588
N +C G+C+ VC+G EC DG E + F CG C+ +C
Sbjct: 11 NEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQFWRC 70
Query: 1589 NQLVDCADGSDEKNC 1603
+ VDC +GSDE+ C
Sbjct: 71 DGQVDCDNGSDEQGC 85
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 46.2 bits (108), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 97/253 (38%), Gaps = 81/253 (32%)
Query: 1297 PWQAALY----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWV-ARLGTLRRGTKLPSP 1351
PWQA + +G C ++S+ ++L+A HCF ++ + +G +R +
Sbjct: 235 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLE---- 290
Query: 1352 YEQLRPISKIILHPQY-----VDAG----FINDISILKMKT--PFSNYVRPICLPHPNTP 1400
I ++ HP Y +AG + D++++K+K + +RPICL P
Sbjct: 291 ------IEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL-----P 339
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDT-----------LQEVQLPIISTAE----------- 1438
T+GT + R+ P T Q+++ +S E
Sbjct: 340 CTEGTTRAL----------RLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIK 389
Query: 1439 -------CRKRTLFLPLYR--------VTENMFCAGFERGGRD--ACLGDSGGPLMCQEP 1481
C + + P Y VT C G D C GDSGGPL+ +
Sbjct: 390 NGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHK- 448
Query: 1482 DGRWSLMGVTSNG 1494
R+ +GV S G
Sbjct: 449 RSRFIQVGVISWG 461
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 46.2 bits (108), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 97/253 (38%), Gaps = 81/253 (32%)
Query: 1297 PWQAALY----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWV-ARLGTLRRGTKLPSP 1351
PWQA + +G C ++S+ ++L+A HCF ++ + +G +R +
Sbjct: 227 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLE---- 282
Query: 1352 YEQLRPISKIILHPQY-----VDAG----FINDISILKMKT--PFSNYVRPICLPHPNTP 1400
I ++ HP Y +AG + D++++K+K + +RPICL P
Sbjct: 283 ------IEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL-----P 331
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDT-----------LQEVQLPIISTAE----------- 1438
T+GT + R+ P T Q+++ +S E
Sbjct: 332 CTEGTTRAL----------RLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIK 381
Query: 1439 -------CRKRTLFLPLYR--------VTENMFCAGFERGGRD--ACLGDSGGPLMCQEP 1481
C + + P Y VT C G D C GDSGGPL+ +
Sbjct: 382 NGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHK- 440
Query: 1482 DGRWSLMGVTSNG 1494
R+ +GV S G
Sbjct: 441 RSRFIQVGVISWG 453
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 45.8 bits (107), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 97/253 (38%), Gaps = 81/253 (32%)
Query: 1297 PWQAALY----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWV-ARLGTLRRGTKLPSP 1351
PWQA + +G C ++S+ ++L+A HCF ++ + +G +R +
Sbjct: 28 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLE---- 83
Query: 1352 YEQLRPISKIILHPQY-----VDAG----FINDISILKMKT--PFSNYVRPICLPHPNTP 1400
I ++ HP Y +AG + D++++K+K + +RPICL P
Sbjct: 84 ------IEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL-----P 132
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDT-----------LQEVQLPIISTAE----------- 1438
T+GT + R+ P T Q+++ +S E
Sbjct: 133 CTEGTTRAL----------RLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIK 182
Query: 1439 -------CRKRTLFLPLYR--------VTENMFCAGFERGGRD--ACLGDSGGPLMCQEP 1481
C + + P Y VT C G D C GDSGGPL+ +
Sbjct: 183 NGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHK- 241
Query: 1482 DGRWSLMGVTSNG 1494
R+ +GV S G
Sbjct: 242 RSRFIQVGVISWG 254
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With Factors
B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With Factors
B And D
Length = 732
Score = 45.4 bits (106), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 97/253 (38%), Gaps = 81/253 (32%)
Query: 1297 PWQAALY----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWV-ARLGTLRRGTKLPSP 1351
PWQA + +G C ++S+ ++L+A HCF ++ + +G +R +
Sbjct: 460 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLE---- 515
Query: 1352 YEQLRPISKIILHPQY-----VDAG----FINDISILKMKT--PFSNYVRPICLPHPNTP 1400
I ++ HP Y +AG + D++++K+K + +RPICL P
Sbjct: 516 ------IEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL-----P 564
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDT-----------LQEVQLPIISTAE----------- 1438
T+GT + R+ P T Q+++ +S E
Sbjct: 565 CTEGTTRAL----------RLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIK 614
Query: 1439 -------CRKRTLFLPLYR--------VTENMFCAGFERGGRD--ACLGDSGGPLMCQEP 1481
C + + P Y VT C G D C GDSGGPL+ +
Sbjct: 615 NGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHK- 673
Query: 1482 DGRWSLMGVTSNG 1494
R+ +GV S G
Sbjct: 674 RSRFIQVGVISWG 686
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 45.1 bits (105), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 97/253 (38%), Gaps = 81/253 (32%)
Query: 1297 PWQAALY----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWV-ARLGTLRRGTKLPSP 1351
PWQA + +G C ++S+ ++L+A HCF ++ + +G +R +
Sbjct: 479 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLE---- 534
Query: 1352 YEQLRPISKIILHPQY-----VDAG----FINDISILKMKT--PFSNYVRPICLPHPNTP 1400
I ++ HP Y +AG + D++++K+K + +RPICL P
Sbjct: 535 ------IEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL-----P 583
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDT-----------LQEVQLPIISTAE----------- 1438
T+GT + R+ P T Q+++ +S E
Sbjct: 584 CTEGTTRAL----------RLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIK 633
Query: 1439 -------CRKRTLFLPLYR--------VTENMFCAGFERGGRD--ACLGDSGGPLMCQEP 1481
C + + P Y VT C G D C GDSGGPL+ +
Sbjct: 634 NGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHK- 692
Query: 1482 DGRWSLMGVTSNG 1494
R+ +GV S G
Sbjct: 693 RSRFIQVGVISWG 705
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor B
Length = 741
Score = 45.1 bits (105), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 59/253 (23%), Positives = 97/253 (38%), Gaps = 81/253 (32%)
Query: 1297 PWQAALY----KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWV-ARLGTLRRGTKLPSP 1351
PWQA + +G C ++S+ ++L+A HCF ++ + +G +R +
Sbjct: 469 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLE---- 524
Query: 1352 YEQLRPISKIILHPQY-----VDAG----FINDISILKMKT--PFSNYVRPICLPHPNTP 1400
I ++ HP Y +AG + D++++K+K + +RPICL P
Sbjct: 525 ------IEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICL-----P 573
Query: 1401 LTDGTLCTVVGWGQLFEIGRVFPDT-----------LQEVQLPIISTAE----------- 1438
T+GT + R+ P T Q+++ +S E
Sbjct: 574 CTEGTTRAL----------RLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIK 623
Query: 1439 -------CRKRTLFLPLYR--------VTENMFCAGFERGGRD--ACLGDSGGPLMCQEP 1481
C + + P Y VT C G D C GDSGGPL+ +
Sbjct: 624 NGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHK- 682
Query: 1482 DGRWSLMGVTSNG 1494
R+ +GV S G
Sbjct: 683 RSRFIQVGVISWG 695
>pdb|3P5C|L Chain L, The Structure Of The LdlrPCSK9 COMPLEX REVEALS THE RECEPTOR
IN AN Extended Conformation
Length = 440
Score = 44.7 bits (104), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 993 CEMNSSFRCGNGECVSIGSKCNQLVDCADGSDE--KNCSCADFLKSQFLTRKICDGIIDC 1050
CE + F+C +GEC+++ CN DC D SDE K C + L + +C+
Sbjct: 1 CEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIKECGTNECLDNNGGCSHVCN----- 55
Query: 1051 WDFSDEYECEWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQ-CINL 1100
D YEC +CP+ + + R C+ I +C D Q C+NL
Sbjct: 56 -DLKIGYEC--------LCPDGFQLVAQRR-CEDIDECQDPDTCSQLCVNL 96
Score = 38.9 bits (89), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 23/69 (33%), Positives = 33/69 (47%), Gaps = 8/69 (11%)
Query: 1568 CEMNSSFRCGNGECVSIGSKCNQLVDCADGSDE--KNCSCADFLKSQFLTRKICDGIIDC 1625
CE + F+C +GEC+++ CN DC D SDE K C + L + +C+
Sbjct: 1 CEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIKECGTNECLDNNGGCSHVCN----- 55
Query: 1626 WDFSDEYEC 1634
D YEC
Sbjct: 56 -DLKIGYEC 63
Score = 35.4 bits (80), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 38/87 (43%), Gaps = 6/87 (6%)
Query: 1541 NGHRCPLGECLPKARVCNGYMECSDGKCEMNSSFRCGNGECVSIGSKCNQLVDCADGSDE 1600
N +C GEC+ +VCN +C D E CG EC+ C+ + C D
Sbjct: 5 NKFKCHSGECITLDKVCNMARDCRDWSDEPIK--ECGTNECLDNNGGCSHV--CNDLKIG 60
Query: 1601 KNCSCADFLKSQFLTRKICDGIIDCWD 1627
C C D Q + ++ C+ I +C D
Sbjct: 61 YECLCPDGF--QLVAQRRCEDIDECQD 85
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 42.4 bits (98), Expect = 0.002, Method: Composition-based stats.
Identities = 19/43 (44%), Positives = 26/43 (60%), Gaps = 1/43 (2%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCF 1327
IVGG S P+Q +L F CG +LI+ QW++SA HC+
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCY 42
>pdb|2KNY|A Chain A, Fusion Construct Of Cr17 From Lrp-1 And Apoe Residues 130-14
Length = 80
Score = 42.4 bits (98), Expect = 0.002, Method: Composition-based stats.
Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 1058 ECEWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDE 1094
E + C P + CP + VC+ LCDG KDC G DE
Sbjct: 5 EGKTCGPSSFSCPGTHVCVPERWLCDGDKDCADGADE 41
>pdb|2KNX|A Chain A, Solution Structure Of Complement Repeat Cr17 From Lrp-1
Length = 50
Score = 41.6 bits (96), Expect = 0.004, Method: Composition-based stats.
Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 1058 ECEWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDE 1094
E + C P + CP + VC+ LCDG KDC G DE
Sbjct: 3 EGKTCGPSSFSCPGTHVCVPERWLCDGDKDCADGADE 39
>pdb|1EPT|B Chain B, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 82
Score = 40.8 bits (94), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 30/61 (49%)
Query: 1353 EQLRPISKIILHPQYVDAGFINDISILKMKTPFSNYVRPICLPHPNTPLTDGTLCTVVGW 1412
EQ +KII HP + NDI ++K+ +P + R + P + GT C + GW
Sbjct: 19 EQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISGW 78
Query: 1413 G 1413
G
Sbjct: 79 G 79
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 40.4 bits (93), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 47/233 (20%), Positives = 91/233 (39%), Gaps = 16/233 (6%)
Query: 1285 IVGGGNARLGSWPWQAALYKEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRR 1344
I+GG + + PW + + + CG ++++ ++++A C + G+ R
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKPFCGGSILTANFVITAAQCVDGTKPSDISIHYGSSYR 60
Query: 1345 GTKLPSPYEQLRPISKIILHPQYVDAGFINDISILKMKTPFS---NYVRPICLPHPNTPL 1401
TK S + I + HP + N+ ++++ + P + I LP
Sbjct: 61 TTKGTS--VMAKKIYIVRYHPLTMQ----NNYAVIETEMPIKLDDKTTKKIELPSLLYDP 114
Query: 1402 TDGTLCTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYR-VTENMFCAGF 1460
T V GWG + L E ++ C ++ + + + + +FCAG
Sbjct: 115 EPDTSVLVSGWGSTNFKSLEYSGDLMEANFTVVDRKSCEEQYKQIEADKYIYDGVFCAGG 174
Query: 1461 ERGGRDACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYI 1513
E GD+G P + +L+GV S + P V+ +V Y+
Sbjct: 175 EYDETYIGYGDAGDPAVQNG-----TLVGVASY-ISSMPSEFPSVFLRVGYYV 221
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 39.7 bits (91), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 33/236 (13%)
Query: 1297 PWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRRGTKLPSPYEQL 1355
PWQ L EG+ CG +I + ++L+ C + R T++ S +
Sbjct: 65 PWQVKLTNSEGKDFCGGVIIRENFVLTTAKCSL-------LHRNITVKTYFNRTSQDPLM 117
Query: 1356 RPISKIILHPQY-VDAGFINDISILKMKTPFS--NYVRPICLP------HPNTPLTDGTL 1406
I+ + +H +Y DAG ND+S+L+++ P P+C P H P T G L
Sbjct: 118 IKITHVHVHMRYDADAGE-NDLSLLELEWPIQCPGAGLPVCTPEKDFAEHLLIPRTRGLL 176
Query: 1407 CTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRD 1466
GW + G ++L + ++ EC + + VT +C ER
Sbjct: 177 ---SGWAR---NGTDLGNSLTTRPVTLVEGEECGQ----VLNVTVTTRTYC---ERSSVA 223
Query: 1467 ACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNMAA 1522
A + G ++ +E G W L GV + +A+ V TKVS Y W M A
Sbjct: 224 A-MHWMDGSVVTREHRGSWFLTGVLGSQPVGGQAHMVLV-TKVSRYSLWFKQIMNA 277
>pdb|1LDL|A Chain A, Three-Dimensional Structure Of A Cysteine-Rich Repeat From
The Low-Density Lipoprotein Receptor
Length = 48
Score = 37.4 bits (85), Expect = 0.073, Method: Composition-based stats.
Identities = 16/39 (41%), Positives = 24/39 (61%), Gaps = 1/39 (2%)
Query: 1567 KCEMNSSFRCGNGECVSIGSKCNQLVDCADGSDEKNCSC 1605
+CE N F+C +G+C+S C+ +C DGSDE +C
Sbjct: 7 RCERNE-FQCQDGKCISYKWVCDGSAECQDGSDESQETC 44
Score = 36.6 bits (83), Expect = 0.13, Method: Composition-based stats.
Identities = 16/38 (42%), Positives = 23/38 (60%), Gaps = 1/38 (2%)
Query: 993 CEMNSSFRCGNGECVSIGSKCNQLVDCADGSDEKNCSC 1030
CE N F+C +G+C+S C+ +C DGSDE +C
Sbjct: 8 CERNE-FQCQDGKCISYKWVCDGSAECQDGSDESQETC 44
>pdb|2FYJ|A Chain A, Nmr Solution Structure Of Calcium-Loaded Lrp Double Module
pdb|2FYL|B Chain B, Haddock Model Of The Complex Between Double Module Of Lrp,
Cr56, And First Domain Of Receptor Associated Protein,
Rap- D1
Length = 82
Score = 37.0 bits (84), Expect = 0.083, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 33/74 (44%), Gaps = 10/74 (13%)
Query: 1541 NGHRCPLGECLPKARVCNGYMECSDGKCEMNSS----------FRCGNGECVSIGSKCNQ 1590
N C G C+P + C+ +C D E S F C NG C++I +C+
Sbjct: 8 NQFSCASGRCIPISWTCDLDDDCGDRSDESASCAYPTCFPLTQFTCNNGRCININWRCDN 67
Query: 1591 LVDCADGSDEKNCS 1604
DC D SDE CS
Sbjct: 68 DNDCGDNSDEAGCS 81
Score = 33.9 bits (76), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 19/31 (61%)
Query: 999 FRCGNGECVSIGSKCNQLVDCADGSDEKNCS 1029
F C NG C++I +C+ DC D SDE CS
Sbjct: 51 FTCNNGRCININWRCDNDNDCGDNSDEAGCS 81
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 37.0 bits (84), Expect = 0.093, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 1297 PWQAALY-KEGEFQCGATLISDQWLLSAGHCFYRAQDDYWVARLGTLRRGTKLPSPYEQL 1355
PWQ L EG+ CG +I + ++L+ C + R T++ S +
Sbjct: 106 PWQVKLTNSEGKDFCGGVIIRENFVLTTAKCSL-------LHRNITVKTYFNRTSQDPLM 158
Query: 1356 RPISKIILHPQY-VDAGFINDISILKMKTPFS--NYVRPICLP------HPNTPLTDGTL 1406
I+ + +H +Y DAG ND+S+L+++ P P+C P H P T G L
Sbjct: 159 IKITHVHVHMRYDADAGE-NDLSLLELEWPIQCPGAGLPVCTPEKDFAEHLLIPRTRGLL 217
Query: 1407 CTVVGWGQLFEIGRVFPDTLQEVQLPIISTAECRKRTLFLPLYRVTENMFCAGFERGGRD 1466
GW + G ++L + ++ EC + + VT +C ER
Sbjct: 218 ---SGWAR---NGTDLGNSLTTRPVTLVEGEECGQ----VLNVTVTTRTYC---ERSSVA 264
Query: 1467 ACLGDSGGPLMCQEPDGRWSLMGVTSNGYGCARANRPGVYTKVSNYIPWLYNNM 1520
A + G ++ +E G W L GV + +A+ + TKVS Y W M
Sbjct: 265 A-MHWMDGSVVTREHRGSWFLTGVLGSQPVGGQAHMV-LVTKVSRYSLWFKQIM 316
>pdb|3T5O|A Chain A, Crystal Structure Of Human Complement Component C6
pdb|4A5W|B Chain B, Crystal Structure Of C5b6
pdb|4E0S|B Chain B, Crystal Structure Of C5b-6
Length = 913
Score = 35.8 bits (81), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 15/37 (40%), Positives = 23/37 (62%)
Query: 992 ECEMNSSFRCGNGECVSIGSKCNQLVDCADGSDEKNC 1028
E + + FRC +G C++ +CN DC D SDE++C
Sbjct: 116 EADCKNKFRCDSGRCIARKLECNGENDCGDNSDERDC 152
Score = 35.0 bits (79), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 20/30 (66%)
Query: 1574 FRCGNGECVSIGSKCNQLVDCADGSDEKNC 1603
FRC +G C++ +CN DC D SDE++C
Sbjct: 123 FRCDSGRCIARKLECNGENDCGDNSDERDC 152
>pdb|1AJJ|A Chain A, Ldl Receptor Ligand-Binding Module 5, Calcium-Coordinating
Length = 37
Score = 35.4 bits (80), Expect = 0.26, Method: Composition-based stats.
Identities = 14/31 (45%), Positives = 20/31 (64%)
Query: 999 FRCGNGECVSIGSKCNQLVDCADGSDEKNCS 1029
F C +GEC+ +C+ DC D SDE+NC+
Sbjct: 7 FHCLSGECIHSSWRCDGGPDCKDKSDEENCA 37
Score = 35.4 bits (80), Expect = 0.26, Method: Composition-based stats.
Identities = 14/31 (45%), Positives = 20/31 (64%)
Query: 1574 FRCGNGECVSIGSKCNQLVDCADGSDEKNCS 1604
F C +GEC+ +C+ DC D SDE+NC+
Sbjct: 7 FHCLSGECIHSSWRCDGGPDCKDKSDEENCA 37
>pdb|2FCW|B Chain B, Structure Of A Complex Between The Pair Of The Ldl Receptor
Ligand-Binding Modules 3-4 And The Receptor Associated
Protein (Rap)
Length = 80
Score = 35.4 bits (80), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 39/98 (39%), Gaps = 30/98 (30%)
Query: 997 SSFRCGNGECVSIGSKCNQLVDCADGSDEKNCSCADFLKSQFLTRKICDGIIDCWDFSDE 1056
+ FRC +G+C+S C+ DC DGSDE +C LT
Sbjct: 6 AEFRCHDGKCISRQFVCDSDRDCLDGSDEASCP--------VLT---------------- 41
Query: 1057 YECEWCSPGQYICPNSRVCIERTRLCDGIKDCPLGDDE 1094
C P + C NS CI + CD DC G DE
Sbjct: 42 -----CGPASFQC-NSSTCIPQLWACDNDPDCEDGSDE 73
Score = 33.1 bits (74), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 24/69 (34%), Positives = 32/69 (46%), Gaps = 8/69 (11%)
Query: 1572 SSFRCGNGECVSIGSKCNQLVDCADGSDEKNCSCADFLKSQFLTRK--------ICDGII 1623
+ FRC +G+C+S C+ DC DGSDE +C + F CD
Sbjct: 6 AEFRCHDGKCISRQFVCDSDRDCLDGSDEASCPVLTCGPASFQCNSSTCIPQLWACDNDP 65
Query: 1624 DCWDFSDEY 1632
DC D SDE+
Sbjct: 66 DCEDGSDEW 74
Score = 33.1 bits (74), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 39/87 (44%), Gaps = 13/87 (14%)
Query: 1062 CSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQCINLFPIETRSPSSTYLRNAMQGRS 1121
CS ++ C + + CI R +CD +DC G DE C P+ T P+S Q S
Sbjct: 3 CSQAEFRCHDGK-CISRQFVCDSDRDCLDGSDEASC----PVLTCGPAS------FQCNS 51
Query: 1122 DVPIRVHQRTDNNPKHVLQDGEDSYLQ 1148
I DN+P +DG D + Q
Sbjct: 52 STCIPQLWACDNDPD--CEDGSDEWPQ 76
Score = 32.7 bits (73), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 8/65 (12%)
Query: 1544 RCPLGECLPKARVCNGYMECSDGKCEMN--------SSFRCGNGECVSIGSKCNQLVDCA 1595
RC G+C+ + VC+ +C DG E + +SF+C + C+ C+ DC
Sbjct: 9 RCHDGKCISRQFVCDSDRDCLDGSDEASCPVLTCGPASFQCNSSTCIPQLWACDNDPDCE 68
Query: 1596 DGSDE 1600
DGSDE
Sbjct: 69 DGSDE 73
>pdb|2M0P|A Chain A, Solution Structure Of The Tenth Complement Type Repeat Of
Human Megalin
Length = 52
Score = 35.0 bits (79), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 15/34 (44%), Positives = 22/34 (64%)
Query: 995 MNSSFRCGNGECVSIGSKCNQLVDCADGSDEKNC 1028
+++ + C N +C+S C+ DC DGSDEKNC
Sbjct: 8 LDTQYTCDNHQCISKNWVCDTDNDCGDGSDEKNC 41
Score = 35.0 bits (79), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 15/34 (44%), Positives = 22/34 (64%)
Query: 1570 MNSSFRCGNGECVSIGSKCNQLVDCADGSDEKNC 1603
+++ + C N +C+S C+ DC DGSDEKNC
Sbjct: 8 LDTQYTCDNHQCISKNWVCDTDNDCGDGSDEKNC 41
Score = 31.2 bits (69), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 16/36 (44%), Positives = 19/36 (52%), Gaps = 1/36 (2%)
Query: 1062 CSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQC 1097
C QY C N + CI + +CD DC G DEK C
Sbjct: 7 CLDTQYTCDNHQ-CISKNWVCDTDNDCGDGSDEKNC 41
>pdb|2LGP|A Chain A, Solution Structure Of La45 From Ldlr
Length = 94
Score = 34.7 bits (78), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 24/84 (28%), Positives = 38/84 (45%), Gaps = 3/84 (3%)
Query: 948 PSSFNFNQVNGIPILTKVYTKVSKTNSTSK--ERNQTEFHLSVNRSECEMNSSFRCGNGE 1005
P+SF N IP L + + + +R + + + S C F C +GE
Sbjct: 9 PASFQCNSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSA-FEFHCLSGE 67
Query: 1006 CVSIGSKCNQLVDCADGSDEKNCS 1029
C+ +C+ DC D SDE+NC+
Sbjct: 68 CIHSSWRCDGGPDCKDKSDEENCA 91
Score = 32.3 bits (72), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 24/77 (31%), Positives = 33/77 (42%), Gaps = 7/77 (9%)
Query: 1062 CSPGQYICPNSRVCIERTRLCDGIKDCPLGDDE--KQCINLFPIE-TRSPSSTYLRNAMQ 1118
C P + C NS CI + CD DC G DE ++C L+ + SP S + + +
Sbjct: 7 CGPASFQC-NSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLS 65
Query: 1119 GRSDVPIRVHQRTDNNP 1135
G I R D P
Sbjct: 66 GEC---IHSSWRCDGGP 79
Score = 32.0 bits (71), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 36/73 (49%), Gaps = 18/73 (24%)
Query: 1550 CLPKARVCNGYMECSDG------KC------EMNSS------FRCGNGECVSIGSKCNQL 1591
C+P+ C+ +C DG +C + +SS F C +GEC+ +C+
Sbjct: 19 CIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLSGECIHSSWRCDGG 78
Query: 1592 VDCADGSDEKNCS 1604
DC D SDE+NC+
Sbjct: 79 PDCKDKSDEENCA 91
>pdb|1XFE|A Chain A, Solution Structure Of The La7-Egfa Pair From The Ldl
Receptor
Length = 83
Score = 33.1 bits (74), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 24/73 (32%), Positives = 35/73 (47%), Gaps = 8/73 (10%)
Query: 989 NRSECEMNSSFRCGNGECVSIGSKCNQLVDCADGSDE--KNCSCADFLKSQFLTRKICDG 1046
N + CE + F+C +GEC+++ CN DC D SDE K C + L + +C+
Sbjct: 2 NVTLCEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIKECGTNECLDNNGGCSHVCN- 60
Query: 1047 IIDCWDFSDEYEC 1059
D YEC
Sbjct: 61 -----DLKIGYEC 68
Score = 32.7 bits (73), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 23/69 (33%), Positives = 33/69 (47%), Gaps = 8/69 (11%)
Query: 1568 CEMNSSFRCGNGECVSIGSKCNQLVDCADGSDE--KNCSCADFLKSQFLTRKICDGIIDC 1625
CE + F+C +GEC+++ CN DC D SDE K C + L + +C+
Sbjct: 6 CEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIKECGTNECLDNNGGCSHVCN----- 60
Query: 1626 WDFSDEYEC 1634
D YEC
Sbjct: 61 -DLKIGYEC 68
>pdb|1QQE|A Chain A, Crystal Structure Of The Vesicular Transport Protein Sec17
Length = 292
Score = 32.7 bits (73), Expect = 1.7, Method: Composition-based stats.
Identities = 19/53 (35%), Positives = 28/53 (52%), Gaps = 4/53 (7%)
Query: 691 PNISDHIINDFSDSLLDKISVGDSPSLSEEAPPLDNGDDNFSTTEESRKVILN 743
PN +D ++F SL+D ++ GDS LSE DNF ++ + ILN
Sbjct: 230 PNFADSRESNFLKSLIDAVNEGDSEQLSEHCKEF----DNFMRLDKWKITILN 278
>pdb|3DNT|A Chain A, Structures Of Mdt Proteins
pdb|3DNT|B Chain B, Structures Of Mdt Proteins
pdb|3DNU|A Chain A, Structure Of Mdt Protein
Length = 440
Score = 32.3 bits (72), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 544 GNLDEVLKAYKANRTMSSIQKKNDFVSSETAFNGDLAIMESSNEY-------QYAHTIRT 596
L+EVL AYKA+ + I+++NDF S A++ N++ H I+
Sbjct: 123 ARLEEVLTAYKADIPLGXIREENDFRISVAGAQEKTALLRIGNDWCIPKGITPTTHIIKL 182
Query: 597 P-GNRHSPVVTL 607
P G P TL
Sbjct: 183 PIGEIRQPNATL 194
>pdb|3HZI|A Chain A, Structure Of Mdt Protein
Length = 440
Score = 32.3 bits (72), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 544 GNLDEVLKAYKANRTMSSIQKKNDFVSSETAFNGDLAIMESSNEY-------QYAHTIRT 596
L+EVL AYKA+ + I+++NDF S A++ N++ H I+
Sbjct: 123 ARLEEVLTAYKADIPLGXIREENDFRISVAGAQEKTALLRIGNDWCIPKGITPTTHIIKL 182
Query: 597 P-GNRHSPVVTL 607
P G P TL
Sbjct: 183 PIGEIRQPNATL 194
>pdb|3TPD|A Chain A, Structure Of Phipa, Monoclinic Form
Length = 440
Score = 32.0 bits (71), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 544 GNLDEVLKAYKANRTMSSIQKKNDFVSSETAFNGDLAIMESSNEY-------QYAHTIRT 596
L+EVL AYKA+ + I+++NDF S A++ N++ H I+
Sbjct: 123 ARLEEVLTAYKADIPLGMIREENDFRISVAGAQEKTALLRIGNDWCIPKGITPTTHIIKL 182
Query: 597 P-GNRHSPVVTL 607
P G P TL
Sbjct: 183 PIGEIRQPNATL 194
>pdb|2WIU|A Chain A, Mercury-Modified Bacterial Persistence Regulator Hipba
pdb|2WIU|C Chain C, Mercury-Modified Bacterial Persistence Regulator Hipba
Length = 446
Score = 32.0 bits (71), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 544 GNLDEVLKAYKANRTMSSIQKKNDFVSSETAFNGDLAIMESSNEY-------QYAHTIRT 596
L+EVL AYKA+ + I+++NDF S A++ N++ H I+
Sbjct: 123 ARLEEVLTAYKADIPLGMIREENDFRISVAGAQEKTALLRIGNDWCIPKGITPTTHIIKL 182
Query: 597 P-GNRHSPVVTL 607
P G P TL
Sbjct: 183 PIGEIRQPNATL 194
>pdb|3TPT|A Chain A, Structure Of Hipa(D309q) Bound To Adp
pdb|3TPT|B Chain B, Structure Of Hipa(D309q) Bound To Adp
Length = 440
Score = 32.0 bits (71), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 544 GNLDEVLKAYKANRTMSSIQKKNDFVSSETAFNGDLAIMESSNEY-------QYAHTIRT 596
L+EVL AYKA+ + I+++NDF S A++ N++ H I+
Sbjct: 123 ARLEEVLTAYKADIPLGMIREENDFRISVAGAQEKTALLRIGNDWCIPKGITPTTHIIKL 182
Query: 597 P-GNRHSPVVTL 607
P G P TL
Sbjct: 183 PIGEIRQPNATL 194
>pdb|3FBR|A Chain A, Structure Of Hipa-Amppnp-Peptide
Length = 437
Score = 32.0 bits (71), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 544 GNLDEVLKAYKANRTMSSIQKKNDFVSSETAFNGDLAIMESSNEY-------QYAHTIRT 596
L+EVL AYKA+ + I+++NDF S A++ N++ H I+
Sbjct: 123 ARLEEVLTAYKADIPLGMIREENDFRISVAGAQEKTALLRIGNDWCIPKGITPTTHIIKL 182
Query: 597 P-GNRHSPVVTL 607
P G P TL
Sbjct: 183 PIGEIRQPNATL 194
>pdb|2GTL|O Chain O, Lumbricus Erythrocruorin At 3.5a Resolution
Length = 215
Score = 32.0 bits (71), Expect = 2.8, Method: Composition-based stats.
Identities = 16/44 (36%), Positives = 23/44 (52%), Gaps = 1/44 (2%)
Query: 1055 DEYECEWCSPGQYICP-NSRVCIERTRLCDGIKDCPLGDDEKQC 1097
+E E C ++ C + CI + +CDG DC G+DEK C
Sbjct: 48 EELEDPSCDEHEHQCGGDDPQCISKLFVCDGHNDCRNGEDEKDC 91
>pdb|3DNV|A Chain A, Mdt Protein
Length = 440
Score = 32.0 bits (71), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 544 GNLDEVLKAYKANRTMSSIQKKNDFVSSETAFNGDLAIMESSNEY-------QYAHTIRT 596
L+EVL AYKA+ + I+++NDF S A++ N++ H I+
Sbjct: 123 ARLEEVLTAYKADIPLGMIREENDFRISVAGAQEKTALLRIGNDWCIPKGITPTTHIIKL 182
Query: 597 P-GNRHSPVVTL 607
P G P TL
Sbjct: 183 PIGEIRQPNATL 194
>pdb|1CR8|A Chain A, Low Density Lipoprotein Receptor-Related Protein Complement
Repeat 8
Length = 42
Score = 31.6 bits (70), Expect = 4.3, Method: Composition-based stats.
Identities = 15/39 (38%), Positives = 23/39 (58%), Gaps = 2/39 (5%)
Query: 1566 GKCEMNSSFRCG-NGECVSIGSKCNQLVDCADGSDEKNC 1603
G C + F+C +G C+ + +C+ DC D SDEK+C
Sbjct: 2 GGCHTDE-FQCRLDGLCIPLRWRCDGDTDCMDSSDEKSC 39
Score = 30.8 bits (68), Expect = 6.2, Method: Composition-based stats.
Identities = 13/31 (41%), Positives = 20/31 (64%), Gaps = 1/31 (3%)
Query: 999 FRCG-NGECVSIGSKCNQLVDCADGSDEKNC 1028
F+C +G C+ + +C+ DC D SDEK+C
Sbjct: 9 FQCRLDGLCIPLRWRCDGDTDCMDSSDEKSC 39
>pdb|1D2L|A Chain A, Nmr Solution Structure Of Complement-Like Repeat Cr3 From
The Low Density Lipoprotein Receptor-Related Protein
(Lrp) . Evidence For Specific Binding To The Receptor
Binding Domain Of Human Alpha-2 Macroglobulin
Length = 45
Score = 31.2 bits (69), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 19/33 (57%), Gaps = 1/33 (3%)
Query: 1062 CSPGQYICPNSRVCIERTRLCDGIKDCPLGDDE 1094
C PG++ C NSR CI+ CDG DC DE
Sbjct: 6 CQPGEFACANSR-CIQERWKCDGDNDCLDNSDE 37
>pdb|2UZX|B Chain B, Structure Of The Human Receptor Tyrosine Kinase Met In
Complex With The Listeria Monocytogenes Invasion Protein
Inlb: Crystal Form I
pdb|2UZX|D Chain D, Structure Of The Human Receptor Tyrosine Kinase Met In
Complex With The Listeria Monocytogenes Invasion Protein
Inlb: Crystal Form I
pdb|2UZY|B Chain B, Structure Of The Human Receptor Tyrosine Kinase Met In
Complex With The Listeria Monocytogenes Invasion Protein
Inlb: Low Resolution, Crystal Form Ii
pdb|2UZY|D Chain D, Structure Of The Human Receptor Tyrosine Kinase Met In
Complex With The Listeria Monocytogenes Invasion Protein
Inlb: Low Resolution, Crystal Form Ii
Length = 727
Score = 31.2 bits (69), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 11/91 (12%)
Query: 1331 QDDYWVARLGTLRRGTKLPS---PYEQLRPISKIILHPQYVDAGFINDISILKMKTPFSN 1387
Q+ Y + G ++ TK+P + S+ + P +V G+ +D + +
Sbjct: 477 QNGYTLVITG--KKITKIPLNGLGCRHFQSCSQCLSAPPFVQCGWCHDKCVRSEECLSGT 534
Query: 1388 YVRPICLP-----HPNT-PLTDGTLCTVVGW 1412
+ + ICLP PN+ PL GT T+ GW
Sbjct: 535 WTQQICLPAIYKVFPNSAPLEGGTRLTICGW 565
>pdb|3TPB|A Chain A, Structure Of Hipa(S150a)
Length = 440
Score = 31.2 bits (69), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 21/72 (29%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 544 GNLDEVLKAYKANRTMSSIQKKNDFVSSETAFNGDLAIMESSNEY-------QYAHTIRT 596
L+EVL AYKA+ + I+++NDF + A++ N++ H I+
Sbjct: 123 ARLEEVLTAYKADIPLGMIREENDFRIAVAGAQEKTALLRIGNDWCIPKGITPTTHIIKL 182
Query: 597 P-GNRHSPVVTL 607
P G P TL
Sbjct: 183 PIGEIRQPNATL 194
>pdb|1FAX|L Chain L, Coagulation Factor Xa Inhibitor Complex
Length = 96
Score = 30.8 bits (68), Expect = 6.9, Method: Composition-based stats.
Identities = 22/75 (29%), Positives = 32/75 (42%), Gaps = 11/75 (14%)
Query: 1011 SKCNQLVDCADGSDEKNCSCADFLKS---QFLTRKIC---DGIIDCWDFSDEYECE---W 1061
S C C DG E C+C + + + TRK+C +G DC F E +
Sbjct: 10 SPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNG--DCDQFCHEEQASVVCS 67
Query: 1062 CSPGQYICPNSRVCI 1076
C+ G + N + CI
Sbjct: 68 CARGYTLADNGKACI 82
>pdb|2AD1|A Chain A, Human Sulfotransferase Sult1c2
pdb|2GWH|A Chain A, Human Sulfotranferase Sult1c2 In Complex With Pap And
Pentachlorophenol
pdb|2GWH|B Chain B, Human Sulfotranferase Sult1c2 In Complex With Pap And
Pentachlorophenol
Length = 298
Score = 30.8 bits (68), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 19/58 (32%), Positives = 28/58 (48%), Gaps = 2/58 (3%)
Query: 756 NGTHELTVKNERTGKMAQDFLLHSNIHKMKFDRGKKDQAVNSGS--SDRMDHGRAPFV 811
N HE+ E GK D +L +H FD K++ N S ++ MDH +PF+
Sbjct: 202 NPKHEIQKLAEFIGKKLDDKVLDKIVHYTSFDVMKQNPMANYSSIPAEIMDHSISPFM 259
>pdb|1K7B|A Chain A, Nmr Solution Structure Of Stva47, The Viral-Binding Domain
Of Tva
Length = 47
Score = 30.8 bits (68), Expect = 7.2, Method: Composition-based stats.
Identities = 17/40 (42%), Positives = 20/40 (50%), Gaps = 4/40 (10%)
Query: 1062 CSPGQYIC---PNSR-VCIERTRLCDGIKDCPLGDDEKQC 1097
C PGQ+ C P + C + LCDG DC G DE C
Sbjct: 7 CPPGQFRCSEPPGAHGECYPQDWLCDGHPDCDDGRDEWGC 46
>pdb|2JM4|A Chain A, The Solution Nmr Structure Of The Relaxin (Rxfp1) Receptor
Ldla Module
Length = 43
Score = 30.4 bits (67), Expect = 8.3, Method: Composition-based stats.
Identities = 13/36 (36%), Positives = 18/36 (50%)
Query: 1062 CSPGQYICPNSRVCIERTRLCDGIKDCPLGDDEKQC 1097
CS G + C N C+ + C+G+ DC DE C
Sbjct: 7 CSLGYFPCGNITKCLPQLLHCNGVDDCGNQADEDNC 42
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.316 0.132 0.395
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 46,607,385
Number of Sequences: 62578
Number of extensions: 1926535
Number of successful extensions: 6135
Number of sequences better than 100.0: 411
Number of HSP's better than 100.0 without gapping: 366
Number of HSP's successfully gapped in prelim test: 45
Number of HSP's that attempted gapping in prelim test: 4172
Number of HSP's gapped (non-prelim): 623
length of query: 1634
length of database: 14,973,337
effective HSP length: 112
effective length of query: 1522
effective length of database: 7,964,601
effective search space: 12122122722
effective search space used: 12122122722
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 58 (26.9 bits)